Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 1183 articles:
HTML format
Text format



Single Articles


    December 2018
  1. HANSON CM, Mirza I, Kumapley R, Ogbuanu I, et al
    Response to comments on "Enhancing immunization during second year of life by reducing missed opportunities for vaccinations in 46 countries".
    Vaccine. 2018;36:7908.
    PubMed     Text format    


  2. THYSEN SM, Fisker AB
    Reducing missed opportunities for vaccinations should be done with eyes wide open.
    Vaccine. 2018;36:7907.
    PubMed     Text format    


    November 2018
  3. SHIBLI R, Rishpon S, Cohen-Dar M, Kandlik Y, et al
    What affects pediatric healthcare providers to encourage receipt of routine childhood vaccinations? Results from the Northern District of Israel, 2016.
    Vaccine. 2018 Nov 30. pii: S0264-410X(18)31576.
    PubMed     Text format     Abstract available


  4. CIRUELA P, Izquierdo C, Broner S, Munoz-Almagro C, et al
    The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage.
    Vaccine. 2018;36:7744-7752.
    PubMed     Text format     Abstract available


  5. BRESEE JS, McKinlay MA, Abramson J, Klugman KP, et al
    Global Funders Consortium for Universal Influenza Vaccine Development.
    Vaccine. 2018 Nov 29. pii: S0264-410X(18)31560.
    PubMed     Text format    


  6. FREW PM, Murden R, Mehta CC, Chamberlain AT, et al
    Development of a US trust measure to assess and monitor parental confidence in the vaccine system.
    Vaccine. 2018 Nov 29. pii: S0264-410X(18)31312.
    PubMed     Text format     Abstract available


  7. NAKAYAMA T
    Causal relationship between immunological responses and adverse reactions following vaccination.
    Vaccine. 2018 Nov 29. pii: S0264-410X(18)31568.
    PubMed     Text format     Abstract available


  8. DUSZYNSKI KM, Pratt NL, Lynch JW, Berry JG, et al
    Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality. A population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and t
    Vaccine. 2018 Nov 28. pii: S0264-410X(18)31548.
    PubMed     Text format     Abstract available


  9. FLAXMAN A, Yamaguchi Y, van Diemen PM, Rollier C, et al
    Heterogeneous early immune responses to the S. aureus EapH2 antigen induced by gastrointestinal tract colonisation impact the response to subsequent vaccination.
    Vaccine. 2018 Nov 28. pii: S0264-410X(18)31588.
    PubMed     Text format     Abstract available


  10. JRADI H, Bawazir A
    Knowledge, attitudes, and practices among Saudi women regarding cervical cancer, human papillomavirus (HPV) and corresponding vaccine.
    Vaccine. 2018 Nov 28. pii: S0264-410X(18)31590.
    PubMed     Text format     Abstract available


  11. FABER MT, Duun-Henriksen AK, Dehlendorff C, Tatla MK, et al
    Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy.
    Vaccine. 2018 Nov 28. pii: S0264-410X(18)31553.
    PubMed     Text format     Abstract available


  12. LANGEDIJK AC, van Aalst M, Meek B, van Leeuwen EMM, et al
    Long-term pneumococcal vaccine immunogenicity following allogeneic hematopoietic stem cell transplantation.
    Vaccine. 2018 Nov 27. pii: S0264-410X(18)31578.
    PubMed     Text format     Abstract available


  13. DAWA J, Chaves SS, Ba Nguz A, Kalani R, et al
    Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG).
    Vaccine. 2018 Nov 27. pii: S0264-410X(18)31587.
    PubMed     Text format     Abstract available


  14. JEONG JH, Kim EH, Lloren KKS, Kwon JJ, et al
    Preclinical evaluation of the efficacy of an H5N8 vaccine candidate (IDCDC-RG43A) in mouse and ferret models for pandemic preparedness.
    Vaccine. 2018 Nov 27. pii: S0264-410X(18)31589.
    PubMed     Text format     Abstract available


  15. SATZKE C, Dunne EM, Choummanivong M, Ortika BD, et al
    Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine.
    Vaccine. 2018 Nov 27. pii: S0264-410X(18)31464.
    PubMed     Text format     Abstract available


  16. ELSHINA E, Allen ER, Flaxman A, van Diemen PM, et al
    Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease.
    Vaccine. 2018 Nov 27. pii: S0264-410X(18)31559.
    PubMed     Text format     Abstract available


  17. ABI JAOUDE J, Khair D, Dagher H, Saad H, et al
    Factors associated with Human Papilloma Virus (HPV) vaccine recommendation by physicians in Lebanon, a cross-sectional study.
    Vaccine. 2018;36:7562-7567.
    PubMed     Text format     Abstract available


  18. NAPOLITANO F, Gualdieri L, Santagati G, Angelillo IF, et al
    Knowledge and attitudes toward HPV infection and vaccination among immigrants and refugees in Italy.
    Vaccine. 2018;36:7536-7541.
    PubMed     Text format     Abstract available


  19. REN S, Holliday E, Hure A, Peel R, et al
    Pneumococcal polysaccharide vaccine associated with reduced lengths of stay for cardiovascular events hospital admissions: Experience from the Hunter Community Study.
    Vaccine. 2018;36:7520-7524.
    PubMed     Text format     Abstract available


  20. PASTOR Y, Camacho AI, Zuniga-Ripa A, Merchan A, et al
    Towards a subunit vaccine from a Shigella flexneri DeltatolR mutant.
    Vaccine. 2018;36:7509-7519.
    PubMed     Text format     Abstract available


  21. VAN DE BURGWAL LHM, Ribeiro CDS, Van der Waal MB, Claassen E, et al
    Towards improved process efficiency in vaccine innovation: The Vaccine Innovation Cycle as a validated, conceptual stage-gate model.
    Vaccine. 2018;36:7496-7508.
    PubMed     Text format     Abstract available


  22. PECENKA C, Debellut F, Bar-Zeev N, Anwari P, et al
    Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
    Vaccine. 2018;36:7472-7478.
    PubMed     Text format     Abstract available


  23. KARTHIGESU SP, Chisholm JS, Coall DA
    Do grandparents influence parents' decision to vaccinate their children? A systematic review.
    Vaccine. 2018;36:7456-7462.
    PubMed     Text format     Abstract available


  24. VAJO Z, Kalabay L, Vajo P, Balaton G, et al
    Licensing the first reduced, 6microg dose whole virion, aluminum adjuvanted seasonal influenza vaccine - A randomized-controlled multicenter trial.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31562.
    PubMed     Text format     Abstract available


  25. YU W, Lee LA, Liu Y, Scherpbier RW, et al
    Vaccine-preventable disease control in the People's Republic of China: 1949-2016.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31357.
    PubMed     Text format     Abstract available


  26. HEGAZY-HASSAN W, Zepeda-Escobar JA, Ochoa-Garcia L, Contreras-Ortiz JME, et al
    TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31564.
    PubMed     Text format     Abstract available


  27. KOCHHAR S, Excler JL, Bok K, Gurwith M, et al
    Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31235.
    PubMed     Text format     Abstract available


  28. QUEENAN AM, Dowling DJ, Cheng WK, Fae K, et al
    Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.
    Vaccine. 2018 Nov 23. pii: S0264-410X(18)31551.
    PubMed     Text format     Abstract available


  29. CAMPBELL ZA, Otieno L, Shirima GM, Marsh TL, et al
    Drivers of vaccination preferences to protect a low-value livestock resource: Willingness to pay for Newcastle disease vaccines by smallholder households.
    Vaccine. 2018 Nov 23. pii: S0264-410X(18)31583.
    PubMed     Text format     Abstract available


  30. MCCLURE DL, Jacobsen SJ, Klein NP, Naleway AL, et al
    Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders.
    Vaccine. 2018 Nov 23. pii: S0264-410X(18)31561.
    PubMed     Text format     Abstract available


  31. PEZZOTTI P, Bellino S, Riccardo F, Lucaroni F, et al
    Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007-2016.
    Vaccine. 2018 Nov 23. pii: S0264-410X(18)31572.
    PubMed     Text format     Abstract available


  32. MATYSIAK-KLOSE D, Santibanez S, Schwerdtfeger C, Koch J, et al
    Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany.
    Vaccine. 2018 Nov 23. pii: S0264-410X(18)31455.
    PubMed     Text format     Abstract available


  33. RIDDELL CA, Bhat N, Bont LJ, Dupont WD, et al
    Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis.
    Vaccine. 2018 Nov 22. pii: S0264-410X(18)31407.
    PubMed     Text format     Abstract available


  34. AKHTAR M, Chowdhury MI, Bhuiyan TR, Kaim J, et al
    Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELI
    Vaccine. 2018 Nov 22. pii: S0264-410X(18)31563.
    PubMed     Text format     Abstract available


  35. TARANTOLA A, Tejiokem MC, Briggs DJ
    Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31542.
    PubMed     Text format     Abstract available


  36. BOLLAERTS K, Verstraeten T, Cohet C
    Observational studies of non-specific effects of Diphtheria-Tetanus-Pertussis vaccines in low-income countries: Assessing the potential impact of study characteristics, bias and confounding through meta-regression.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31574.
    PubMed     Text format     Abstract available


  37. MCMORROW ML, Tempia S, Walaza S, Treurnicht FK, et al
    Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31573.
    PubMed     Text format     Abstract available


  38. BERNSTEIN DI, Pullum DA, Cardin RD, Bravo FJ, et al
    The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31565.
    PubMed     Text format     Abstract available


  39. VESIKARI T, Borrow R, Da Costa X, Thomas S, et al
    Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31497.
    PubMed     Text format     Abstract available


  40. STEAD M, Critchlow N, Eadie D, Sullivan F, et al
    Mandatory policies for influenza vaccination: Views of managers and healthcare workers in England.
    Vaccine. 2018 Nov 20. pii: S0264-410X(18)31556.
    PubMed     Text format     Abstract available


  41. CHEN J, Yu X, Zheng Q, Hou L, et al
    The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
    Vaccine. 2018 Nov 20. pii: S0264-410X(18)31523.
    PubMed     Text format     Abstract available


  42. KOVACS E, Sahin-Toth J, Tothpal A, Kristof K, et al
    Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary.
    Vaccine. 2018 Nov 20. pii: S0264-410X(18)31549.
    PubMed     Text format     Abstract available


  43. LOPEZ AL, Harris JB, Raguindin PF, Aldaba J, et al
    Introduction of inactivated poliovirus vaccine in the Philippines: Effect on health care provider and infant caregiver attitudes and practices.
    Vaccine. 2018;36:7399-7407.
    PubMed     Text format     Abstract available


  44. CROWCROFT NS, Klein NP
    A framework for research on vaccine effectiveness.
    Vaccine. 2018;36:7286-7293.
    PubMed     Text format     Abstract available


  45. HURLEY LP, Allison MA, Dooling KL, O'Leary ST, et al
    Primary care physicians' experience with zoster vaccine live (ZVL) and awareness and attitudes regarding the new recombinant zoster vaccine (RZV).
    Vaccine. 2018;36:7408-7414.
    PubMed     Text format     Abstract available


  46. DEMEURE CE, Derbise A, Guillas C, Gerke C, et al
    Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
    Vaccine. 2018 Nov 19. pii: S0264-410X(18)31545.
    PubMed     Text format     Abstract available


  47. DE SERRES G, Billard MN, Gariepy MC, Rouleau I, et al
    Short-term safety of 4CMenB vaccine during a mass meningococcal B vaccination campaign in Quebec, Canada.
    Vaccine. 2018 Nov 19. pii: S0264-410X(18)31492.
    PubMed     Text format     Abstract available


  48. DENG Y, Cai W, Li J, Li Y, et al
    Evaluation of the genetic stability of Sabin strains and the consistency of inactivated poliomyelitis vaccine made from Sabin strains using direct deep-sequencing.
    Vaccine. 2018 Nov 19. pii: S0264-410X(18)31543.
    PubMed     Text format     Abstract available


  49. DIAMOS AG, Larios D, Brown L, Kilbourne J, et al
    Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen.
    Vaccine. 2018 Nov 17. pii: S0264-410X(18)31544.
    PubMed     Text format     Abstract available


  50. SEPPALA EM, Lopez-Perea N, Torres de Mier MV, Echevarria JE, et al
    Last cases of rubella and congenital rubella syndrome in Spain, 1997-2016: The success of a vaccination program.
    Vaccine. 2018 Nov 16. pii: S0264-410X(18)31539.
    PubMed     Text format     Abstract available


  51. TUCKERMAN J, Misan S, Salih S, Joseph Xavier B, et al
    Influenza vaccination: Uptake and associations in a cross-sectional study of children with special risk medical conditions.
    Vaccine. 2018 Nov 16. pii: S0264-410X(18)31299.
    PubMed     Text format     Abstract available


  52. DONG B, Wang L, Nie S, Li X, et al
    Anti-glioma effect of intracranial vaccination with tumor cell lysate plus flagellin in mice.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)30550.
    PubMed     Text format     Abstract available


  53. NAGASHIMA S, Yamamoto C, Ko K, Chuon C, et al
    Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31541.
    PubMed     Text format     Abstract available


  54. MILLIGAN GN, Schnierle BS, McAuley AJ, Beasley DWC, et al
    Defining a correlate of protection for chikungunya virus vaccines.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31399.
    PubMed     Text format     Abstract available


  55. BIELECKI K, Kirolos A, Willocks LJ, Pollock KG, et al
    Low uptake of nasal influenza vaccine in polish and other ethnic minority children in Edinburgh, Scotland.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31552.
    PubMed     Text format     Abstract available


  56. ESPOSITO D, Titievsky L, Beachler DC, Hawes JCL, et al
    Incidence of outcomes relevant to vaccine safety monitoring in a US commercially-insured population.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31418.
    PubMed     Text format     Abstract available


  57. KUROVA N, Timofeeva EV, Guiso N, Macina D, et al
    A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31516.
    PubMed     Text format     Abstract available


  58. YUE X, Black CL, Williams WW, Lu PJ, et al
    Influenza vaccination among adults living with persons at high-risk for complications from influenza during early 2016-17 influenza season.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31499.
    PubMed     Text format     Abstract available


  59. VALENTINI S, Santoro G, Baffetta F, Franceschi S, et al
    Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31469.
    PubMed     Text format     Abstract available


  60. KAHN KE, Santibanez TA, Zhai Y, Bridges CB, et al
    Association between patient reminders and influenza vaccination status among children.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31395.
    PubMed     Text format     Abstract available


  61. BACCI JL, Hansen R, Ree C, Reynolds MJ, et al
    The effects of vaccination forecasts and value-based payment on adult immunizations by community pharmacists.
    Vaccine. 2018 Nov 13. pii: S0264-410X(18)31540.
    PubMed     Text format     Abstract available


  62. PAN WK, Seidman JC, Ali A, Hoest C, et al
    Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.
    Vaccine. 2018 Nov 12. pii: S0264-410X(18)30746.
    PubMed     Text format     Abstract available



  63. Dengue vaccine: WHO position paper, September 2018 - Recommendations.
    Vaccine. 2018 Nov 10. pii: S0264-410X(18)31339.
    PubMed     Text format     Abstract available


  64. SHANG M, Chung JR, Jackson ML, Jackson LA, et al
    Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016.
    Vaccine. 2018 Nov 9. pii: S0264-410X(18)31490.
    PubMed     Text format     Abstract available


  65. HUANG H, Gao P, Gao Z, Wang L, et al
    A big pertussis outbreak in a primary school with high vaccination coverage in northern China: An evidence of the emerging of the disease in China.
    Vaccine. 2018 Nov 9. pii: S0264-410X(18)31518.
    PubMed     Text format     Abstract available


  66. CHEN S, Lin F, Chen S, Hu Q, et al
    Development of a live attenuated vaccine against Muscovy duck reovirus infection.
    Vaccine. 2018 Nov 9. pii: S0264-410X(18)31502.
    PubMed     Text format     Abstract available


  67. RATHI N, Desai S, Kawade A, Venkatramanan P, et al
    A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
    Vaccine. 2018 Nov 9. pii: S0264-410X(18)31515.
    PubMed     Text format     Abstract available


  68. HOEVE CE, van Haren A, Sturkenboom MCJM, Straus SMJM, et al
    Spontaneous reports of vaccination errors in the European regulatory database EudraVigilance: A descriptive study.
    Vaccine. 2018 Nov 8. pii: S0264-410X(18)31501.
    PubMed     Text format     Abstract available


  69. MUNOZ FM, Jackson LA, Swamy GK, Edwards KM, et al
    Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.
    Vaccine. 2018 Nov 8. pii: S0264-410X(18)31475.
    PubMed     Text format     Abstract available


  70. ADETIFA IMO, Karia B, Mutuku A, Bwanaali T, et al
    Coverage and timeliness of vaccination and the validity of routine estimates: Insights from a vaccine registry in Kenya.
    Vaccine. 2018 Nov 8. pii: S0264-410X(18)31504.
    PubMed     Text format     Abstract available


  71. MACIAS PARRA M, Gentile A, Vazquez Narvaez JA, Capdevila A, et al
    Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants: A phase 3b, randomized controlled trial.
    Vaccine. 2018 Nov 7. pii: S0264-410X(18)31493.
    PubMed     Text format     Abstract available


  72. BURNETT E, Van Trang N, Rayamajhi A, Yousafzai MT, et al
    Preparing for safety monitoring after rotavirus vaccine introduction - Assessment of baseline epidemiology of intussusception among children <2years of age in four Asian countries.
    Vaccine. 2018 Nov 7. pii: S0264-410X(18)31500.
    PubMed     Text format     Abstract available


  73. WOOD ME, Griebel P, Huizenga ML, Lockwood S, et al
    Accelerated onset of chronic wasting disease in elk (Cervus canadensis) vaccinated with a PrP(Sc)-specific vaccine and housed in a prion contaminated environment.
    Vaccine. 2018 Nov 7. pii: S0264-410X(18)31425.
    PubMed     Text format     Abstract available


  74. WILCOX CR, Bottrell K, Paterson P, Schulz WS, et al
    Influenza and pertussis vaccination in pregnancy: Portrayal in online media articles and perceptions of pregnant women and healthcare professionals.
    Vaccine. 2018 Nov 3. pii: S0264-410X(18)31489.
    PubMed     Text format     Abstract available


  75. WANG X, Li M, Lin Z, Pan H, et al
    Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine.
    Vaccine. 2018 Nov 2. pii: S0264-410X(18)31486.
    PubMed     Text format     Abstract available


  76. HAATVEIT HM, Hodneland K, Braaen S, Hansen EF, et al
    DNA vaccine expressing the non-structural proteins of Piscine orthoreovirus delay the kinetics of PRV infection and induces moderate protection against heart -and skeletal muscle inflammation in Atlantic salmon (Salmo salar).
    Vaccine. 2018 Nov 2. pii: S0264-410X(18)31491.
    PubMed     Text format     Abstract available


  77. POLLOCK KG, Tait B, Tait J, Bielecki K, et al
    Evidence of decreased HPV vaccine acceptance in Polish communities within Scotland.
    Vaccine. 2018 Nov 2. pii: S0264-410X(18)31494.
    PubMed     Text format     Abstract available


  78. DESAI S, Schanzer DL, Silva A, Rotondo J, et al
    Trends in Canadian infant pertussis hospitalizations in the pre- and post-acellular vaccine era, 1981-2016.
    Vaccine. 2018 Nov 1. pii: S0264-410X(18)31413.
    PubMed     Text format     Abstract available


  79. TRUMBO SP, Silver D, Domenti O, Gasoyan H, et al
    Strengthening legal frameworks for vaccination: The experiences of Armenia, Georgia, and Moldova.
    Vaccine. 2018 Nov 1. pii: S0264-410X(18)31454.
    PubMed     Text format     Abstract available


    October 2018
  80. BOCQUIER A, Fressard L, Cortaredona S, Zaytseva A, et al
    Social differentiation of vaccine hesitancy among French parents and the mediating role of trust and commitment to health: A nationwide cross-sectional study.
    Vaccine. 2018 Oct 31. pii: S0264-410X(18)31472.
    PubMed     Text format     Abstract available


  81. YANG X, Zhang D, Ou W
    Pneumococcal vaccination patterns among persons aged 65years or older in the United States: A retrospective database analysis.
    Vaccine. 2018 Oct 31. pii: S0264-410X(18)31367.
    PubMed     Text format     Abstract available


  82. SHEDRAWY J, Henriksson M, Hergens MP, Askling HH, et al
    Estimating costs and health outcomes of publicly funded tick-born encephalitis vaccination: A cost-effectiveness analysis.
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31473.
    PubMed     Text format     Abstract available


  83. GILBERT BE, Patel N, Lu H, Liu Y, et al
    Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31458.
    PubMed     Text format     Abstract available


  84. MARTIRE B, Azzari C, Badolato R, Canessa C, et al
    Corrigendum to: "Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET)" [Vaccine 36 (2018) Pages 3541-3542].
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31424.
    PubMed     Text format    


  85. AHMED N, Quinn SC, Hancock GR, Freimuth VS, et al
    Social media use and influenza vaccine uptake among White and African American adults.
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31415.
    PubMed     Text format     Abstract available


  86. WILLAME C, Lin L, Vetter V, Baril L, et al
    Reply to Lee et al.'s letter to the editor pertaining to our publication entitled "Pain caused by measles, mumps, and rubella vaccines: A systematic literature review".
    Vaccine. 2018;36:6589-6590.
    PubMed     Text format    


  87. LEE AW, Saldutti LP, Wolfson LJ, Stek JE, et al
    To the editor: Response to Willame, et al., published in Vaccine 35 (2017) 5551-5558, entitled "Pain caused by measles, mumps, and rubella vaccines: A systematic literature review".
    Vaccine. 2018;36:6587-6588.
    PubMed     Text format    


  88. DATEY A, Shreenivas M, Chandrasekharan G, Joseph J, et al
    Rewiring of one carbon metabolism in Salmonella serves as an excellent live vaccine against systemic salmonellosis.
    Vaccine. 2018 Oct 29. pii: S0264-410X(18)31466.
    PubMed     Text format     Abstract available


  89. ARAUJO IL, Dummer LA, Rodrigues PRC, Dos Santos AG Jr, et al
    Immune responses in bovines to recombinant glycoprotein D of bovine herpesvirus type 5 as vaccine antigen.
    Vaccine. 2018 Oct 28. pii: S0264-410X(18)31467.
    PubMed     Text format     Abstract available


  90. MOSAHEB M, Wetzler LM
    Meningococcal PorB induces a robust and diverse antigen specific T cell response as a vaccine adjuvant.
    Vaccine. 2018 Oct 28. pii: S0264-410X(18)31459.
    PubMed     Text format     Abstract available


  91. SCHURINK-VAN 'T KLOOSTER TM, Donken R, Schepp RM, van der Klis FRM, et al
    Persistence of immune response following bivalent HPV vaccination: A follow-up study among girls routinely vaccinated with a two-dose schedule.
    Vaccine. 2018 Oct 27. pii: S0264-410X(18)31370.
    PubMed     Text format     Abstract available


  92. BOIGARD H, Cimica V, Galarza JM
    Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature.
    Vaccine. 2018 Oct 27. pii: S0264-410X(18)31457.
    PubMed     Text format     Abstract available


  93. HIRTH J, McGrath CJ, Kuo YF, Rupp RE, et al
    Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26year old females in the U.S.
    Vaccine. 2018 Oct 27. pii: S0264-410X(18)31462.
    PubMed     Text format     Abstract available


  94. PERCIACCANTE A, Coralli A, Bianucci R
    Vaccines: The oxymoron of Italian health policy.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31404.
    PubMed     Text format    


  95. BERKLEY S
    Political will and vaccine legislation.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31402.
    PubMed     Text format    


  96. LOVRIC MAKARIC Z, Kolaric B, Tomljenovic M, Posavec M, et al
    Attitudes and beliefs related to childhood vaccinations among parents of 6years old children in Zagreb, Croatia.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31421.
    PubMed     Text format     Abstract available


  97. IKILEZI G, Zlavog B, Augusto OJ, Sherr K, et al
    Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31430.
    PubMed     Text format     Abstract available


  98. CALO WA, Gilkey MB, Malo TL, Robichaud M, et al
    A content analysis of HPV vaccination messages available online.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31419.
    PubMed     Text format     Abstract available


  99. BEKKAT-BERKANI R, Romano-Mazzotti L
    Understanding the unique characteristics of seasonal influenza illness to improve vaccine uptake in the US.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31393.
    PubMed     Text format     Abstract available


  100. ZHANG H, Wen W, Zhao Z, Wang J, et al
    Enhanced protective immunity to CSFV E2 subunit vaccine by using IFN-gamma as immunoadjuvant in weaning piglets.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31396.
    PubMed     Text format     Abstract available


  101. GAGNEUR A, Gosselin V, Dube E
    Motivational interviewing: A promising tool to address vaccine hesitancy.
    Vaccine. 2018;36:6553-6555.
    PubMed     Text format    


  102. ZHAI Y, Santibanez TA, Kahn KE, Black CL, et al
    Paid sick leave benefits, influenza vaccination, and taking sick days due to influenza-like illness among U.S. workers.
    Vaccine. 2018 Oct 22. pii: S0264-410X(18)31405.
    PubMed     Text format     Abstract available


  103. LOEB M, Russell ML, Neupane B, Thanabalan V, et al
    A randomized, blinded, placebo-controlled trial comparing antibody responses to homeopathic and conventional vaccines in university students.
    Vaccine. 2018 Oct 20. pii: S0264-410X(18)31232.
    PubMed     Text format     Abstract available


  104. HEINSBROEK E, Tafatatha T, Phiri A, Swarthout TD, et al
    Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination.
    Vaccine. 2018 Oct 20. pii: S0264-410X(18)31387.
    PubMed     Text format     Abstract available


  105. WANG Q, Yue N, Zheng M, Wang D, et al
    Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31411.
    PubMed     Text format     Abstract available


  106. D'ALESSIO F, Koopman G, Houard S, Remarque EJ, et al
    Workshop report: Experimental animal models for universal influenza vaccines.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31390.
    PubMed     Text format     Abstract available


  107. THOMAS LF, Bellet C, Rushton J
    Using economic and social data to improve veterinary vaccine development: Learning lessons from human vaccinology.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31410.
    PubMed     Text format     Abstract available


  108. MCGAVIN ZA, Wagner AL, Carlson BF, Power LE, et al
    Childhood full and under-vaccination in Nigeria, 2013.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31409.
    PubMed     Text format     Abstract available


  109. ZHANG L, Durr E, Galli JD, Cosmi S, et al
    Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31398.
    PubMed     Text format     Abstract available


  110. SANTIBANEZ TA, Kahn KE, Bridges CB
    Do parents prefer inactivated or live attenuated influenza vaccine for their children?
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31408.
    PubMed     Text format     Abstract available


  111. CANNON JW, Jack S, Wu Y, Zhang J, et al
    An economic case for a vaccine to prevent group A streptococcus skin infections.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31352.
    PubMed     Text format     Abstract available


  112. CHIDO-AMAJUOYI OG, Wonodi C, Mantey D, Perez A, et al
    Prevalence and correlates of never vaccinated Nigerian children, aged 1-5years.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31358.
    PubMed     Text format     Abstract available


  113. HRABER P, Bradfute S, Clarke E, Ye C, et al
    Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31388.
    PubMed     Text format     Abstract available


  114. SALAT J, Formanova P, Hunady M, Eyer L, et al
    Development and testing of a new tick-borne encephalitis virus vaccine candidate for veterinary use.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31400.
    PubMed     Text format     Abstract available


  115. THANG HV, Huong VM, Victor JC, Van CB, et al
    Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31365.
    PubMed     Text format     Abstract available


  116. ATTWELL K, Navin MC, Lopalco PL, Jestin C, et al
    Recent vaccine mandates in the United States, Europe and Australia: A comparative study.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31371.
    PubMed     Text format     Abstract available


  117. TOKARS JI, Rolfes MA, Foppa IM, Reed C, et al
    An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States.
    Vaccine. 2018 Oct 13. pii: S0264-410X(18)31392.
    PubMed     Text format     Abstract available


  118. BARRERA J, Brake DA, Schutta C, Ettyreddy D, et al
    Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Vaccine. 2018 Oct 13. pii: S0264-410X(18)31397.
    PubMed     Text format     Abstract available


  119. NUGENT G, Yockney IJ, Cross ML, Buddle BM, et al
    Low-dose BCG vaccination protects free-ranging cattle against naturally-acquired bovine tuberculosis.
    Vaccine. 2018 Oct 13. pii: S0264-410X(18)31391.
    PubMed     Text format     Abstract available


  120. YEOLEKAR LR, Ganguly M, Tyagi P, Ingle NB, et al
    Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
    Vaccine. 2018 Oct 12. pii: S0264-410X(18)31354.
    PubMed     Text format     Abstract available


  121. GERRETSEN HE, Capone S, Vitelli A, Reyes LS, et al
    Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection.
    Vaccine. 2018 Oct 11. pii: S0264-410X(18)31351.
    PubMed     Text format     Abstract available


  122. SASAKI E, Momose H, Hiradate Y, Mizukami T, et al
    Establishment of a novel safety assessment method for vaccine adjuvant development.
    Vaccine. 2018 Oct 11. pii: S0264-410X(18)31361.
    PubMed     Text format     Abstract available


  123. PIRCON JY, Talarico CA, Bollaerts K, Hausdorff WP, et al
    The choice of analytical methodology can alter conclusions regarding herd effects of paediatric pneumococcal vaccination programmes.
    Vaccine. 2018 Oct 10. pii: S0264-410X(18)31355.
    PubMed     Text format     Abstract available


  124. ZHANG Z, Dong Z, Wang Q, Carr MJ, et al
    Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.
    Vaccine. 2018 Oct 10. pii: S0264-410X(18)31350.
    PubMed     Text format     Abstract available


  125. GILCA V, Sauvageau C, Panicker G, De Serres G, et al
    Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - A randomized clinical trial.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31326.
    PubMed     Text format     Abstract available


  126. ODEVALL L, Hong D, Digilio L, Sahastrabuddhe S, et al
    The Euvichol story - Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31276.
    PubMed     Text format     Abstract available


  127. SCHAEFERS MM, Duan B, Mizrahi B, Lu R, et al
    PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31362.
    PubMed     Text format     Abstract available


  128. BOCKSTAL V, Tiemessen MM, Achterberg R, Van Wordragen C, et al
    An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6(R) cell culture platform is immunogenic and safe in a non-human primate model.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31349.
    PubMed     Text format     Abstract available


  129. CHANGALUCHA J, Steenson R, Grieve E, Cleaveland S, et al
    The need to improve access to rabies post-exposure vaccines: Lessons from Tanzania.
    Vaccine. 2018 Oct 8. pii: S0264-410X(18)31243.
    PubMed     Text format     Abstract available


  130. WUTZLER P, Casabona G, Cnops J, Akpo EIH, et al
    Herpes zoster in the context of varicella vaccination - An equation with several variables.
    Vaccine. 2018 Oct 8. pii: S0264-410X(18)31262.
    PubMed     Text format     Abstract available


  131. AKSULAR M, Calvo-Pinilla E, Marin-Lopez A, Ortego J, et al
    A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model.
    Vaccine. 2018 Oct 8. pii: S0264-410X(18)31341.
    PubMed     Text format     Abstract available


  132. LEE VY, Booy R, Skinner SR, Fong J, et al
    The effect of exercise on local and systemic adverse reactions after vaccinations - Outcomes of two randomized controlled trials.
    Vaccine. 2018 Oct 6. pii: S0264-410X(18)31345.
    PubMed     Text format     Abstract available


  133. ABEBE A, Getahun M, Mapaseka SL, Beyene B, et al
    Impact of rotavirus vaccine introduction and genotypic characteristics of rotavirus strains in children less than 5years of age with gastroenteritis in Ethiopia: 2011-2016.
    Vaccine. 2018 Oct 6. pii: S0264-410X(18)31317.
    PubMed     Text format     Abstract available


  134. MUGO NR, Eckert L, Magaret AS, Cheng A, et al
    Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status.
    Vaccine. 2018 Oct 5. pii: S0264-410X(18)31328.
    PubMed     Text format     Abstract available


  135. GROMIS A, Liu K
    The roles of neighborhood composition and autism prevalence on vaccination exemption pockets: A population-wide study.
    Vaccine. 2018 Oct 5. pii: S0264-410X(18)31298.
    PubMed     Text format     Abstract available


  136. IBRAHIM R, Ali SA, Kazi AM, Rizvi A, et al
    Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting.
    Vaccine. 2018 Oct 5. pii: S0264-410X(18)31314.
    PubMed     Text format     Abstract available


  137. BARTSCH SM, Taitel MS, DePasse JV, Cox SN, et al
    Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
    Vaccine. 2018 Oct 5. pii: S0264-410X(18)31300.
    PubMed     Text format     Abstract available


  138. HUNGERFORD D, Vivancos R, Read JM, Bonnett LJ, et al
    Mitigating bias in observational vaccine effectiveness studies using simulated comparator populations: Application to rotavirus vaccination in the UK.
    Vaccine. 2018 Oct 4. pii: S0264-410X(18)31320.
    PubMed     Text format     Abstract available


  139. TIFREA DF, Pal S, Le Bon C, Giusti F, et al
    Co-delivery of amphipol-conjugated adjuvant with antigen, and adjuvant combinations, enhance immune protection elicited by a membrane protein-based vaccine against a mucosal challenge with Chlamydia.
    Vaccine. 2018 Oct 4. pii: S0264-410X(18)31324.
    PubMed     Text format     Abstract available


  140. SALMONS B, Lim PY, Djurup R, Cardosa J, et al
    Non-clinical safety assessment of repeated intramuscular administration of an EV-A71 VLP vaccine in rabbits.
    Vaccine. 2018 Oct 4. pii: S0264-410X(18)31331.
    PubMed     Text format     Abstract available


  141. MUKERJI R, Hendrickson C, Genschmer KR, Park SS, et al
    The diversity of the proline-rich domain of pneumococcal surface protein A (PspA): Potential relevance to a broad-spectrum vaccine.
    Vaccine. 2018 Oct 4. pii: S0264-410X(18)31174.
    PubMed     Text format     Abstract available


  142. TSUZUKI S, Schwehm M, Eichner M
    Corrigendum to "Simulation studies to assess the long-term effects of Japan's change from trivalent to quadrivalent influenza vaccination" [Vaccine 36 (2018) 624-630].
    Vaccine. 2018 Oct 3. pii: S0264-410X(18)31315.
    PubMed     Text format    


  143. ROBISON SG, Thomas AR
    Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design.
    Vaccine. 2018 Oct 1. pii: S0264-410X(18)31319.
    PubMed     Text format     Abstract available


  144. ZHANG C, Huang X, Chen S, Li Y, et al
    Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid.
    Vaccine. 2018 Oct 1. pii: S0264-410X(18)31295.
    PubMed     Text format     Abstract available


    September 2018
  145. BORG K, Sutton K, Beasley M, Tull F, et al
    Communication-based interventions for increasing influenza vaccination rates among Aboriginal children: A randomised controlled trial.
    Vaccine. 2018 Sep 29. pii: S0264-410X(18)31269.
    PubMed     Text format     Abstract available


  146. GORDON CL, Hutchings CL, Highton AJ, Colston JM, et al
    Memory inflation following adenoviral vaccination depends on IL-21.
    Vaccine. 2018 Sep 29. pii: S0264-410X(18)31330.
    PubMed     Text format     Abstract available


  147. MIYAMOTO N, Mochizuki S, Kobiyama K, Ishii KJ, et al
    Corrigendum to "Designing an immunocyte-targeting delivery system by use of beta-glucan" [Vaccine 36 (2018) 186-189].
    Vaccine. 2018 Sep 29. pii: S0264-410X(18)31316.
    PubMed     Text format    


  148. HAYASHI T, Lynch HE, Geyer S, Yoshida K, et al
    Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort.
    Vaccine. 2018 Sep 28. pii: S0264-410X(18)31323.
    PubMed     Text format     Abstract available


  149. HAN Y, Peng X, Li K, Jiang X, et al
    Potent effect of KISS1-54 DNA vaccine compared with KISS1-10 DNA vaccine in inhibiting the fertility of female rats.
    Vaccine. 2018 Sep 28. pii: S0264-410X(18)31322.
    PubMed     Text format     Abstract available


  150. FERLITO C, Biselli R, Mariotti S, von Hunolstein C, et al
    Tetanus-diphtheria vaccination in adults: the long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1 *01.
    Vaccine. 2018 Sep 27. pii: S0264-410X(18)31301.
    PubMed     Text format     Abstract available


  151. LAIRD RM, Ma Z, Dorabawila N, Pequegnat B, et al
    Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella.
    Vaccine. 2018 Sep 27. pii: S0264-410X(18)31321.
    PubMed     Text format     Abstract available


  152. HARRIS SL, Tan C, Andrew L, Hao L, et al
    The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci.
    Vaccine. 2018 Sep 27. pii: S0264-410X(18)30747.
    PubMed     Text format     Abstract available


  153. KIELY M, Billard MN, Toth E, Zafack JG, et al
    Investigation of an increase in large local reactions following vaccine schedule change to include DTaP-HB-IPV-Hib (Infanrix-hexa(R)) and MMRV (ProQuad(R)) at 18months of age.
    Vaccine. 2018 Sep 27. pii: S0264-410X(18)31318.
    PubMed     Text format     Abstract available


  154. SCHNEIDER K, Gronhoj C, Hahn CH, von Buchwald C, et al
    Therapeutic human papillomavirus vaccines in head and neck cancer: A systematic review of current clinical trials.
    Vaccine. 2018 Sep 26. pii: S0264-410X(18)31277.
    PubMed     Text format     Abstract available


  155. TENG Z, Sun S, Chen H, Huang J, et al
    Golden-star nanoparticles as adjuvant effectively promotes immune response to foot-and-mouth disease virus-like particles vaccine.
    Vaccine. 2018 Sep 26. pii: S0264-410X(18)31290.
    PubMed     Text format     Abstract available


  156. GOLDFARB IT, Jaffe E, James K, Drapkin Lyerly A, et al
    Pregnant women's attitudes toward Zika virus vaccine trial participation.
    Vaccine. 2018 Sep 26. pii: S0264-410X(18)31311.
    PubMed     Text format     Abstract available


  157. JUAN-GINER A, Tchaton M, Jemmy JP, Soumah A, et al
    Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline workers in Guinea.
    Vaccine. 2018 Sep 25. pii: S0264-410X(18)31246.
    PubMed     Text format     Abstract available


  158. SAYEDAHMED EE, Kumari R, Shukla S, Hassan AO, et al
    Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy.
    Vaccine. 2018 Sep 25. pii: S0264-410X(18)31291.
    PubMed     Text format     Abstract available


  159. DOKE K, Fitzgerald SA, Barral RL, Griffin P, et al
    Concomitant HPV and MenACWY vaccination among sixth and seventh graders receiving Tdap.
    Vaccine. 2018 Sep 25. pii: S0264-410X(18)31216.
    PubMed     Text format     Abstract available


  160. STUURMAN AL, Riera M, Lamprianou S, Perez-Vilar S, et al
    Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment.
    Vaccine. 2018 Sep 25. pii: S0264-410X(18)31293.
    PubMed     Text format     Abstract available


  161. TILEY KS, White JM, Andrews N, Ramsay M, et al
    Inequalities in childhood vaccination timing and completion in London.
    Vaccine. 2018 Sep 25. pii: S0264-410X(18)31292.
    PubMed     Text format     Abstract available


  162. BURKHARDT M, Reiter K, Nguyen V, Suzuki M, et al
    Assessment of the impact of manufacturing changes on the physicochemical properties of the recombinant vaccine carrier ExoProtein A.
    Vaccine. 2018 Sep 24. pii: S0264-410X(18)31297.
    PubMed     Text format     Abstract available


  163. WANG Y, Resch T, Esona MD, Moon SS, et al
    A DS-1 like G9P[6] human strain CDC-6 as a new rotavirus vaccine candidate.
    Vaccine. 2018 Sep 24. pii: S0264-410X(18)31184.
    PubMed     Text format     Abstract available


  164. MCCOY JD, Painter JE, Jacobsen KH
    Perceptions of vaccination within a Christian homeschooling community in Pennsylvania.
    Vaccine. 2018 Sep 22. pii: S0264-410X(18)31296.
    PubMed     Text format     Abstract available


  165. CHU K, Ying Z, Wang L, Hu Y, et al
    Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: A phase II, randomized, dose-finding trial.
    Vaccine. 2018 Sep 21. pii: S0264-410X(18)31272.
    PubMed     Text format     Abstract available


  166. GREENBERG D, Hoover PA, Vesikari T, Peltier C, et al
    Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.
    Vaccine. 2018 Sep 20. pii: S0264-410X(18)30323.
    PubMed     Text format     Abstract available


  167. FISCHER T, Spohn M, Olearo F, Zinser ME, et al
    Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOV.
    Vaccine. 2018 Sep 20. pii: S0264-410X(18)31265.
    PubMed     Text format     Abstract available


  168. HENRY O, Brzostek J, Czajka H, Leviniene G, et al
    Corrigendum to "One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life" [Vaccine 36 (2018) 381-387].
    Vaccine. 2018 Sep 20. pii: S0264-410X(18)31271.
    PubMed     Text format    


  169. SCHURINK-VAN'T KLOOSTER TM, Kemmeren JM, van der Maas NAT, van de Putte EM, et al
    No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls.
    Vaccine. 2018 Sep 19. pii: S0264-410X(18)31268.
    PubMed     Text format     Abstract available


  170. MOMOSE H, Sasaki E, Kuramitsu M, Hamaguchi I, et al
    Gene expression profiling toward the next generation safety control of influenza vaccines and adjuvants in Japan.
    Vaccine. 2018 Sep 19. pii: S0264-410X(18)31270.
    PubMed     Text format     Abstract available


  171. DEHLENDORFF C, Sparen P, Baldur-Felskov B, Herweijer E, et al
    Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.
    Vaccine. 2018 Sep 18. pii: S0264-410X(18)31258.
    PubMed     Text format     Abstract available


  172. BERTRAN K, Lee DH, Criado MF, Balzli CL, et al
    Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Vaccine. 2018 Sep 18. pii: S0264-410X(18)31264.
    PubMed     Text format     Abstract available


  173. WISE LD, Wolf JJ, Plitnick LM
    Evaluation of a 9-valent HPV vaccine in Sprague-Dawley rats: Nonclinical studies assessing general, reproductive, and developmental toxicity.
    Vaccine. 2018 Sep 17. pii: S0264-410X(18)31211.
    PubMed     Text format     Abstract available


  174. HOSSAIN A, Politi C, Mandalia N, Cohen AL, et al
    Expenditures on vaccine-preventable disease surveillance: Analysis and evaluation of comprehensive multi-year plans (cMYPs) for immunization.
    Vaccine. 2018 Sep 17. pii: S0264-410X(18)31077.
    PubMed     Text format     Abstract available


  175. EDOUARD S, Al-Tawfiq JA, Memish ZA, Yezli S, et al
    Impact of the Hajj on pneumococcal carriage and the effect of various pneumococcal vaccines.
    Vaccine. 2018 Sep 17. pii: S0264-410X(18)31266.
    PubMed     Text format     Abstract available


  176. RICHARDSON JS, Messonnier ML, Prosser LA
    Preferences for health economics presentations among vaccine policymakers and researchers.
    Vaccine. 2018 Sep 17. pii: S0264-410X(18)31178.
    PubMed     Text format     Abstract available


  177. VERMA A, Burns DL
    Improving the stability of recombinant anthrax protective antigen vaccine.
    Vaccine. 2018 Sep 15. pii: S0264-410X(18)31261.
    PubMed     Text format     Abstract available


  178. MARIA DE SOUZA MORAIS S, Ferreira Rodigues N, Ingrid Oliveira da Silva N, Aparecido Salvador E, et al
    Serum albumin nanoparticles vaccine provides protection against a lethal Pseudomonas aeruginosa challenge.
    Vaccine. 2018 Sep 15. pii: S0264-410X(18)31210.
    PubMed     Text format     Abstract available


  179. SMITH MA, Hall M, Lew JB, Canfell K, et al
    Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand.
    Vaccine. 2018 Sep 14. pii: S0264-410X(18)31202.
    PubMed     Text format     Abstract available


  180. DIALLO A, Victor JC, Feser J, Ortiz JR, et al
    Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naive children in a randomized clinical trial in rural Senegal.
    Vaccine. 2018 Sep 14. pii: S0264-410X(18)31158.
    PubMed     Text format     Abstract available


  181. TOEPP A, Larson M, Wilson G, Grinnage-Pulley T, et al
    Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosis.
    Vaccine. 2018 Sep 12. pii: S0264-410X(18)31245.
    PubMed     Text format     Abstract available


  182. MIYAZAKI A, Kandasamy S, Michael H, Langel SN, et al
    Protein deficiency reduces efficacy of oral attenuated human rotavirus vaccine in a human infant fecal microbiota transplanted gnotobiotic pig model.
    Vaccine. 2018 Sep 12. pii: S0264-410X(18)31244.
    PubMed     Text format     Abstract available


  183. FORTNER KB, Swamy GK, Broder KR, Jimenez-Truque N, et al
    Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women.
    Vaccine. 2018 Sep 12. pii: S0264-410X(18)30942.
    PubMed     Text format     Abstract available


  184. CARRELL RK, Stanton RA, Ethier SP, LaRue AC, et al
    ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen.
    Vaccine. 2018 Sep 12. pii: S0264-410X(18)31257.
    PubMed     Text format     Abstract available


  185. DENDLE C, Stuart RL, Mulley WR, Holdsworth SR, et al
    Pneumococcal vaccination in adult solid organ transplant recipients: A review of current evidence.
    Vaccine. 2018 Sep 11. pii: S0264-410X(18)31209.
    PubMed     Text format     Abstract available


  186. KHATOON N, Ojha R, Mishra A, Prajapati VK, et al
    Examination of antigenic proteins of Trypanosoma cruzi to fabricate an epitope-based subunit vaccine by exploiting epitope mapping mechanism.
    Vaccine. 2018 Sep 11. pii: S0264-410X(18)31239.
    PubMed     Text format     Abstract available


  187. CAO Z, Chen D, Yang Y, Zhang D, et al
    Effectiveness of post-exposure prophylaxis during varicella outbreaks among primary and middle school students in Shanghai: An analysis of three-year surveillance data.
    Vaccine. 2018;36:5754-5759.
    PubMed     Text format     Abstract available


  188. KHAN MN, Pryharski K, Pichichero ME
    Immunogenicity and protective efficacy of monovalent PCVs containing 22F and 33F polysaccharides in mouse models of colonization and co-infection.
    Vaccine. 2018;36:5701-5708.
    PubMed     Text format     Abstract available


  189. CHEN C, Beutels P, Wood J, Menzies R, et al
    Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.
    Vaccine. 2018 Sep 10. pii: S0264-410X(18)31234.
    PubMed     Text format     Abstract available


  190. BARTHOLOMEUS E, De Neuter N, Meysman P, Suls A, et al
    Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders.
    Vaccine. 2018 Sep 8. pii: S0264-410X(18)31236.
    PubMed     Text format     Abstract available


  191. THOMSON A, Vallee-Tourangeau G, Suggs LS
    Strategies to increase vaccine acceptance and uptake: From behavioral insights to context-specific, culturally-appropriate, evidence-based communications and interventions.
    Vaccine. 2018 Sep 7. pii: S0264-410X(18)31140.
    PubMed     Text format    


  192. ULENDORF JACOBSEN S, Valentiner-Branth P, Molbak K
    Examining determinants for reporting suspected adverse events following HPV vaccination in Denmark.
    Vaccine. 2018 Sep 7. pii: S0264-410X(18)31190.
    PubMed     Text format     Abstract available


  193. ZHANG C, Li LH, Wang J, Zhao Z, et al
    Enhanced protective immunity against spring viremia of carp virus infection can be induced by recombinant subunit vaccine conjugated to single-walled carbon nanotubes.
    Vaccine. 2018 Sep 7. pii: S0264-410X(18)31110.
    PubMed     Text format     Abstract available


  194. PNIEWSKI T, Milczarek M, Wojas-Turek J, Pajtasz-Piasecka E, et al
    Plant lyophilisate carrying S-HBsAg as an oral booster vaccine against HBV.
    Vaccine. 2018 Sep 6. pii: S0264-410X(18)31241.
    PubMed     Text format     Abstract available


  195. ALBANESE GA, Lee DH, Cheng IN, Hilt DA, et al
    Biological and molecular characterization of ArkGA: A novel Arkansas serotype vaccine that is highly attenuated, efficacious, and protective against homologous challenge.
    Vaccine. 2018 Sep 6. pii: S0264-410X(18)31228.
    PubMed     Text format     Abstract available


  196. BRANDON D, Kimmel M, Kuriyakose SO, Kostanyan L, et al
    Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
    Vaccine. 2018 Sep 6. pii: S0264-410X(18)31180.
    PubMed     Text format     Abstract available


  197. PEZZOTTI P, Bellino S, Prestinaci F, Iacchini S, et al
    Reply to letters to the Editor: Bellavite P. Factors that influenced the historical trends of tetanus and diphtheria. Donzelli A, Duca P. More than 70,000 deaths prevented by vaccination against three diseases in about 75years? The estimation seems ex
    Vaccine. 2018;36:5508-5509.
    PubMed     Text format    


  198. DONZELLI A, Duca P
    More than 70,000 deaths prevented by vaccination against three diseases in about 75years? The estimation seems exaggerated.
    Vaccine. 2018;36:5507.
    PubMed     Text format    


  199. SU QD, He SH, Yi Y, Qiu F, et al
    Intranasal vaccination with ebola virus GP amino acids 258-601 protects mice against lethal challenge.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31238.
    PubMed     Text format     Abstract available


  200. MATTHEWS I, Lu X, Dawson H, Bricout H, et al
    Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31166.
    PubMed     Text format     Abstract available


  201. MUHSEN IN, Aljurf M, Wingard JR, Poland GA, et al
    Vaccinating donors for hematopoietic cell transplantation: A systematic review and future perspectives.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31173.
    PubMed     Text format     Abstract available


  202. FISKER AB, Thysen SM
    Non-live pentavalent vaccines after live measles vaccine may increase mortality.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31233.
    PubMed     Text format     Abstract available


  203. MCGRATH LJ, Layton JB, Krueger WS, Kshirsagar AV, et al
    High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010-2013.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31229.
    PubMed     Text format     Abstract available


  204. HORSINGTON J, Nfon C, Gonzales JL, Singanallur N, et al
    Protection in sheep against heterologous challenge with serotype Asia-1 foot-and-mouth disease virus using high potency vaccine.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31213.
    PubMed     Text format     Abstract available


  205. MOKADDAS EM, Shibl AM, Elgouhary A, Elsobky M, et al
    Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31076.
    PubMed     Text format     Abstract available


  206. MORGENSTERN K, Xie Y, Palladino G, Barr JR, et al
    Reference antigen-free and antibody-free LTD-IDMS assay for influenza H7N9 vaccine in vitro potency determination.
    Vaccine. 2018 Sep 4. pii: S0264-410X(18)31204.
    PubMed     Text format     Abstract available


  207. GROOM HC, Irving SA, Koppolu P, Smith N, et al
    Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study.
    Vaccine. 2018 Sep 4. pii: S0264-410X(18)31214.
    PubMed     Text format     Abstract available


  208. TAM YH, Ng TWY, Chu DKW, Fang VJ, et al
    The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17.
    Vaccine. 2018 Sep 3. pii: S0264-410X(18)31215.
    PubMed     Text format     Abstract available


  209. NZOLO D, Engo Biongo A, Kuemmerle A, Lusakibanza M, et al
    Safety profile of fractional dosing of the 17DD Yellow Fever Vaccine among males and females: Experience of a community-based pharmacovigilance in Kinshasa, DR Congo.
    Vaccine. 2018 Sep 3. pii: S0264-410X(18)31181.
    PubMed     Text format     Abstract available


  210. SOUZA CK, Rajao DS, Sandbulte MR, Lopes S, et al
    The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease.
    Vaccine. 2018 Sep 1. pii: S0264-410X(18)31212.
    PubMed     Text format     Abstract available


  211. ROOZBEHANI M, Falak R, Mohammadi M, Hemphill A, et al
    Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection.
    Vaccine. 2018 Sep 1. pii: S0264-410X(18)31208.
    PubMed     Text format     Abstract available


  212. MOMBELLI M, Rettby N, Perreau M, Pascual M, et al
    Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
    Vaccine. 2018 Sep 1. pii: S0264-410X(18)31186.
    PubMed     Text format     Abstract available


    August 2018
  213. CHIU HT, Shen LJ, Chen YC, Lin JH, et al
    Effect of statin use on the risk of medically attended acute respiratory illness among influenza vaccinated elderly.
    Vaccine. 2018 Aug 30. pii: S0264-410X(18)31206.
    PubMed     Text format     Abstract available


  214. WESTFALL J, Yates JL, Van Slyke G, Ehrbar D, et al
    Thermal stability and epitope integrity of a lyophilized ricin toxin subunit vaccine.
    Vaccine. 2018 Aug 29. pii: S0264-410X(18)31188.
    PubMed     Text format     Abstract available


  215. MOHANTY S, Leader AE, Gibeau E, Johnson C, et al
    Using Facebook to reach adolescents for human papillomavirus (HPV) vaccination.
    Vaccine. 2018 Aug 29. pii: S0264-410X(18)31189.
    PubMed     Text format     Abstract available


  216. BRUXELLE JF, Tsapis N, Hoys S, Collignon A, et al
    Protection against Clostridium difficile infection in a hamster model by oral vaccination using flagellin FliC-loaded pectin beads.
    Vaccine. 2018 Aug 29. pii: S0264-410X(18)31122.
    PubMed     Text format     Abstract available


  217. ESPOSITO S, Pugni L, Mosca F, Principi N, et al
    Rotarix(R) and RotaTeq(R) administration to preterm infants in the neonatal intensive care unit: Review of available evidence.
    Vaccine. 2018;36:5430-5434.
    PubMed     Text format     Abstract available


  218. VILCA LM, Esposito S
    The crucial role of maternal care providers as vaccinators for pregnant women.
    Vaccine. 2018;36:5379-5384.
    PubMed     Text format     Abstract available


  219. BONANNI P, Bonaccorsi G, Lorini C, Santomauro F, et al
    Focusing on the implementation of 21st century vaccines for adults.
    Vaccine. 2018;36:5358-5365.
    PubMed     Text format     Abstract available


  220. MAVER PJ, Poljak M
    Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review.
    Vaccine. 2018;36:5416-5423.
    PubMed     Text format     Abstract available


  221. ESPOSITO S, Principi N
    Herpes zoster prevention: A difficult problem to solve.
    Vaccine. 2018;36:5442-5448.
    PubMed     Text format     Abstract available


  222. VENKATRAMAN N, Silman D, Folegatti PM, Hill AVS, et al
    Vaccines against Ebola virus.
    Vaccine. 2018;36:5454-5459.
    PubMed     Text format     Abstract available


  223. WILKINS AL, Snape MD
    Emerging clinical experience with vaccines against group B meningococcal disease.
    Vaccine. 2018;36:5470-5476.
    PubMed     Text format     Abstract available


  224. POLAND GA, Ovsyannikova IG, Kennedy RB
    Personalized vaccinology: A review.
    Vaccine. 2018;36:5350-5357.
    PubMed     Text format     Abstract available


  225. KOWALZIK F, Faber J, Knuf M
    MMR and MMRV vaccines.
    Vaccine. 2018;36:5402-5407.
    PubMed     Text format     Abstract available


  226. OBANDO-PACHECO P, Rivero-Calle I, Gomez-Rial J, Rodriguez-Tenreiro Sanchez C, et al
    New perspectives for hexavalent vaccines.
    Vaccine. 2018;36:5485-5494.
    PubMed     Text format     Abstract available


  227. LUCERO Y, Vidal R, O'Ryan G M
    Norovirus vaccines under development.
    Vaccine. 2018;36:5435-5441.
    PubMed     Text format     Abstract available


  228. DATTA SS, O'Connor PM, Jankovic D, Muscat M, et al
    Progress and challenges in measles and rubella elimination in the WHO European Region.
    Vaccine. 2018;36:5408-5415.
    PubMed     Text format     Abstract available


  229. BONANNI P, Zanella B, Santomauro F, Lorini C, et al
    Safety and perception: What are the greatest enemies of HPV vaccination programmes?
    Vaccine. 2018;36:5424-5429.
    PubMed     Text format     Abstract available


  230. PRYMULA R, Shaw J, Chlibek R, Urbancikova I, et al
    Vaccination in newly arrived immigrants to the European Union.
    Vaccine. 2018;36:5385-5390.
    PubMed     Text format     Abstract available


  231. BEN-SHIMOL S, Givon-Lavi N, Grisaru-Soen G, Megged O, et al
    Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
    Vaccine. 2018;36:5477-5484.
    PubMed     Text format     Abstract available


  232. MORINO S, Tanaka-Taya K, Satoh H, Arai S, et al
    Descriptive epidemiology of varicella based on national surveillance data before and after the introduction of routine varicella vaccination with two doses in Japan, 2000-2017.
    Vaccine. 2018 Aug 27. pii: S0264-410X(18)31177.
    PubMed     Text format     Abstract available


  233. FOOKS AR, Banyard AC, Ertl HCJ
    New human rabies vaccines in the pipeline.
    Vaccine. 2018 Aug 25. pii: S0264-410X(18)31168.
    PubMed     Text format     Abstract available


  234. SHIMIZU H, Seki K, Shiga K, Nakayama T, et al
    Safety and efficacy of DTaP-IPV vaccine use in healthcare workers for prevention of pertussis.
    Vaccine. 2018 Aug 25. pii: S0264-410X(18)31176.
    PubMed     Text format     Abstract available


  235. WHITAKER JA, von Itzstein MS, Poland GA
    Strategies to maximize influenza vaccine impact in older adults.
    Vaccine. 2018 Aug 25. pii: S0264-410X(18)31169.
    PubMed     Text format     Abstract available


  236. GONGAL G, Sampath G
    Introduction of intradermal rabies vaccination - A paradigm shift in improving post-exposure prophylaxis in Asia.
    Vaccine. 2018 Aug 24. pii: S0264-410X(18)31163.
    PubMed     Text format     Abstract available


  237. STONE K, Akpalu Y, Horney J
    Use of the Community Assessment for Public Health Response (CASPER) method to assess influenza vaccination and activity in Brazos County, Texas.
    Vaccine. 2018 Aug 24. pii: S0264-410X(18)31139.
    PubMed     Text format     Abstract available


  238. PACI JT, Paci I
    The time has come for a Phase 3 trial of an Epstein-Barr virus vaccine.
    Vaccine. 2018 Aug 24. pii: S0264-410X(18)31164.
    PubMed     Text format    


  239. POULOS C, Standaert B, Sloesen B, Stryjewska I, et al
    Preferences for vaccines against children's diarrheal illness among mothers in Poland and Hungary.
    Vaccine. 2018 Aug 24. pii: S0264-410X(18)31108.
    PubMed     Text format     Abstract available


  240. WEDLOCK PT, Mitgang EA, Siegmund S, DePasse J, et al
    Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.
    Vaccine. 2018 Aug 23. pii: S0264-410X(18)31135.
    PubMed     Text format     Abstract available


  241. NEWALL AT, Chen C, Wood JG, Stockwell MS, et al
    Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States.
    Vaccine. 2018 Aug 23. pii: S0264-410X(18)31114.
    PubMed     Text format     Abstract available


  242. RIVADENEIRA MF, Bassanesi SL, Fuchs SC
    Socioeconomic inequalities and measles immunization coverage in Ecuador: A spatial analysis.
    Vaccine. 2018;36:5251-5257.
    PubMed     Text format     Abstract available


  243. VORSTERS A, Van Damme P
    HPV immunization programs: Ensuring their sustainability and resilience.
    Vaccine. 2018;36:5219-5221.
    PubMed     Text format    


  244. HADJ MB, Bouguerra H, Saffar F, Chelly S, et al
    Observational study of vaccine effectiveness 20years after the introduction of universal hepatitis B vaccination in Tunisia.
    Vaccine. 2018 Aug 22. pii: S0264-410X(18)31167.
    PubMed     Text format     Abstract available


  245. COWLEY D, Nirwati H, Donato CM, Bogdanovic-Sakran N, et al
    Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia.
    Vaccine. 2018 Aug 22. pii: S0264-410X(18)31136.
    PubMed     Text format     Abstract available


  246. KILPI TM, Jokinen J, Puumalainen T, Nieminen H, et al
    Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial.
    Vaccine. 2018 Aug 22. pii: S0264-410X(18)31129.
    PubMed     Text format     Abstract available


  247. ESPOSITO S, Principi N, Rezza G, Bonanni P, et al
    Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward.
    Vaccine. 2018 Aug 21. pii: S0264-410X(18)31170.
    PubMed     Text format     Abstract available


  248. PATTERSON J, Kagina BM, Gold M, Hussey GD, et al
    Comparison of adverse events following immunisation with acellular and whole-cell pertussis vaccines: A systematic review.
    Vaccine. 2018 Aug 21. pii: S0264-410X(18)31131.
    PubMed     Text format     Abstract available


  249. SHONO A, Hoshi SL, Kondo M
    The impact on vaccination coverage following introduction of a routine pneumococcal vaccination programme for the elderly in Japan.
    Vaccine. 2018 Aug 21. pii: S0264-410X(18)31132.
    PubMed     Text format     Abstract available


  250. FU H, Lin HH, Hallett TB, Arinaminpathy N, et al
    Modelling the effect of discontinuing universal Bacillus Calmette-Guerin vaccination in an intermediate tuberculosis burden setting.
    Vaccine. 2018 Aug 21. pii: S0264-410X(18)31128.
    PubMed     Text format     Abstract available


  251. PRINCIPI N, Esposito S
    Aluminum in vaccines: Does it create a safety problem?
    Vaccine. 2018 Aug 20. pii: S0264-410X(18)31165.
    PubMed     Text format     Abstract available


  252. GVOZDENOVIC E, Vetter V, Willame C, Rosillon D, et al
    Impact of history of febrile convulsions on the risk difference of febrile convulsions with the tetravalent measles-mumps-rubella-varicella vaccine: Post-hoc exploratory analysis of results from a matched-cohort study.
    Vaccine. 2018 Aug 18. pii: S0264-410X(18)31127.
    PubMed     Text format     Abstract available


  253. COHEN AL, Aliabadi N, Serhan F, Tate JE, et al
    Using surveillance and economic data to make informed decisions about rotavirus vaccine introduction.
    Vaccine. 2018 Aug 18. pii: S0264-410X(18)30672.
    PubMed     Text format     Abstract available


  254. CHICHESTER JA, Green BJ, Jones RM, Shoji Y, et al
    Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults.
    Vaccine. 2018 Aug 17. pii: S0264-410X(18)31159.
    PubMed     Text format     Abstract available


  255. VAN AALST M, Langedijk AC, Spijker R, de Bree GJ, et al
    The effect of immunosuppressive agents on immunogenicity of pneumococcal vaccination: A systematic review and meta-analysis.
    Vaccine. 2018 Aug 16. pii: S0264-410X(18)31008.
    PubMed     Text format     Abstract available


  256. CUI A, Zhu Z, Mao N, Si Y, et al
    Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.
    Vaccine. 2018 Aug 16. pii: S0264-410X(18)31137.
    PubMed     Text format     Abstract available


  257. WEIBEL D, Sturkenboom M, Black S, de Ridder M, et al
    Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.
    Vaccine. 2018 Aug 16. pii: S0264-410X(18)31115.
    PubMed     Text format     Abstract available


  258. WEI L, Xie X, Liu J, Zhao Y, et al
    Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-up.
    Vaccine. 2018 Aug 16. pii: S0264-410X(18)31116.
    PubMed     Text format     Abstract available


  259. SUGA S, Ishiwada N, Sasaki Y, Akeda H, et al
    A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
    Vaccine. 2018 Aug 16. pii: S0264-410X(18)31138.
    PubMed     Text format     Abstract available


  260. PHAM TT, Le HM, Nguyen DT, Maertens K, et al
    Assessment of the timely administration of the hepatitis B and BCG birth dose and the primary infant vaccination schedule in 2015-2016 in the Mekong Delta, Viet Nam.
    Vaccine. 2018 Aug 16. pii: S0264-410X(18)31109.
    PubMed     Text format     Abstract available


  261. HARA M, Nakagomi O
    Role of rotavirus vaccination on an emerging G8P[8] rotavirus strain causing an outbreak in central Japan.
    Vaccine. 2018;36:5109.
    PubMed     Text format    


  262. HADJIPANAYIS A, Efstathiou E, Michaelidou K, Papaevangelou V, et al
    Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
    Vaccine. 2018 Aug 13. pii: S0264-410X(18)31130.
    PubMed     Text format     Abstract available


  263. SHI H, Dong S, Zhang X, Chen X, et al
    Phage vaccines displaying YGKDVKDLFDYAQE epitope induce protection against systemic candidiasis in mouse model.
    Vaccine. 2018 Aug 13. pii: S0264-410X(18)31120.
    PubMed     Text format     Abstract available


  264. AMDISEN L, Kristensen ML, Rytter D, Molbak K, et al
    Identification of determinants associated with uptake of the first dose of the human papillomavirus vaccine in Denmark.
    Vaccine. 2018 Aug 12. pii: S0264-410X(18)31113.
    PubMed     Text format     Abstract available


  265. LEE SH, Kang HJ, Lee DH, Kang SM, et al
    Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection.
    Vaccine. 2018 Aug 11. pii: S0264-410X(18)31125.
    PubMed     Text format     Abstract available


  266. CHOE YJ, Park K, Park E, Kong I, et al
    School entry vaccination requirement program: Experience from the Republic of Korea.
    Vaccine. 2018 Aug 11. pii: S0264-410X(18)30943.
    PubMed     Text format    


  267. NOUCHIKIAN L, Roque C, Song JY, Rahman N, et al
    An intrinsic fluorescence method for the determination of protein concentration in vaccines containing aluminum salt adjuvants.
    Vaccine. 2018 Aug 11. pii: S0264-410X(18)31112.
    PubMed     Text format     Abstract available


  268. MCLEAN HQ, Fiebelkorn AP, Ogee-Nwankwo A, Hao L, et al
    Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults.
    Vaccine. 2018 Aug 11. pii: S0264-410X(18)31117.
    PubMed     Text format     Abstract available


  269. WORLD HEALTH ORGANIZATION
    Rabies vaccines: WHO position paper, April 2018 - Recommendations.
    Vaccine. 2018 Aug 11. pii: S0264-410X(18)30902.
    PubMed     Text format     Abstract available


  270. HOLMGREN J, Nordqvist S, Blomquist M, Jeverstam F, et al
    Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
    Vaccine. 2018 Aug 10. pii: S0264-410X(18)31082.
    PubMed     Text format     Abstract available



  271. Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15months: A phase III, randomized, non-inferiority trial.
    Vaccine. 2018 Aug 10. pii: S0264-410X(18)31096.
    PubMed     Text format     Abstract available


  272. LONCOMAN CA, Hartley CA, Coppo MJC, Browning GF, et al
    Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
    Vaccine. 2018 Aug 10. pii: S0264-410X(18)31121.
    PubMed     Text format     Abstract available


  273. DAMJANOVIC D, He L, Symes J, Gajewska B, et al
    In vitro assessment of biological activity and stability of the ALVAC-HIV vaccine.
    Vaccine. 2018 Aug 10. pii: S0264-410X(18)31003.
    PubMed     Text format     Abstract available


  274. DESAI S, Rathi N, Kawade A, Venkatramanan P, et al
    Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL(R) with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine.
    Vaccine. 2018 Aug 10. pii: S0264-410X(18)31073.
    PubMed     Text format     Abstract available


  275. PAN X, Shu M, Ma R, Fang T, et al
    Varicella breakthrough infection and effectiveness of 2-dose varicella vaccine in China.
    Vaccine. 2018 Aug 10. pii: S0264-410X(18)30632.
    PubMed     Text format     Abstract available


  276. NADARZYNSKI T, Smith H, Richardson D, Bremner S, et al
    Men who have sex with men who do not access sexual health clinics nor disclose sexual orientation are unlikely to receive the HPV vaccine in the UK.
    Vaccine. 2018;36:5065-5070.
    PubMed     Text format     Abstract available


  277. SHI W, Kou Y, Xiao J, Zhang L, et al
    Comparison of immunogenicity, efficacy and transcriptome changes of inactivated rabies virus vaccine with different adjuvants.
    Vaccine. 2018;36:5020-5029.
    PubMed     Text format     Abstract available


  278. SHEIKH S, Biundo E, Courcier S, Damm O, et al
    A report on the status of vaccination in Europe.
    Vaccine. 2018;36:4979-4992.
    PubMed     Text format     Abstract available


  279. AYRLE H, Mevissen M, Kaske M, Vogtlin A, et al
    Colostral transmission of BTV-8 antibodies from dairy cows six years after vaccination.
    Vaccine. 2018 Aug 9. pii: S0264-410X(18)31124.
    PubMed     Text format     Abstract available


  280. QIN J, Zhang Y, Shen X, Gong L, et al
    H7 virus-like particles assembled by hemagglutinin containing H3N2 transmembrane domain and M1 induce broad homologous and heterologous protection in mice.
    Vaccine. 2018;36:5030-5036.
    PubMed     Text format     Abstract available


  281. ELWOOD JM, Ameratunga R
    Autoimmune diseases after hepatitis B immunization in adults: Literature review and meta-analysis, with reference to 'autoimmune/autoinflammatory syndrome induced by adjuvants' (ASIA).
    Vaccine. 2018 Aug 9. pii: S0264-410X(18)31094.
    PubMed     Text format     Abstract available


  282. PATRICIA D'SOUZA M, Allen MA, Baumblatt JAG, Boggiano C, et al
    Innovative approaches to track lymph node germinal center responses to evaluate development of broadly neutralizing antibodies in human HIV vaccine trials.
    Vaccine. 2018 Aug 7. pii: S0264-410X(18)31080.
    PubMed     Text format     Abstract available


  283. HASAN AZ, Saha S, Saha SK, Sahakyan G, et al
    Using pneumococcal and rotavirus surveillance in vaccine decision-making: A series of case studies in Bangladesh, Armenia and the Gambia.
    Vaccine. 2018;36.
    PubMed     Text format     Abstract available


  284. YU Y, Guo J, Li D, Liu Y, et al
    Development of a human papillomavirus type 6/11 vaccine candidate for the prevention of condyloma acuminatum.
    Vaccine. 2018;36.
    PubMed     Text format     Abstract available


  285. GILBERT A, Johnson S, Walker N, Wickham C, et al
    Efficacy of Ontario Rabies Vaccine Baits (ONRAB) against rabies infection in raccoons.
    Vaccine. 2018;36.
    PubMed     Text format     Abstract available


  286. PRICE GE, Lo CY, Misplon JA, Epstein SL, et al
    Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen.
    Vaccine. 2018;36.
    PubMed     Text format     Abstract available


  287. COLEY S, Hoefer D, Rausch-Phung E
    A population-based reminder intervention to improve human papillomavirus vaccination rates among adolescents at routine vaccination age.
    Vaccine. 2018;36.
    PubMed     Text format     Abstract available


  288. FRENCK RW JR, Baqar S, Alexander W, Dickey M, et al
    A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei.
    Vaccine. 2018;36.
    PubMed     Text format     Abstract available


  289. HU H, Roth JP, Yu Q
    Generation of a recombinant Newcastle disease virus expressing two foreign genes for use as a multivalent vaccine and gene therapy vector.
    Vaccine. 2018;36.
    PubMed     Text format     Abstract available


  290. SHINJOH M, Sugaya N, Yamaguchi Y, Iibuchi N, et al
    Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season.
    Vaccine. 2018 Aug 6. pii: S0264-410X(18)31074.
    PubMed     Text format     Abstract available


  291. AGUDELO CI, DeAntonio R, Castaneda E
    Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean 2010-2015: A systematic review and a time series analysis.
    Vaccine. 2018;36.
    PubMed     Text format     Abstract available


  292. CASTANEDA-ORJUELA C, De la Hoz-Restrepo F
    How cost effective is switching universal vaccination from PCV10 to PCV13? A case study from a developing country.
    Vaccine. 2018 Aug 4. pii: S0264-410X(18)31098.
    PubMed     Text format     Abstract available


  293. ITELL HL, McGuire EP, Muresan P, Cunningham CK, et al
    Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines.
    Vaccine. 2018 Aug 4. pii: S0264-410X(18)31017.
    PubMed     Text format     Abstract available


  294. PUGLIESE-GARCIA M, Heyerdahl L, Mwamba C, Nkwemu S, et al
    Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka, Zambia.
    Vaccine. 2018 Aug 4. pii: S0264-410X(18)31011.
    PubMed     Text format     Abstract available


  295. WU S, Pan Y, Zhang X, Zhang L, et al
    Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Vaccine. 2018 Aug 4. pii: S0264-410X(18)31097.
    PubMed     Text format     Abstract available


  296. DOBRICA MO, Lazar C, Paruch L, van Eerde A, et al
    Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice.
    Vaccine. 2018 Aug 3. pii: S0264-410X(18)31081.
    PubMed     Text format     Abstract available


  297. YEUNG KHT, Tarrant M, Chan KCC, Tam WH, et al
    Increasing influenza vaccine uptake in children: A randomised controlled trial.
    Vaccine. 2018 Aug 2. pii: S0264-410X(18)31075.
    PubMed     Text format     Abstract available


  298. UCAKAR V, Fafangel M, Kraigher A
    Vaccine confidence among mothers of young children, Slovenia, 2016.
    Vaccine. 2018 Aug 1. pii: S0264-410X(18)31071.
    PubMed     Text format     Abstract available


  299. DE WALS P
    Commentary on paradoxical observations pertaining to the impact of the 13-valent pneumococcal conjugate vaccine on serotype 3 Streptococcus pneumoniae infections in children.
    Vaccine. 2018 Aug 1. pii: S0264-410X(18)31078.
    PubMed     Text format    


  300. THOMPSON MG, Pierse N, Sue Huang Q, Prasad N, et al
    Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.
    Vaccine. 2018 Aug 1. pii: S0264-410X(18)30997.
    PubMed     Text format     Abstract available


    July 2018
  301. NEMOTO M, Inagaki M, Tamura N, Bannai H, et al
    Evaluation of inactivated vaccines against equine group A rotaviruses by use of a suckling mouse model.
    Vaccine. 2018 Jul 31. pii: S0264-410X(18)31064.
    PubMed     Text format     Abstract available


  302. GAYTHORPE KAM, Trotter CL, Conlan AJK
    Modelling norovirus transmission and vaccination.
    Vaccine. 2018 Jul 31. pii: S0264-410X(18)31049.
    PubMed     Text format     Abstract available


  303. ORTQVIST A, Brytting M, Leval A, Hergens MP, et al
    Impact of repeated influenza vaccinations in persons over 65years of age: A large population-based cohort study of severe influenza over six consecutive seasons, 2011/12-2016/17.
    Vaccine. 2018 Jul 31. pii: S0264-410X(18)31046.
    PubMed     Text format     Abstract available


  304. HOWARD N, Walls H, Bell S, Mounier-Jack S, et al
    The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: A comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda.
    Vaccine. 2018 Jul 31. pii: S0264-410X(18)31072.
    PubMed     Text format     Abstract available


  305. WELSCH JA, Senders S, Essink B, Klein T, et al
    Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents - Results from a randomized, controlled, observer-blind phase II study.
    Vaccine. 2018 Jul 27. pii: S0264-410X(18)30946.
    PubMed     Text format     Abstract available


  306. KOUTOUZIS EI, Daikos GL, Chatzichristou P, Michos AG, et al
    Characteristics of Streptococcus pneumoniae serotype 19A isolates from children in the pre and post Conjugate Vaccine Era. Single center experience 1986-2015.
    Vaccine. 2018 Jul 27. pii: S0264-410X(18)31062.
    PubMed     Text format     Abstract available


  307. DOMEK GJ, O'Leary ST, Bull S, Bronsert M, et al
    Measuring vaccine hesitancy: Field testing the WHO SAGE Working Group on Vaccine Hesitancy survey tool in Guatemala.
    Vaccine. 2018 Jul 27. pii: S0264-410X(18)31015.
    PubMed     Text format     Abstract available


  308. RAVEN S, Urbanus A, de Gee A, Hoebe C, et al
    Predictors of hepatitis B vaccination completion among people who use drugs participating in a national program of targeted vaccination.
    Vaccine. 2018 Jul 27. pii: S0264-410X(18)31014.
    PubMed     Text format     Abstract available


  309. PALLIVATHUCAL LB, Noymer A
    Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)30999.
    PubMed     Text format     Abstract available


  310. NOH JY, Choi WS, Song JY, Lee HS, et al
    Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)30987.
    PubMed     Text format     Abstract available


  311. STATLER VA, Albano FR, Airey J, Sawlwin DC, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59months of age: A phase 3, randomized, noninferiority study.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)31005.
    PubMed     Text format     Abstract available


  312. SUN B, Yu S, Zhao D, Guo S, et al
    Polysaccharides as vaccine adjuvants.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)31009.
    PubMed     Text format     Abstract available


  313. PANOVSKA-GRIFFITHS J, Crowe S, Pagel C, Shiri T, et al
    A method for evaluating and comparing immunisation schedules that cover multiple diseases: Illustrative application to the UK routine childhood vaccine schedule.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)30749.
    PubMed     Text format     Abstract available


  314. FORD AJ, Alwan NA
    Use of social networking sites and women's decision to receive vaccinations during pregnancy: A cross-sectional study in the UK.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)30988.
    PubMed     Text format     Abstract available


  315. POLJAK M
    Editorial: Progress in vaccines and vaccination - Best of ECCMID 2016.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)31019.
    PubMed     Text format    


  316. FERDMAN J, Palladino G, Liao HX, Moody MA, et al
    Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59(R)-adjuvanted pandemic 2009 H1N1 vaccine.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)30895.
    PubMed     Text format     Abstract available


  317. SKUFCA J, Ollgren J, Artama M, Ruokokoski E, et al
    The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)30925.
    PubMed     Text format     Abstract available


  318. BOUKHVALOVA MS, Mbaye A, Kovtun S, Yim KC, et al
    Improving ability of RSV microneutralization assay to detect G-specific and cross-reactive neutralizing antibodies through immortalized cell line selection.
    Vaccine. 2018;36:4657-4662.
    PubMed     Text format     Abstract available


  319. PENNINGTON SH, Ferreira DM, Reine J, Nyirenda TS, et al
    Longevity of duodenal and peripheral T-cell and humoral responses to live-attenuated Salmonella Typhi strain Ty21a.
    Vaccine. 2018;36:4725-4733.
    PubMed     Text format     Abstract available


  320. YEZLI S, Gautret P, Assiri AM, Gessner BD, et al
    Prevention of meningococcal disease at mass gatherings: Lessons from the Hajj and Umrah.
    Vaccine. 2018;36:4603-4609.
    PubMed     Text format     Abstract available


  321. RIAZ A, Husain S, Yousafzai MT, Nisar I, et al
    Reasons for non-vaccination and incomplete vaccinations among children in Pakistan.
    Vaccine. 2018 Jul 24. pii: S0264-410X(18)30993.
    PubMed     Text format     Abstract available


  322. JAYESHBHAI C, Hajam IA, Verma AK, Bhanuprakash V, et al
    Chemokine CCL20 plasmid improves protective efficacy of the Montanide ISA 206 adjuvanted foot-and-mouth disease vaccine in mice model.
    Vaccine. 2018 Jul 24. pii: S0264-410X(18)30933.
    PubMed     Text format     Abstract available


  323. MARTINEZ AC, Prymula R, Valdivieso MM, Del Carmen Otero Reigada M, et al
    Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study.
    Vaccine. 2018 Jul 24. pii: S0264-410X(18)30989.
    PubMed     Text format     Abstract available


  324. MACHADO A, Kislaya I, Santos AJ, Gaio V, et al
    Factors associated to repeated influenza vaccination in the Portuguese adults with chronic conditions.
    Vaccine. 2018 Jul 24. pii: S0264-410X(18)31010.
    PubMed     Text format     Abstract available


  325. WERNIKE K, Mundt A, Link EK, Aebischer A, et al
    N-terminal domain of Schmallenberg virus envelope protein Gc delivered by recombinant equine herpesvirus type 1 and modified vaccinia virus Ankara: Immunogenicity and protective efficacy in cattle.
    Vaccine. 2018 Jul 23. pii: S0264-410X(18)31016.
    PubMed     Text format     Abstract available


  326. KASPER AK, Pallotta AM, Kovacs CS, Spinner ML, et al
    Infectious diseases consult improves vaccination adherence in kidney transplant candidates.
    Vaccine. 2018 Jul 23. pii: S0264-410X(18)30899.
    PubMed     Text format     Abstract available


  327. DANOVARO-HOLLIDAY MC, Dansereau E, Rhoda DA, Brown DW, et al
    Collecting and using reliable vaccination coverage survey estimates: Summary and recommendations from the "Meeting to share lessons learnt from the roll-out of the updated WHO Vaccination Coverage Cluster Survey Reference Manual and to set an operatio
    Vaccine. 2018 Jul 21. pii: S0264-410X(18)30949.
    PubMed     Text format     Abstract available


  328. HOSHI SL, Seposo X, Okubo I, Kondo M, et al
    Cost-effectiveness analysis of pertussis vaccination during pregnancy in Japan.
    Vaccine. 2018 Jul 21. pii: S0264-410X(18)30995.
    PubMed     Text format     Abstract available


  329. HU WG, Steigerwald R, Kalla M, Volkmann A, et al
    Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses.
    Vaccine. 2018 Jul 20. pii: S0264-410X(18)30905.
    PubMed     Text format     Abstract available


  330. ARAKI K, Hara M, Tsugawa T, Shimanoe C, et al
    Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children.
    Vaccine. 2018 Jul 20. pii: S0264-410X(18)30937.
    PubMed     Text format     Abstract available


  331. GESUALDO F, Zamperini N, Tozzi AE
    To talk better about vaccines, we should talk less about vaccines.
    Vaccine. 2018 Jul 19. pii: S0264-410X(18)30994.
    PubMed     Text format    


  332. MUANGCHANA C, Thanormwat Y, Kongsiang A
    Workshops advocating ASEAN Vaccine Security and Self-Reliance (AVSSR): A regional initiative.
    Vaccine. 2018 Jul 19. pii: S0264-410X(18)30624.
    PubMed     Text format     Abstract available


  333. HARVEY MJ, Denton BT, Prosser LA, Hutton DW, et al
    Determining the optimal strategy for the herpes zoster vaccine in adults.
    Vaccine. 2018 Jul 18. pii: S0264-410X(18)30900.
    PubMed     Text format     Abstract available


  334. GRIFFIN JB, Yu L, Watson D, Turner N, et al
    Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine.
    Vaccine. 2018 Jul 18. pii: S0264-410X(18)30941.
    PubMed     Text format     Abstract available


  335. SHENTON LM, Wagner AL, Carlson BF, Mubarak MY, et al
    Vaccination status of children aged 1-4years in Afghanistan and associated factors, 2015.
    Vaccine. 2018 Jul 17. pii: S0264-410X(18)30986.
    PubMed     Text format     Abstract available


  336. RISALDE MA, Lopez V, Contreras M, Mateos-Hernandez L, et al
    Control of mycobacteriosis in zebrafish (Danio rerio) mucosally vaccinated with heat-inactivated Mycobacterium bovis.
    Vaccine. 2018;36:4447-4453.
    PubMed     Text format     Abstract available


  337. SAITOH A, Okabe N
    Progress and challenges for the Japanese immunization program: Beyond the "vaccine gap".
    Vaccine. 2018;36:4582-4588.
    PubMed     Text format     Abstract available


  338. LE MEUR JB, Ayukawa H, Proulx JF, De Wals P, et al
    Prevalence of middle ear abnormalities from otitis media in relation with pneumococcal vaccine use in the Inuit population of Nunavik, province of Quebec, Canada.
    Vaccine. 2018 Jul 16. pii: S0264-410X(18)30938.
    PubMed     Text format     Abstract available


  339. ALQAHTANI AS, Tashani M, Ridda I, Gamil A, et al
    Burden of clinical infections due to S. pneumoniae during Hajj: A systematic review.
    Vaccine. 2018;36:4440-4446.
    PubMed     Text format     Abstract available


  340. MACINTYRE CR, Kpozehouen E, Kunasekaran M, Harriman K, et al
    Measles control in Australia - threats, opportunities and future needs.
    Vaccine. 2018;36:4393-4398.
    PubMed     Text format     Abstract available


  341. MAKARKOV AI, Patel AR, Bainov V, Ward BJ, et al
    A novel serological assay for influenza based on DiD fluorescence dequenching that is free from observer bias and potentially automatable - A proof of concept study.
    Vaccine. 2018;36:4485-4493.
    PubMed     Text format     Abstract available


  342. MOORE BD, New RRC, Butcher W, Mahood R, et al
    Dual route vaccination for plague with emergency use applications.
    Vaccine. 2018 Jul 14. pii: S0264-410X(18)30867.
    PubMed     Text format     Abstract available


  343. WOLFF E, Elfstrom KM, Haugen Cange H, Larsson S, et al
    Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour.
    Vaccine. 2018 Jul 14. pii: S0264-410X(18)30948.
    PubMed     Text format     Abstract available


  344. ZHANG L, Pan Y, Hackert V, van der Hoek W, et al
    The 2015-2016 influenza epidemic in Beijing, China: Unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness.
    Vaccine. 2018 Jul 14. pii: S0264-410X(18)30947.
    PubMed     Text format     Abstract available


  345. CURRAN D, Patterson B, Varghese L, Van Oorschot D, et al
    Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States.
    Vaccine. 2018 Jul 13. pii: S0264-410X(18)30935.
    PubMed     Text format     Abstract available


  346. ZHAO X, Liang S, Dai Q, Jia R, et al
    Regulated delayed attenuation enhances the immunogenicity and protection provided by recombinant Salmonellaenterica serovar Typhimurium vaccines expressing serovar Choleraesuis O-polysaccharides.
    Vaccine. 2018 Jul 12. pii: S0264-410X(18)30939.
    PubMed     Text format     Abstract available


  347. ONUIGBO E, Iseghohimhen J, Chah K, Gyang M, et al
    Chitosan/alginate microparticles for the oral delivery of fowl typhoid vaccine: Innate and acquired immunity.
    Vaccine. 2018 Jul 12. pii: S0264-410X(18)30753.
    PubMed     Text format     Abstract available


  348. RHEINGANS R, Anderson JD 4th, Bagamian KH, Laytner LA, et al
    Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan.
    Vaccine. 2018 Jul 12. pii: S0264-410X(18)30172.
    PubMed     Text format     Abstract available


  349. HATTA Y, Boltz D, Sarawar S, Kawaoka Y, et al
    Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.
    Vaccine. 2018 Jul 12. pii: S0264-410X(18)30894.
    PubMed     Text format     Abstract available


  350. RHEINGANS R, Anderson JD 4th, Bagamian KH, Pecenka CJ, et al
    Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People's Democratic Republic.
    Vaccine. 2018 Jul 11. pii: S0264-410X(18)30173.
    PubMed     Text format     Abstract available


  351. DUNSCH D, Wicker S
    Visual Vaccinology: Changing public perception.
    Vaccine. 2018 Jul 11. pii: S0264-410X(18)30944.
    PubMed     Text format    


  352. MARTINEZ CPD, Linares-Perez N, Toledo-Romani ME, Delgado YR, et al
    Safety and immunogenicity of the Cuban heptavalent pneumococcal conjugate vaccine in healthy infants. Results from a double-blind randomized control trial Phase I.
    Vaccine. 2018 Jul 10. pii: S0264-410X(18)30634.
    PubMed     Text format     Abstract available


  353. THANGSUPANIMITCHAI N, Edwards AD
    Mixing is required for uniform reconstitution of filter-dried protein antigens in a single-injection vaccine formulation.
    Vaccine. 2018 Jul 10. pii: S0264-410X(18)30929.
    PubMed     Text format     Abstract available


  354. RAILEY AF, Lembo T, Palmer GH, Shirima GM, et al
    Spatial and temporal risk as drivers for adoption of foot and mouth disease vaccination.
    Vaccine. 2018 Jul 6. pii: S0264-410X(18)30910.
    PubMed     Text format     Abstract available


  355. MARECHAL C, Lal H, Poder A, Ferguson M, et al
    Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults >/=50years of age: A randomized trial.
    Vaccine. 2018;36:4278-4286.
    PubMed     Text format     Abstract available


  356. PAIGE LAKE BA, Kasting ML, Malo T, Giuliano AR, et al
    An environmental scan to examine stakeholder perspectives on human papillomavirus vaccination: A mixed methods study.
    Vaccine. 2018 Jul 5. pii: S0264-410X(18)30924.
    PubMed     Text format     Abstract available


  357. KURONUMA K, Honda H, Mikami T, Saito A, et al
    Response to pneumococcal vaccine in interstitial lung disease patients: Influence of systemic immunosuppressive treatment.
    Vaccine. 2018 Jul 5. pii: S0264-410X(18)30903.
    PubMed     Text format     Abstract available


  358. APAYDIN KZ, Fontenot HB, Borba CPC, Shtasel DL, et al
    Three-dose HPV vaccine completion among sexual and gender minority young adults at a Boston community health center.
    Vaccine. 2018 Jul 5. pii: S0264-410X(18)30898.
    PubMed     Text format     Abstract available


  359. PUSHKO P, Tretyakova I, Hidajat R, Sun X, et al
    Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone.
    Vaccine. 2018;36:4346-4353.
    PubMed     Text format     Abstract available


  360. GAMAOUN R
    National cervical cancer prevention program in the Arab States: Strategies and cost-minimization study of the Tunisian case.
    Vaccine. 2018 Jul 5. pii: S0264-410X(18)30921.
    PubMed     Text format     Abstract available


  361. HARRISON N, Poeppl W, Miksch M, Machold K, et al
    Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases.
    Vaccine. 2018 Jul 3. pii: S0264-410X(18)30906.
    PubMed     Text format     Abstract available


  362. HABER M, Lopman BA, Tate JE, Shi M, et al
    A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness.
    Vaccine. 2018 Jul 3. pii: S0264-410X(18)30923.
    PubMed     Text format     Abstract available


  363. RODRIGUEZ SA, Savas LS, Baumler E, Nyitray AG, et al
    Parental predictors of HPV vaccine initiation among low-income Hispanic females aged 11-17years.
    Vaccine. 2018 Jul 3. pii: S0264-410X(18)30922.
    PubMed     Text format     Abstract available


  364. FARAG NH, Mansour Z, Torossian L, Said R, et al
    Feasibility of jet injector use during inactivated poliovirus vaccine house-to-house vaccination campaigns.
    Vaccine. 2018 Jul 3. pii: S0264-410X(18)30826.
    PubMed     Text format     Abstract available


    June 2018
  365. MASSOT E, Epaulard O
    Midwives' perceptions of vaccines and their role as vaccinators: The emergence of a new immunization corps.
    Vaccine. 2018 Jun 30. pii: S0264-410X(18)30891.
    PubMed     Text format     Abstract available


  366. AUTA A, Adewuyi EO, Kureh GT, Onoviran N, et al
    Hepatitis B vaccination coverage among health-care workers in Africa: A systematic review and meta-analysis.
    Vaccine. 2018 Jun 30. pii: S0264-410X(18)30871.
    PubMed     Text format     Abstract available


  367. BRADY RC, Jackson LA, Frey SE, Shane AL, et al
    Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women.
    Vaccine. 2018 Jun 28. pii: S0264-410X(18)30864.
    PubMed     Text format     Abstract available


  368. GRASSE M, Meryk A, Miggitsch C, Grubeck-Loebenstein B, et al
    GM-CSF improves the immune response to the diphtheria-component in a multivalent vaccine.
    Vaccine. 2018 Jun 28. pii: S0264-410X(18)30861.
    PubMed     Text format     Abstract available


  369. LIU W, Wong YC, Chen SMY, Tang J, et al
    DNA prime/MVTT boost regimen with HIV-1 mosaic Gag enhances the potency of antigen-specific immune responses.
    Vaccine. 2018 Jun 28. pii: S0264-410X(18)30888.
    PubMed     Text format     Abstract available


  370. JARZAB A, Witkowska D, Ziomek E, Setner B, et al
    Cyclic OmpC peptidic epitope conjugated to tetanus toxoid as a potential vaccine candidate against shigellosis.
    Vaccine. 2018 Jun 27. pii: S0264-410X(18)30865.
    PubMed     Text format     Abstract available


  371. RIVERA L, Schwarz TF, Kim KH, Kim YK, et al
    Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized
    Vaccine. 2018 Jun 27. pii: S0264-410X(18)30517.
    PubMed     Text format     Abstract available


  372. RERMRUAY R, Rungmaitree S, Chatpornvorarux S, Brukesawan C, et al
    Clinical features and outcomes of Bacille Calmette-Guerin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization.
    Vaccine. 2018;36:4046-4053.
    PubMed     Text format     Abstract available


  373. DURRHEIM DN, Orenstein WA, Schluter WW
    Assessing population immunity for measles elimination - The promise and peril of serosurveys.
    Vaccine. 2018;36:4001-4003.
    PubMed     Text format    


  374. PING X, Hu W, Xiong R, Zhang X, et al
    Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence.
    Vaccine. 2018 Jun 27. pii: S0264-410X(18)30889.
    PubMed     Text format     Abstract available


  375. YOU JHS, Ming WK, Lee CF, Tsang OT, et al
    Potential cost-effectiveness of adjuvanted herpes zoster subunit vaccine for older adults in Hong Kong.
    Vaccine. 2018 Jun 26. pii: S0264-410X(18)30890.
    PubMed     Text format     Abstract available


  376. STEELFISHER GK, Blendon RJ, Haydarov R, Lodge W 2nd, et al
    Threats to oral polio vaccine acceptance in Somalia: Polling in an outbreak.
    Vaccine. 2018 Jun 26. pii: S0264-410X(18)30814.
    PubMed     Text format     Abstract available


  377. HECHTER RC, Qian L, Luo Y, Ling Grant DS, et al
    Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus.
    Vaccine. 2018 Jun 26. pii: S0264-410X(18)30863.
    PubMed     Text format     Abstract available


  378. LIU X, Zhao D, Jia L, Xu H, et al
    Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus.
    Vaccine. 2018 Jun 25. pii: S0264-410X(18)30868.
    PubMed     Text format     Abstract available


  379. BOHM K, Krause G, Sievers C
    Response to comment on: Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology.
    Vaccine. 2018;36:3885.
    PubMed     Text format    


  380. HERZOG C, Mayorga O
    Serologic differential diagnosis of hepatitis A virus (HAV) infected and vaccinated individuals: How long persist antibodies to non-structural HAV proteins?
    Vaccine. 2018;36:3883-3884.
    PubMed     Text format    


  381. SCHELTEMA NM, Kavelaars XM, Thorburn K, Hennus MP, et al
    Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy.
    Vaccine. 2018 Jun 22. pii: S0264-410X(18)30837.
    PubMed     Text format     Abstract available


  382. SCHLAUDECKER EP, Ambroggio L, McNeal MM, Finkelman FD, et al
    Declining responsiveness to influenza vaccination with progression of human pregnancy.
    Vaccine. 2018 Jun 22. pii: S0264-410X(18)30796.
    PubMed     Text format     Abstract available


  383. KARA PD, Mather AS, Pretorius A, Chetty T, et al
    Characterisation of putative immunomodulatory gene knockouts of lumpy skin disease virus in cattle towards an improved vaccine.
    Vaccine. 2018 Jun 22. pii: S0264-410X(18)30833.
    PubMed     Text format     Abstract available


  384. RIVERA L, Chanthavanich P, Poder A, Suryakiran PV, et al
    MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial.
    Vaccine. 2018;36:3967-3975.
    PubMed     Text format     Abstract available


  385. HINCAPIE-PALACIO D, Hoyos MC, Ochoa J, Montoya N, et al
    Effect of maternal immunization against pertussis in Medellin and the metropolitan area, Colombia, 2016-2017.
    Vaccine. 2018;36:3984-3991.
    PubMed     Text format     Abstract available


  386. DEMCZUK WHB, Martin I, Desai S, Griffith A, et al
    Serotype distribution of invasive Streptococcus pneumoniae in adults 65years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016.
    Vaccine. 2018 Jun 21. pii: S0264-410X(18)30834.
    PubMed     Text format     Abstract available


  387. BRANDAO LGP, Santoro-Lopes G, Oliveira SS, da Silva EE, et al
    Seroprevalence of antibodies against the three serotypes of poliovirus and IPV vaccine response in adult solid organ transplant candidates.
    Vaccine. 2018 Jun 21. pii: S0264-410X(18)30859.
    PubMed     Text format     Abstract available


  388. BIGGART R, Finn A, Marlow R
    Lack of impact of rotavirus vaccination on childhood seizure hospitalizations in England - An interrupted time series analysis.
    Vaccine. 2018 Jun 21. pii: S0264-410X(18)30857.
    PubMed     Text format     Abstract available


  389. RAMANATHAN R, Voigt EA, Kennedy RB, Poland GA, et al
    Knowledge gaps persist and hinder progress in eliminating mumps.
    Vaccine. 2018;36:3721-3726.
    PubMed     Text format     Abstract available


  390. ROSENBERG DANZIGER C, Anis E, Gordon ES, Grotto I, et al
    Reintroducing OPV in Israel on the journey to global polio eradication - Estimation at a low rate of contraindicated population.
    Vaccine. 2018;36:3717-3720.
    PubMed     Text format     Abstract available


  391. HOENIG LJ, Jackson AC, Dickinson GM
    The early use of Pasteur's rabies vaccine in the United States.
    Vaccine. 2018 Jun 16. pii: S0264-410X(18)30623.
    PubMed     Text format     Abstract available


  392. PANDEY RK, Ali M, Ojha R, Bhatt TK, et al
    Development of multi-epitope driven subunit vaccine in secretory and membrane protein of Plasmodium falciparum to convey protection against malaria infection.
    Vaccine. 2018 Jun 16. pii: S0264-410X(18)30748.
    PubMed     Text format     Abstract available


  393. FINNEGAN G, Holt D, English PM, Glismann S, et al
    Lessons from an online vaccine communication project.
    Vaccine. 2018 Jun 16. pii: S0264-410X(18)30612.
    PubMed     Text format     Abstract available


  394. MWENDA JM, Parashar UD, Cohen AL, Tate JE, et al
    Impact of rotavirus vaccines in Sub-Saharan African countries.
    Vaccine. 2018 Jun 15. pii: S0264-410X(18)30854.
    PubMed     Text format     Abstract available


  395. JIAO H, Yang H, Zhao D, Chen J, et al
    Design and immune characterization of a novel Neisseria gonorrhoeae DNA vaccine using bacterial ghosts as vector and adjuvant.
    Vaccine. 2018 Jun 15. pii: S0264-410X(18)30817.
    PubMed     Text format     Abstract available


  396. GILLAM F, Zhang C
    Epitope selection and their placement for increased virus neutralization in a novel vaccination strategy for porcine epidemic diarrhea virus utilizing the Hepatitis B virus core antigen.
    Vaccine. 2018 Jun 15. pii: S0264-410X(18)30831.
    PubMed     Text format     Abstract available


  397. VUJADINOVIC M, Khan S, Oosterhuis K, Uil TG, et al
    Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses.
    Vaccine. 2018 Jun 15. pii: S0264-410X(18)30840.
    PubMed     Text format     Abstract available


  398. KOUL PA, Mir H
    The biggest barrier to influenza vaccination in pregnant females in India: Poor sensitization of the care providers.
    Vaccine. 2018;36:3569-3570.
    PubMed     Text format    


  399. YAN Q, Cheng Z, Liu H, Shan W, et al
    Enhancement of Ag85B DNA vaccine immunogenicity against tuberculosis by dissolving microneedles in mice.
    Vaccine. 2018 Jun 14. pii: S0264-410X(18)30841.
    PubMed     Text format     Abstract available


  400. ORTIZ JR
    Implementation of maternal influenza immunization programs.
    Vaccine. 2018;36:3571.
    PubMed     Text format    


  401. LEAL KS, de Oliveira Silva MT, de Fatima Silva Rezende A, Bezerra FSB, et al
    Recombinant M. bovis BCG expressing the PLD protein promotes survival in mice challenged with a C. pseudotuberculosis virulent strain.
    Vaccine. 2018;36:3578-3583.
    PubMed     Text format     Abstract available


  402. OZAWA S, Yemeke TT, Thompson KM
    Systematic review of the incremental costs of interventions that increase immunization coverage.
    Vaccine. 2018;36:3641-3649.
    PubMed     Text format     Abstract available


  403. KUMAR L, Puliyel J
    New pentavalent rotavirus vaccine shows little efficacy against diarrhea.
    Vaccine. 2018 Jun 13. pii: S0264-410X(18)30772.
    PubMed     Text format    


  404. TRANTHAM L, Kurosky SK, Zhang D, Johnson KD, et al
    Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States.
    Vaccine. 2018 Jun 13. pii: S0264-410X(18)30788.
    PubMed     Text format     Abstract available


  405. ZHANG J, Wang M, Zhou N, Shen Y, et al
    Evaluation of carbopol as an adjuvant on the effectiveness of progressive atrophic rhinitis vaccine.
    Vaccine. 2018 Jun 13. pii: S0264-410X(18)30839.
    PubMed     Text format     Abstract available


  406. ZIMMERMANN P, Curtis N
    The influence of the intestinal microbiome on vaccine responses.
    Vaccine. 2018 Jun 13. pii: S0264-410X(18)30563.
    PubMed     Text format     Abstract available


  407. KOWALEWICZ-KULBAT M, Szpakowski P, Locht C, Biet F, et al
    Tuberculin skin test reaction is related to memory, but not naive CD4(+) T cell responses to mycobacterial stimuli in BCG-vaccinated young adults.
    Vaccine. 2018 Jun 13. pii: S0264-410X(18)30708.
    PubMed     Text format     Abstract available


  408. SHEN AK, Warnock R, Chu S, Kelman JA, et al
    Receipt of other routinely recommended vaccines relative to receipt of seasonal influenza vaccines: Trends from medicare administrative data, 2013-2015.
    Vaccine. 2018 Jun 13. pii: S0264-410X(18)30836.
    PubMed     Text format     Abstract available


  409. CATALDI JR, Dempsey AF, Allison MA, O'Leary ST, et al
    Impact of publicly available vaccination rates on parental school and child care choice.
    Vaccine. 2018 Jun 13. pii: S0264-410X(18)30828.
    PubMed     Text format     Abstract available


  410. WALLACE AS, Krey K, Hustedt J, Burnett E, et al
    Assessment of vaccine wastage rates, missed opportunities, and related knowledge, attitudes and practices during introduction of a second dose of measles-containing vaccine into Cambodia's national immunization program.
    Vaccine. 2018 Jun 12. pii: S0264-410X(18)30821.
    PubMed     Text format     Abstract available


  411. STRASSBERG ER, Power M, Schulkin J, Stark LM, et al
    Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy.
    Vaccine. 2018 Jun 12. pii: S0264-410X(18)30800.
    PubMed     Text format     Abstract available


  412. SIMWAKA JC, Mpabalwani EM, Seheri M, Peenze I, et al
    Diversity of rotavirus strains circulating in children under five years of age who presented with acute gastroenteritis before and after rotavirus vaccine introduction, University Teaching Hospital, Lusaka, Zambia, 2008-2015.
    Vaccine. 2018 Jun 12. pii: S0264-410X(18)30380.
    PubMed     Text format     Abstract available


  413. FOUGERE Y, El Houss S, Suris JC, Rouvenaz-Defago S, et al
    High coverage of hepatitis B vaccination and low prevalence of chronic hepatitis B in migrant children dictate a new catch-up vaccination strategy.
    Vaccine. 2018 Jun 12. pii: S0264-410X(18)30825.
    PubMed     Text format     Abstract available


  414. PEZZOTTI P, Miglietta A, Neri A, Fazio C, et al
    Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30813.
    PubMed     Text format     Abstract available


  415. ENGELHARDT OG, Edge C, Dunleavy U, Guilfoyle K, et al
    Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30742.
    PubMed     Text format     Abstract available


  416. HENKE J, Carlson J, Zani L, Leidenberger S, et al
    Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf".
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30830.
    PubMed     Text format     Abstract available


  417. DOBROVOLSKIENE N, Pasukoniene V, Darinskas A, Krasko JA, et al
    Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30832.
    PubMed     Text format     Abstract available


  418. RUSSO P, Ligsay AD, Olveda R, Choi SK, et al
    A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol(R), a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30769.
    PubMed     Text format     Abstract available


  419. JOYCE C, Scallan CD, Mateo R, Belshe RB, et al
    Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30789.
    PubMed     Text format     Abstract available


  420. HILL S, Entwisle C, Pang Y, Joachim M, et al
    Immunogenicity and mechanisms of action of PnuBioVax, a multi-antigen serotype-independent prophylactic vaccine against infection with Streptococcus pneumoniae.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30801.
    PubMed     Text format     Abstract available


  421. ZHANG Y, Huang S, Zeng Y, Xue C, et al
    Rapid development and evaluation of a live-attenuated QX-like infectious bronchitis virus vaccine.
    Vaccine. 2018 Jun 8. pii: S0264-410X(18)30820.
    PubMed     Text format     Abstract available


  422. WALKER WL, Hills SL, Miller ER, Fischer M, et al
    Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012-2016.
    Vaccine. 2018 Jun 8. pii: S0264-410X(18)30521.
    PubMed     Text format     Abstract available


  423. LIN YL, Cheng PY, Chin CL, Huang LM, et al
    Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine.
    Vaccine. 2018 Jun 8. pii: S0264-410X(18)30756.
    PubMed     Text format     Abstract available


  424. TAN N, Sharma M, Winer R, Galloway D, et al
    Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa.
    Vaccine. 2018 Jun 8. pii: S0264-410X(18)30197.
    PubMed     Text format     Abstract available


  425. LABASTIDA-CONDE RG, Ramirez-Pliego O, Peleteiro-Olmedo M, Lopez-Guerrero DV, et al
    Flagellin is a Th1 polarizing factor for human CD4(+) T cells and induces protection in a murine neonatal vaccination model of rotavirus infection.
    Vaccine. 2018 Jun 8. pii: S0264-410X(18)30816.
    PubMed     Text format     Abstract available


  426. LI Q, Xu Z, Wu T, Peng O, et al
    A flagellin-adjuvanted PED subunit vaccine improved protective efficiency against PEDV variant challenge in pigs.
    Vaccine. 2018 Jun 8. pii: S0264-410X(18)30822.
    PubMed     Text format     Abstract available


  427. VALKENBURG SA, Li OTW, Li A, Bull M, et al
    Protection by universal influenza vaccine is mediated by memory CD4 T cells.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30818.
    PubMed     Text format     Abstract available


  428. CHESSON HW, Meites E, Ekwueme DU, Saraiya M, et al
    Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26years in the United States.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30578.
    PubMed     Text format     Abstract available


  429. DYDA A, McIntyre P, Karki S, MacIntyre CR, et al
    Pertussis vaccination in a cohort of older Australian adults following a cocooning vaccination program.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30786.
    PubMed     Text format     Abstract available


  430. GILCA V, Salmeron-Castro J, Sauvageau C, Ogilvie G, et al
    Early use of the HPV 2-dose vaccination schedule: Leveraging evidence to support policy for accelerated impact.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30168.
    PubMed     Text format     Abstract available


  431. KIELY M, Boulianne N, Talbot D, Ouakki M, et al
    Impact of the addition of new vaccines in the early childhood schedule on vaccine coverage by 24months of age from 2006 to 2016 in Quebec, Canada.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30463.
    PubMed     Text format     Abstract available


  432. BENNETT A, Pollock L, Jere KC, Pitzer VE, et al
    Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30513.
    PubMed     Text format     Abstract available


  433. HU K, Fu M, Guan X, Zhang D, et al
    Penton base induces better protective immune responses than fiber and hexon as a subunit vaccine candidate against adenoviruses.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30797.
    PubMed     Text format     Abstract available


  434. BAAY M, Bollaerts K, Verstraeten T
    A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults.
    Vaccine. 2018 Jun 6. pii: S0264-410X(18)30815.
    PubMed     Text format     Abstract available


  435. PHILLIPS DE, Dieleman JL, Shearer JC, Lim SS, et al
    Childhood vaccines in Uganda and Zambia: Determinants and barriers to vaccine coverage.
    Vaccine. 2018 Jun 6. pii: S0264-410X(18)30795.
    PubMed     Text format     Abstract available


  436. MODI RN, King C, Bar-Zeev N, Colbourn T, et al
    Caregiver recall in childhood vaccination surveys: Systematic review of recall quality and use in low- and middle-income settings.
    Vaccine. 2018 Jun 6. pii: S0264-410X(18)30755.
    PubMed     Text format     Abstract available


  437. MCGREGOR S, Saulo D, Brotherton J, Liu B, et al
    Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30771.
    PubMed     Text format     Abstract available


  438. FOSTER M, Pandey A, Kreimeyer K, Botsis T, et al
    Generation of an annotated reference standard for vaccine adverse event reports.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30745.
    PubMed     Text format     Abstract available


  439. TASHANI M, Alfelali M, Barasheed O, Alqahtani AS, et al
    Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj p
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30516.
    PubMed     Text format     Abstract available


  440. RUSSO R, Bozzola E, Villani A
    Immunization of preterms with hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: The position of the Italian Pediatric Society.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30794.
    PubMed     Text format    


  441. PRINCIPI N, Esposito S
    Vaccine-preventable diseases, vaccines and Guillain-Barre' syndrome.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30798.
    PubMed     Text format     Abstract available


  442. FAN X, Su Q, Qiu F, Yi Y, et al
    Intranasal inoculate of influenza virus vaccine against lethal virus challenge.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30739.
    PubMed     Text format     Abstract available


  443. BRANCHE AR, Yang H, Java J, Wiltse-Holden J, et al
    Effect of prior vaccination on carriage rates of Streptococcus pneumoniae in older adults: A longitudinal surveillance study.
    Vaccine. 2018 Jun 2. pii: S0264-410X(18)30774.
    PubMed     Text format     Abstract available


  444. MULYANI NS, Prasetyo D, Karyana IPG, Sukardi W, et al
    Diarrhea among hospitalized children under five: A call for inclusion of rotavirus vaccine to the national immunization program in Indonesia.
    Vaccine. 2018 Jun 1. pii: S0264-410X(18)30649.
    PubMed     Text format     Abstract available


  445. HENDRIKS J, Hutubessy RCW, Grohmann G, Torelli G, et al
    Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability.
    Vaccine. 2018 Jun 1. pii: S0264-410X(18)30766.
    PubMed     Text format     Abstract available


  446. MULLIGAN K, Snider JT, Arthur P, Frank G, et al
    Examination of universal purchase programs as a driver of vaccine uptake among US States, 1995-2014.
    Vaccine. 2018 Jun 1. pii: S0264-410X(18)30770.
    PubMed     Text format     Abstract available


    May 2018
  447. FISHER DG, Coppock GM, Lopez CB
    Virus-derived immunostimulatory RNA induces type I IFN-dependent antibodies and T-cell responses during vaccination.
    Vaccine. 2018 May 31. pii: S0264-410X(18)30767.
    PubMed     Text format     Abstract available


  448. BEESLAAR J, Absalon J, Balmer P, Srivastava A, et al
    Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults.
    Vaccine. 2018 May 31. pii: S0264-410X(18)30680.
    PubMed     Text format     Abstract available


  449. MOORE HC, Fathima P, Gidding HF, de Klerk N, et al
    Assessment of on-time vaccination coverage in population subgroups: A record linkage cohort study.
    Vaccine. 2018 May 31. pii: S0264-410X(18)30750.
    PubMed     Text format     Abstract available


  450. VERMA S, Sugadev R, Kumar A, Chandna S, et al
    Multi-epitope DnaK peptide vaccine against S.Typhi: An in silico approach.
    Vaccine. 2018 May 31. pii: S0264-410X(18)30773.
    PubMed     Text format     Abstract available


  451. GREGG KA, Harberts E, Gardner FM, Pelletier MR, et al
    A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model.
    Vaccine. 2018 May 31. pii: S0264-410X(18)30768.
    PubMed     Text format     Abstract available


  452. GARRETSON TA, Petrie JG, Martin ET, Monto AS, et al
    Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain.
    Vaccine. 2018 May 31. pii: S0264-410X(18)30752.
    PubMed     Text format     Abstract available


  453. GESSNER BD, Jiang Q, Van Werkhoven CH, Sings HL, et al
    A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands.
    Vaccine. 2018 May 31. pii: S0264-410X(18)30763.
    PubMed     Text format     Abstract available


  454. GAO F, Jiang Y, Li G, Zhou Y, et al
    Porcine reproductive and respiratory syndrome virus expressing E2 of classical swine fever virus protects pigs from a lethal challenge of highly-pathogenic PRRSV and CSFV.
    Vaccine. 2018;36:3269-3277.
    PubMed     Text format     Abstract available


  455. ZHANG W, Sun H, Atiquzzaman M, Sou J, et al
    Influenza vaccination for HIV-positive people: Systematic review and network meta-analysis.
    Vaccine. 2018 May 30. pii: S0264-410X(18)30743.
    PubMed     Text format     Abstract available


  456. XIA J, He X, Du LJ, Liu YY, et al
    Preparation and protective efficacy of a chicken embryo kidney cell-attenuation GI-19/QX-like avian infectious bronchitis virus vaccine.
    Vaccine. 2018 May 30. pii: S0264-410X(18)30760.
    PubMed     Text format     Abstract available


  457. FLEMING JA, Baltrons R, Rowley E, Quintanilla I, et al
    Implementation of maternal influenza immunization in El Salvador: Experiences and lessons learned from a mixed-methods study.
    Vaccine. 2018 May 30. pii: S0264-410X(18)30762.
    PubMed     Text format     Abstract available


  458. ASTILL J, Alkie T, Yitbarek A, Abdelaziz KTA, et al
    Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
    Vaccine. 2018 May 28. pii: S0264-410X(18)30759.
    PubMed     Text format     Abstract available


  459. LIU X, Yang C, Zhong Q, Song Q, et al
    Improved timely birth dose coverage of hepatitis B vaccine narrows the socio-economic inequality in western China in 2011-2016.
    Vaccine. 2018 May 26. pii: S0264-410X(18)30751.
    PubMed     Text format     Abstract available


  460. LIU H, de Almeida RS, Gil P, Majo N, et al
    Can genotype mismatch really affect the level of protection conferred by Newcastle disease vaccines against heterologous virulent strains?
    Vaccine. 2018 May 26. pii: S0264-410X(18)30738.
    PubMed     Text format     Abstract available


  461. CHATTOPADHYAY A, Aguilar PV, Bopp NE, Yarovinsky TO, et al
    A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections.
    Vaccine. 2018 May 25. pii: S0264-410X(18)30761.
    PubMed     Text format     Abstract available


  462. ALEXANDER KE, Tong PL, Macartney K, Beresford R, et al
    Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection.
    Vaccine. 2018 May 25. pii: S0264-410X(18)30744.
    PubMed     Text format     Abstract available


  463. BURGER EA, Campos NG, Sy S, Regan C, et al
    Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country.
    Vaccine. 2018 May 25. pii: S0264-410X(18)30558.
    PubMed     Text format     Abstract available


  464. MARTORELLI L, Garimano N, Fiorentino GA, Vilte DA, et al
    Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
    Vaccine. 2018 May 25. pii: S0264-410X(18)30679.
    PubMed     Text format     Abstract available


  465. HENNINGER ML, Kuntz JL, Firemark AJ, Varga AM, et al
    Feasibility of a pilot intervention to reduce pain and syncope during adolescent vaccination.
    Vaccine. 2018 May 24. pii: S0264-410X(18)30713.
    PubMed     Text format     Abstract available


  466. MARKOWITZ LE, Drolet M, Perez N, Jit M, et al
    Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs.
    Vaccine. 2018 May 22. pii: S0264-410X(18)30117.
    PubMed     Text format     Abstract available


  467. MWANZA-LISULO M, Chomba MS, Chama M, Besa EC, et al
    Retinoic acid elicits a coordinated expression of gut homing markers on T lymphocytes of Zambian men receiving oral Vivotif, but not Rotarix, Dukoral or OPVERO vaccines.
    Vaccine. 2018 May 22. pii: S0264-410X(18)30599.
    PubMed     Text format     Abstract available


  468. KONNO R, Konishi H, Sauvaget C, Ohashi Y, et al
    Effectiveness of HPV vaccination against high grade cervical lesions in Japan.
    Vaccine. 2018 May 21. pii: S0264-410X(18)30668.
    PubMed     Text format     Abstract available


  469. BOYD ED, Phillips JM, Schoenberger YM, Simpson T, et al
    Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers.
    Vaccine. 2018 May 21. pii: S0264-410X(18)30605.
    PubMed     Text format     Abstract available


  470. WANG LJ, Xiao T, Xu C, Li J, et al
    Protective immune response against Toxoplasma gondii elicited by a novel yeast-based vaccine with microneme protein 16.
    Vaccine. 2018 May 21. pii: S0264-410X(18)30715.
    PubMed     Text format     Abstract available


  471. MPABALWANI EM, Simwaka JC, Mwenda JM, Matapo B, et al
    Sustained impact of rotavirus vaccine on rotavirus hospitalisations in Lusaka, Zambia, 2009-2016.
    Vaccine. 2018 May 21. pii: S0264-410X(18)30274.
    PubMed     Text format     Abstract available


  472. LOGAN J, Nederhoff D, Koch B, Griffith B, et al
    'What have you HEARD about the HERD?' Does education about local influenza vaccination coverage and herd immunity affect willingness to vaccinate?
    Vaccine. 2018 May 19. pii: S0264-410X(18)30657.
    PubMed     Text format     Abstract available


  473. PAGLIUSI S, Dennehy M, Kim H
    Vaccines, inspiring innovation in health.
    Vaccine. 2018 May 19. pii: S0264-410X(18)30655.
    PubMed     Text format     Abstract available


  474. YANG YT, Silverman RD
    Mandatory influenza vaccination and religious accommodation for healthcare workers: Lessons from recent legal challenges.
    Vaccine. 2018 May 19. pii: S0264-410X(18)30714.
    PubMed     Text format    


  475. JACKSON LA, Rupp R, Papadimitriou A, Wallace D, et al
    A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate.
    Vaccine. 2018 May 19. pii: S0264-410X(18)30635.
    PubMed     Text format     Abstract available


  476. DBAIBO G, Tinoco Favila JC, Traskine M, Jastorff A, et al
    Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study.
    Vaccine. 2018 May 18. pii: S0264-410X(18)30666.
    PubMed     Text format     Abstract available


  477. DE MENEZES MARTINS R, Maia MLS, de Lima SMB, de Noronha TG, et al
    Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study.
    Vaccine. 2018 May 18. pii: S0264-410X(18)30661.
    PubMed     Text format     Abstract available


  478. CHEN Y, Ma F, Xu Y, Chu X, et al
    Vaccines and the risk of acute disseminated encephalomyelitis.
    Vaccine. 2018 May 18. pii: S0264-410X(18)30703.
    PubMed     Text format     Abstract available


  479. GRIEVES JL, Yin Z, Garcia-Sastre A, Mena I, et al
    A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats.
    Vaccine. 2018 May 17. pii: S0264-410X(18)30609.
    PubMed     Text format     Abstract available


  480. FERNANDO GJP, Hickling J, Jayashi Flores CM, Griffin P, et al
    Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch).
    Vaccine. 2018 May 17. pii: S0264-410X(18)30673.
    PubMed     Text format     Abstract available


  481. BOCKSTAL V, Sanders B, Achterberg R, Tiemessen M, et al
    A comparative study between outbred and inbred rat strains for the use in in vivo IPV potency testing.
    Vaccine. 2018;36:2917-2920.
    PubMed     Text format     Abstract available


  482. MARRIE TJ, Tyrrell GJ, Majumdar SR, Eurich DT, et al
    Invasive pneumococcal disease in Northern Alberta, not a Red Queen but a dark horse.
    Vaccine. 2018;36:2985-2990.
    PubMed     Text format     Abstract available


  483. LUO W, Qu Z, Zhang L, Xie Y, et al
    Recombinant BCG::Rv2645 elicits enhanced protective immunity compared to BCG in vivo with induced ISGylation-related genes and Th1 and Th17 responses.
    Vaccine. 2018;36:2998-3009.
    PubMed     Text format     Abstract available


  484. HOP HT, Arayan LT, Huy TXN, Reyes AWB, et al
    Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Vaccine. 2018;36:3027-3033.
    PubMed     Text format     Abstract available


  485. DILLNER J, Nygard M, Munk C, Hortlund M, et al
    Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30626.
    PubMed     Text format     Abstract available


  486. SCHNAITH AM, Evans EM, Vogt C, Tinsay AM, et al
    An innovative medical school curriculum to address human papillomavirus vaccine hesitancy.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30621.
    PubMed     Text format     Abstract available


  487. HERBERT JA, Kay EJ, Faustini SE, Richter A, et al
    Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30656.
    PubMed     Text format     Abstract available


  488. APAYDIN KZ, Fontenot HB, Shtasel D, Dale SK, et al
    Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30217.
    PubMed     Text format     Abstract available


  489. JONKER EFF, van Ravenhorst MB, Berbers GAM, Visser LG, et al
    Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30704.
    PubMed     Text format     Abstract available


  490. BUTTENHEIM AM, Jones M, Mckown C, Salmon D, et al
    Conditional admission, religious exemption type, and nonmedical vaccine exemptions in California before and after a state policy change.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30670.
    PubMed     Text format     Abstract available


  491. CHUAI X, Xie B, Chen H, Tan X, et al
    The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30681.
    PubMed     Text format     Abstract available


  492. LI T, Wang H, Lu Y, Li Q, et al
    Willingness and influential factors of parents to vaccinate their children with novel inactivated enterovirus 71 vaccines in Guangzhou, China.
    Vaccine. 2018 May 15. pii: S0264-410X(18)30674.
    PubMed     Text format     Abstract available


  493. XU W, Zhang Z, Nfon C, Yang M, et al
    Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
    Vaccine. 2018 May 15. pii: S0264-410X(18)30665.
    PubMed     Text format     Abstract available


  494. CAPEDING MR, Teshome S, Saluja T, Syed KA, et al
    Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children.
    Vaccine. 2018 May 15. pii: S0264-410X(18)30658.
    PubMed     Text format     Abstract available


  495. SCHMIDT AL, Zollo F, Scala A, Betsch C, et al
    Polarization of the vaccination debate on Facebook.
    Vaccine. 2018 May 14. pii: S0264-410X(18)30660.
    PubMed     Text format     Abstract available


  496. HIRSH BAR GAI D, Graybill Z, Voevodsky P, Shittu E, et al
    Evaluating scenarios of locations and capacities for vaccine storage in Nigeria.
    Vaccine. 2018 May 14. pii: S0264-410X(18)30579.
    PubMed     Text format     Abstract available


  497. GAO Y, Pei C, Sun X, Zhang C, et al
    Plasmid pcDNA3.1-s11 constructed based on the S11 segment of grass carp reovirus as DNA vaccine provides immune protection.
    Vaccine. 2018 May 12. pii: S0264-410X(18)30663.
    PubMed     Text format     Abstract available


  498. JAIN S, George PJ, Deng W, Koussa J, et al
    The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4(+) T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway.
    Vaccine. 2018 May 12. pii: S0264-410X(18)30636.
    PubMed     Text format     Abstract available


  499. KAHN KE, Santibanez TA, Zhai Y, Bridges CB, et al
    Association between provider recommendation and influenza vaccination status among children.
    Vaccine. 2018 May 12. pii: S0264-410X(18)30584.
    PubMed     Text format     Abstract available


  500. LONGBOTTOM D, Sait M, Livingstone M, Laroucau K, et al
    Genomic evidence that the live Chlamydia abortus vaccine strain 1B is not attenuated and has the potential to cause disease.
    Vaccine. 2018 May 11. pii: S0264-410X(18)30662.
    PubMed     Text format     Abstract available


  501. DESHMUKH U, Oliveira CR, Griggs S, Coleman E, et al
    Impact of a clinical interventions bundle on uptake of HPV vaccine at an OB/GYN clinic.
    Vaccine. 2018 May 11. pii: S0264-410X(18)30659.
    PubMed     Text format     Abstract available


  502. LAGOUTTE P, Mignon C, Stadthagen G, Potisopon S, et al
    Simultaneous surface display and cargo loading of encapsulin nanocompartments and their use for rational vaccine design.
    Vaccine. 2018 May 11. pii: S0264-410X(18)30654.
    PubMed     Text format     Abstract available


  503. VAN RIJN PA, Maris-Veldhuis MA, Boonstra J, van Gennip RGP, et al
    Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
    Vaccine. 2018 May 11. pii: S0264-410X(18)30664.
    PubMed     Text format     Abstract available


  504. EDIRISURIYA C, Beard FH, Hendry AJ, Dey A, et al
    Australian rubella serosurvey 2012-2013: On track for elimination?
    Vaccine. 2018;36:2794-2798.
    PubMed     Text format     Abstract available


  505. DAGAN R, Ben-Shimol S, Simell B, Greenberg D, et al
    A toddler PCV booster dose following 3 infancy priming doses increases circulating serotype-specific IGG levels but does not increase protection against carriage.
    Vaccine. 2018;36:2774-2782.
    PubMed     Text format     Abstract available


  506. PRENTICE S, Kamushaaga Z, Nash SB, Elliott AM, et al
    Post-immunization leucocytosis and its implications for the management of febrile infants.
    Vaccine. 2018;36:2870-2875.
    PubMed     Text format     Abstract available


  507. YASUI Y, Mitsui T, Nishimura T, Uchida K, et al
    School-age children and adolescents suspected of having been to be infected with pertussis in Japan.
    Vaccine. 2018;36:2910-2915.
    PubMed     Text format     Abstract available


  508. SIBOMANA H, Rugambwa C, Mwenda JM, Sayinzoga F, et al
    Impact of routine rotavirus vaccination on all-cause and rotavirus hospitalizations during the first four years following vaccine introduction in Rwanda.
    Vaccine. 2018 May 10. pii: S0264-410X(18)30145.
    PubMed     Text format     Abstract available


  509. STANLEY M, Dull P
    HPV single-dose vaccination: Impact potential, evidence base and further evaluation.
    Vaccine. 2018 May 10. pii: S0264-410X(18)30273.
    PubMed     Text format    


  510. WANG R, Liao X, Fan D, Wang L, et al
    Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice.
    Vaccine. 2018 May 9. pii: S0264-410X(18)30548.
    PubMed     Text format     Abstract available


  511. ROHDE RL, Adjei Boakye E, Christopher KM, Geneus CJ, et al
    Assessing university students' sexual risk behaviors as predictors of human papillomavirus (HPV) vaccine uptake behavior.
    Vaccine. 2018 May 9. pii: S0264-410X(18)30629.
    PubMed     Text format     Abstract available


  512. COLDIRON ME, Guindo O, Makarimi R, Soumana I, et al
    Safety of a heat-stable rotavirus vaccine among children in Niger: Data from a phase 3, randomized, double-blind, placebo-controlled trial.
    Vaccine. 2018 May 8. pii: S0264-410X(18)30630.
    PubMed     Text format     Abstract available


  513. LANDIS K, Bednarczyk RA, Gaydos LM
    Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen.
    Vaccine. 2018 May 8. pii: S0264-410X(18)30582.
    PubMed     Text format     Abstract available


  514. SAHA A, Hayen A, Ali M, Rosewell A, et al
    Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh.
    Vaccine. 2018 May 8. pii: S0264-410X(18)30604.
    PubMed     Text format     Abstract available


  515. BUSTOS-ARRIAGA J, Gromowski GD, Tsetsarkin KA, Firestone CY, et al
    Decreased accumulation of subgenomic RNA in human cells infected with vaccine candidate DEN4Delta30 increases viral susceptibility to type I interferon.
    Vaccine. 2018 May 8. pii: S0264-410X(18)30607.
    PubMed     Text format     Abstract available


  516. MAGWIRA CA, Taylor MB
    Composition of gut microbiota and its influence on the immunogenicity of oral rotavirus vaccines.
    Vaccine. 2018 May 8. pii: S0264-410X(18)30616.
    PubMed     Text format     Abstract available


  517. ENWERONU-LARYEA CC, Armah G, Sagoe KW, Ansong D, et al
    Sustained impact of rotavirus vaccine introduction on rotavirus gastroenteritis hospitalizations in children <5years of age, Ghana, 2009-2016.
    Vaccine. 2018 May 8. pii: S0264-410X(18)30245.
    PubMed     Text format     Abstract available


  518. THYSEN SM, Fisker AB
    Selecting the right indicators to ensure optimised implementation of BCG vaccination policy.
    Vaccine. 2018 May 7. pii: S0264-410X(18)30602.
    PubMed     Text format    


  519. HARRISON SM, Wei MY, Lamerato LE, Petrie JG, et al
    Multimorbidity is associated with uptake of influenza vaccination.
    Vaccine. 2018 May 7. pii: S0264-410X(18)30628.
    PubMed     Text format     Abstract available


  520. SHAH PD, Marciniak MW, Golden SD, Trogdon JG, et al
    Pharmacies versus doctors' offices for adolescent vaccination.
    Vaccine. 2018 May 7. pii: S0264-410X(18)30608.
    PubMed     Text format     Abstract available


  521. ARRIOLA CS, Vasconez N, Bresee J, Ropero AM, et al
    "Knowledge, attitudes and practices about influenza vaccination among pregnant women and healthcare providers serving pregnant women in Managua, Nicaragua".
    Vaccine. 2018 May 7. pii: S0264-410X(18)30620.
    PubMed     Text format     Abstract available


  522. SVENSSON T, Kattstrom M, Hammarlund Y, Roth D, et al
    Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group.
    Vaccine. 2018 May 7. pii: S0264-410X(18)30619.
    PubMed     Text format     Abstract available


  523. SEO J, Lim J
    Trends in influenza vaccination coverage rates in South Korea from 2005 to 2014: Effect of public health policies on vaccination behavior.
    Vaccine. 2018 May 5. pii: S0264-410X(18)30631.
    PubMed     Text format     Abstract available


  524. JUNG SY, Kang KW, Lee EY, Seo DW, et al
    Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus.
    Vaccine. 2018 May 5. pii: S0264-410X(18)30598.
    PubMed     Text format     Abstract available


  525. YEUNG KHT, Chan KCC, Chan PKS, Lam DSY, et al
    Influenza vaccine effectiveness in hospitalised Hong Kong children: Feasibility of estimates from routine surveillance data.
    Vaccine. 2018 May 5. pii: S0264-410X(18)30588.
    PubMed     Text format     Abstract available


  526. MISRA N, Wines TF, Knopp CL, Hermann R, et al
    Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis.
    Vaccine. 2018 May 5. pii: S0264-410X(18)30564.
    PubMed     Text format     Abstract available


  527. LIM H, In HJ, Lee JA, Sik Yoo J, et al
    The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
    Vaccine. 2018 May 5. pii: S0264-410X(18)30610.
    PubMed     Text format     Abstract available


  528. KOMATSU A, Igimi S, Kawana K
    Optimization of human papillomavirus (HPV) type 16 E7-expressing lactobacillus-based vaccine for induction of mucosal E7-specific IFNgamma-producing cells.
    Vaccine. 2018 May 5. pii: S0264-410X(18)30615.
    PubMed     Text format     Abstract available


  529. MOHAPATRA JK, Das B, Rout M, Sreenivasa BP, et al
    Alternate vaccine strain selection in the wake of emerging foot-and-mouth disease virus serotype A antigenic variants in India.
    Vaccine. 2018 May 4. pii: S0264-410X(18)30614.
    PubMed     Text format     Abstract available


  530. CHEAH BC, Davies J, Singh GR, Wood N, et al
    Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.
    Vaccine. 2018 May 4. pii: S0264-410X(18)30122.
    PubMed     Text format     Abstract available


  531. BREDBERG A, Boe OW, Bredberg J, Whist JE, et al
    Detection of hepatitis B surface antigen in blood following vaccination.
    Vaccine. 2018 May 4. pii: S0264-410X(18)30600.
    PubMed     Text format    


  532. GARGANO JW, Zhou F, Stokley S, Markowitz LE, et al
    Human papillomavirus vaccination in commercially-Insured vaccine-eligible males and females, United States, 2007-2014.
    Vaccine. 2018 May 4. pii: S0264-410X(18)30390.
    PubMed     Text format     Abstract available


  533. HANSON CM, Mirza I, Kumapley R, Ogbuanu I, et al
    Enhancing immunization during second year of life by reducing missed opportunities for vaccinations in 46 countries.
    Vaccine. 2018 May 3. pii: S0264-410X(18)30577.
    PubMed     Text format     Abstract available


  534. POULOS C, Curran D, Anastassopoulou A, De Moerlooze L, et al
    Corrigendum to "German travelers' preferences for travel vaccines assessed by a discrete choice experiment" [Vaccine 36 (2018) 969-978].
    Vaccine. 2018 May 3. pii: S0264-410X(18)30549.
    PubMed     Text format    


  535. GUALANO MR, Bert F, Voglino G, Buttinelli E, et al
    Attitudes towards compulsory vaccination in Italy: Results from the NAVIDAD multicentre study.
    Vaccine. 2018 May 2. pii: S0264-410X(18)30512.
    PubMed     Text format     Abstract available


  536. LOPEZ AL, Raguindin PF, Esparagoza J, Fox K, et al
    Impact of rotavirus vaccine on diarrheal hospitalization and outpatient consultations in the Philippines: First evidence from a middle-income Asian country.
    Vaccine. 2018 May 2. pii: S0264-410X(18)30555.
    PubMed     Text format     Abstract available


  537. DEEPE GS JR, Buesing WR, Ostroff GR, Abraham A, et al
    Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice.
    Vaccine. 2018 May 2. pii: S0264-410X(18)30544.
    PubMed     Text format     Abstract available


  538. BARTOSZKO JJ, McNamara IF, Aras OAZ, Hylton DA, et al
    Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis.
    Vaccine. 2018 May 1. pii: S0264-410X(18)30546.
    PubMed     Text format     Abstract available


    April 2018
  539. HERBERT GS, Vreeland TJ, Clifton GT, Greene JM, et al
    Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors.
    Vaccine. 2018 Apr 30. pii: S0264-410X(18)30585.
    PubMed     Text format     Abstract available


  540. KNUF M, Helm K, Kolhe D, Van Der Wielen M, et al
    Antibody persistence and booster response 68months after vaccination at 2-10years of age with one dose of MenACWY-TT conjugate vaccine.
    Vaccine. 2018 Apr 30. pii: S0264-410X(18)30561.
    PubMed     Text format     Abstract available


  541. DELLEPIANE N, Pagliusi S
    Challenges for the registration of vaccines in emerging countries: Differences in dossier requirements, application and evaluation processes.
    Vaccine. 2018 Apr 30. pii: S0264-410X(18)30405.
    PubMed     Text format     Abstract available


  542. SHUBITZ LF, Powell DA, Trinh HT, Lewis ML, et al
    Viable spores of Coccidioides posadasii Deltacps1 are required for vaccination and provide long lasting immunity.
    Vaccine. 2018 Apr 30. pii: S0264-410X(18)30507.
    PubMed     Text format     Abstract available


  543. GARLAND SM, Cornall AM, Brotherton JML, Wark JD, et al
    Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
    Vaccine. 2018 Apr 30. pii: S0264-410X(18)30587.
    PubMed     Text format     Abstract available


  544. BOEY L, Bral C, Roelants M, De Schryver A, et al
    Attitudes, believes, determinants and organisational barriers behind the low seasonal influenza vaccination uptake in healthcare workers - A cross-sectional survey.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30539.
    PubMed     Text format     Abstract available


  545. VANSKA S, Soderlund-Strand A, Uhnoo I, Lehtinen M, et al
    Estimating effectiveness of HPV vaccination against HPV infection from post-vaccination data in the absence of baseline data.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30580.
    PubMed     Text format     Abstract available


  546. TESSIER E, Warburton F, Tsang C, Rafeeq S, et al
    Population-level factors predicting variation in influenza vaccine uptake among adults and young children in England, 2015/16 and 2016/17.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30581.
    PubMed     Text format     Abstract available


  547. SKIPETROVA A, Wartel TA, Gailhardou S
    Dengue vaccination during pregnancy - An overview of clinical trials data.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30547.
    PubMed     Text format     Abstract available


  548. LU PJ, O'Halloran AC, Williams WW, Nelson NP, et al
    Hepatitis B vaccination coverage among adults aged >/=18years traveling to a country of high or intermediate endemicity, United States, 2015.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30376.
    PubMed     Text format     Abstract available


  549. REGAN AK, Gibbs RA, Effler PV
    An audit of the reliability of influenza vaccination and medical information extracted from eHealth records in general practice.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30583.
    PubMed     Text format     Abstract available


  550. SOMES MP, Turner RM, Dwyer LJ, Newall AT, et al
    Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30560.
    PubMed     Text format     Abstract available


  551. OLWAGEN CP, Adrian PV, Nunes MC, Madhi SA, et al
    Evaluation of the association of pneumococcal conjugate vaccine immunization and density of nasopharyngeal bacterial colonization using a multiplex quantitative polymerase chain reaction assay.
    Vaccine. 2018 Apr 27. pii: S0264-410X(18)30565.
    PubMed     Text format     Abstract available


  552. VAN DE WITTE S, Nauta J, Montomoli E, Weckx J, et al
    A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
    Vaccine. 2018 Apr 27. pii: S0264-410X(18)30538.
    PubMed     Text format     Abstract available


  553. LEE VY, Booy R, Skinner R, Edwards KM, et al
    The effect of exercise on vaccine-related pain, anxiety and fear during HPV vaccinations in adolescents.
    Vaccine. 2018 Apr 27. pii: S0264-410X(18)30576.
    PubMed     Text format     Abstract available


  554. ZHANG N, Nandakumar KS
    Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases.
    Vaccine. 2018 Apr 26. pii: S0264-410X(18)30559.
    PubMed     Text format     Abstract available


  555. LI R, Xie R, Yang C, Rainey J, et al
    Identifying ways to increase seasonal influenza vaccine uptake among pregnant women in China: A qualitative investigation of pregnant women and their obstetricians.
    Vaccine. 2018 Apr 26. pii: S0264-410X(18)30557.
    PubMed     Text format     Abstract available


  556. REEKIE J, Kaldor JM, Mak DB, Ward J, et al
    Long-term impact of childhood hepatitis B vaccination programs on prevalence among Aboriginal and non-Aboriginal women giving birth in Western Australia.
    Vaccine. 2018 Apr 26. pii: S0264-410X(18)30554.
    PubMed     Text format     Abstract available


  557. HJERTNER B, Bengtsson T, Morein B, Paulie S, et al
    A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine.
    Vaccine. 2018 Apr 26. pii: S0264-410X(18)30551.
    PubMed     Text format     Abstract available


  558. LECOUTURIER V, Berry C, Saulnier A, Naville S, et al
    Characterization of recombinant yellow fever-dengue vaccine viruses with human monoclonal antibodies targeting key conformational epitopes.
    Vaccine. 2018 Apr 26. pii: S0264-410X(18)30562.
    PubMed     Text format     Abstract available


  559. ZHANG X, Jiang Q, Xu X, Wang Y, et al
    Immune mechanisms induced by an HSV-1 mutant strain: Discrepancy analysis of the immune system gene profile in comparison with a wild-type strain.
    Vaccine. 2018;36:2394-2402.
    PubMed     Text format     Abstract available


  560. MULOIWA R, Wolter N, Mupere E, Tan T, et al
    Pertussis in Africa: Findings and recommendations of the Global Pertussis Initiative (GPI).
    Vaccine. 2018;36:2385-2393.
    PubMed     Text format     Abstract available


  561. YANG H, Yang H, Li Z, Liu L, et al
    Japanese encephalitis virus/yellow fever virus chimera is safe and confers full protection against yellow fever virus in intracerebrally challenged mice.
    Vaccine. 2018;36:2450-2455.
    PubMed     Text format     Abstract available


  562. OHLROGGE AW, Suggs LS
    Flu vaccination communication in Europe: What does the government communicate and how?
    Vaccine. 2018 Apr 24. pii: S0264-410X(18)30525.
    PubMed     Text format     Abstract available


  563. MOK CC, Ho LY, To CH
    Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30553.
    PubMed     Text format     Abstract available


  564. THAKUR A, Ingvarsson PT, Schmidt ST, Rose F, et al
    Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30552.
    PubMed     Text format     Abstract available


  565. KUCK LR, Byrne-Nash R, Gillis J, Bueter K, et al
    VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30545.
    PubMed     Text format     Abstract available


  566. WU Y, Marsh JA, McBryde ES, Snelling TL, et al
    The influence of incomplete case ascertainment on measures of vaccine efficacy.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30541.
    PubMed     Text format     Abstract available


  567. RAFFERTY E, Hetherington E, Tough S, Aujla S, et al
    The impact of time since vaccination and study design on validity in parental recall of childhood vaccination status in the All Our Families cohort.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30540.
    PubMed     Text format     Abstract available


  568. WALZ PH, Riddell KP, Newcomer BW, Neill JD, et al
    Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30473.
    PubMed     Text format     Abstract available


  569. HANIFI SMA, Ravn H, Aaby P, Bhuiya A, et al
    Where girls are less likely to be fully vaccinated than boys: Evidence from a rural area in Bangladesh.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30556.
    PubMed     Text format     Abstract available


  570. DALE LP, White L, Mitchell M, Faulkner G, et al
    Smartphone app uses loyalty point incentives and push notifications to encourage influenza vaccine uptake.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30487.
    PubMed     Text format     Abstract available


  571. BETSCH C, Bodeker B, Schmid P, Wichmann O, et al
    How baby's first shot determines the development of maternal attitudes towards vaccination.
    Vaccine. 2018 Apr 21. pii: S0264-410X(18)30492.
    PubMed     Text format     Abstract available


  572. VERHEES RAF, Dondorp W, Thijs C, Dinant GJ, et al
    Influenza vaccination in the elderly: Is a trial on mortality ethically acceptable?
    Vaccine. 2018 Apr 21. pii: S0264-410X(18)30510.
    PubMed     Text format     Abstract available


  573. METHNER U
    Immunisation of chickens with live Salmonella vaccines - Role of booster vaccination.
    Vaccine. 2018 Apr 21. pii: S0264-410X(18)30524.
    PubMed     Text format     Abstract available


  574. GOMEZ L, Alvarez F, Betancur D, Onate A, et al
    Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus.
    Vaccine. 2018 Apr 20. pii: S0264-410X(18)30483.
    PubMed     Text format     Abstract available


  575. SUZUKI M, Katsurada N, Le MN, Kaneko N, et al
    Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged >/=65years in Japan.
    Vaccine. 2018 Apr 20. pii: S0264-410X(18)30520.
    PubMed     Text format     Abstract available


  576. TOGASHI T, Mitsuya N, Sumino S, Takanami Y, et al
    Safety, tolerability and immunogenicity of intramuscular administration of PRP-CRM197 Hib vaccine to healthy Japanese children: An open-label trial.
    Vaccine. 2018 Apr 20. pii: S0264-410X(18)30523.
    PubMed     Text format     Abstract available



  577. Response to three Letters to the Editor regarding: Donahue JG, et al. "Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12". Vaccine 35 (2017) 5314-5322.
    Vaccine. 2018;36:2231-2232.
    PubMed     Text format    


  578. AN SJ, Scaria PV, Chen B, Barnafo E, et al
    Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever.
    Vaccine. 2018 Apr 19. pii: S0264-410X(18)30518.
    PubMed     Text format     Abstract available


  579. TANG X, Liu F, Sheng X, Xing J, et al
    Recombinant NADP-dependent isocitrate dehydrogenase of Edwardsiella tarda induces both Th1 and Th2 type immune responses and evokes protective efficacy against edwardsiellosis.
    Vaccine. 2018;36:2337-2345.
    PubMed     Text format     Abstract available


  580. SARKAR I, Garg R, van Drunen Littel-van den Hurk S
    The respiratory syncytial virus fusion protein formulated with a polymer-based adjuvant induces multiple signaling pathways in macrophages.
    Vaccine. 2018;36:2326-2336.
    PubMed     Text format     Abstract available


  581. WEN Y, Palladino G, Xie Y, Ferrari A, et al
    Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
    Vaccine. 2018 Apr 18. pii: S0264-410X(18)30490.
    PubMed     Text format     Abstract available


  582. VINCENT LR, Jerse AE
    Biological feasibility and importance of a gonorrhea vaccine for global public health.
    Vaccine. 2018 Apr 18. pii: S0264-410X(18)30278.
    PubMed     Text format     Abstract available


  583. JACA A, Mathebula L, Iweze A, Pienaar E, et al
    A systematic review of strategies for reducing missed opportunities for vaccination.
    Vaccine. 2018 Apr 18. pii: S0264-410X(18)30511.
    PubMed     Text format     Abstract available


  584. HOSCHLER K, Southern J, Thompson C, Warburton F, et al
    Responses to live attenuated influenza vaccine in children vaccinated previously with Pandemrix (ASO3B adjuvanted pandemic A/H1N1pdm09).
    Vaccine. 2018 Apr 18. pii: S0264-410X(18)30486.
    PubMed     Text format     Abstract available


  585. SZILAGYI PG, Schaffer S, Rand CM, Goldstein NPN, et al
    Impact of elementary school-located influenza vaccinations: A stepped wedge trial across a community.
    Vaccine. 2018 Apr 17. pii: S0264-410X(18)30403.
    PubMed     Text format     Abstract available


  586. GARNER-SPITZER E, Seidl-Friedrich C, Zwazl I, Hofer M, et al
    Allergic patients with and without allergen-specific immunotherapy mount protective immune responses to tick-borne encephalitis vaccination in absence of enhanced side effects or propagation of their Th2 bias.
    Vaccine. 2018 Apr 16. pii: S0264-410X(18)30454.
    PubMed     Text format     Abstract available


  587. LINK-GELLES R, Hofmeister MG, Nelson NP
    Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40years of age: A systematic review of published studies and recommendations for vaccine use.
    Vaccine. 2018 Apr 16. pii: S0264-410X(18)30484.
    PubMed     Text format     Abstract available


  588. SHIBATA N, Kimura S, Hoshino T, Takeuchi M, et al
    Effectiveness of influenza vaccination for children in Japan: Four-year observational study using a large-scale claims database.
    Vaccine. 2018 Apr 13. pii: S0264-410X(18)30460.
    PubMed     Text format     Abstract available


  589. BISSET KA, Paterson P
    Strategies for increasing uptake of vaccination in pregnancy in high-income countries: A systematic review.
    Vaccine. 2018 Apr 13. pii: S0264-410X(18)30482.
    PubMed     Text format     Abstract available


  590. SCHWAMBORN K
    Back to the future - Is the drug repositioning concept applicable to vaccines?
    Vaccine. 2018 Apr 13. pii: S0264-410X(18)30489.
    PubMed     Text format    


  591. WORLD HEALTH ORGANIZATION
    Typhoid vaccines: WHO position paper, March 2018 - Recommendations.
    Vaccine. 2018 Apr 13. pii: S0264-410X(18)30491.
    PubMed     Text format     Abstract available


  592. FONSECA JA, McCaffery JN, Caceres J, Kashentseva E, et al
    Inclusion of the murine IgGkappa signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.
    Vaccine. 2018 Apr 12. pii: S0264-410X(18)30474.
    PubMed     Text format     Abstract available


  593. SEGURA-CERDA CA, Aceves-Sanchez MJ, Marquina-Castillo B, Mata-Espinoza D, et al
    Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence.
    Vaccine. 2018;36:2069-2078.
    PubMed     Text format     Abstract available


  594. VAEZIRAD MM, Koene MG, Wagenaar JA, van Putten JPM, et al
    Chicken immune response following in ovo delivery of bacterial flagellin.
    Vaccine. 2018;36:2139-2146.
    PubMed     Text format     Abstract available


  595. PALOMARES LA, Mukhopadhyay TK, Genzel Y, Lua LHL, et al
    Vaccine Technology VI: Innovative and integrated approaches in vaccine development.
    Vaccine. 2018 Apr 11. pii: S0264-410X(18)30455.
    PubMed     Text format    


  596. METCALFE HJ, Biffar L, Steinbach S, Guzman E, et al
    Ag85A-specific CD4(+) T cell lines derived after boosting BCG-vaccinated cattle with Ad5-85A possess both mycobacterial growth inhibition and anti-inflammatory properties.
    Vaccine. 2018 Apr 11. pii: S0264-410X(18)30437.
    PubMed     Text format     Abstract available


  597. JANI B, Hokororo A, Mchomvu J, Cortese MM, et al
    Detection of rotavirus before and after monovalent rotavirus vaccine introduction and vaccine effectiveness among children in mainland Tanzania.
    Vaccine. 2018 Apr 11. pii: S0264-410X(18)30144.
    PubMed     Text format     Abstract available


  598. MACDONALD SE, Dover DC, Hill MD, Kirton A, et al
    Is varicella vaccination associated with pediatric arterial ischemic stroke? A population-based cohort study.
    Vaccine. 2018 Apr 11. pii: S0264-410X(18)30481.
    PubMed     Text format     Abstract available


  599. STANFIELD BA, Rider PJF, Caskey J, Del Piero F, et al
    Intramuscular vaccination of guinea pigs with the live-attenuated human herpes simplex vaccine VC2 stimulates a transcriptional profile of vaginal Th17 and regulatory Tr1 responses.
    Vaccine. 2018 Apr 11. pii: S0264-410X(18)30444.
    PubMed     Text format     Abstract available


  600. LYAMUYA F, Michael F, Jani B, Fungo Y, et al
    Trends in diarrhea hospitalizations among infants at three hospitals in Tanzania before and after rotavirus vaccine introduction.
    Vaccine. 2018 Apr 11. pii: S0264-410X(17)31615.
    PubMed     Text format     Abstract available


  601. HANEY DJ, Lock MD, Gurwith M, Simon JK, et al
    Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.
    Vaccine. 2018 Apr 11. pii: S0264-410X(18)30480.
    PubMed     Text format     Abstract available


  602. HUIJBERS EJM, van Beijnum JR, Le CT, Langman S, et al
    An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature.
    Vaccine. 2018 Apr 11. pii: S0264-410X(18)30433.
    PubMed     Text format     Abstract available


  603. MA R, Lu L, Zhou T, Pan J, et al
    Mumps disease in Beijing in the era of two-dose vaccination policy, 2005-2016.
    Vaccine. 2018 Apr 10. pii: S0264-410X(18)30443.
    PubMed     Text format     Abstract available


  604. ROBERTS JR, Morella K, Dawley EH, Madden CA, et al
    Direct-to-adolescent text messaging for vaccine reminders: What will parents permit?
    Vaccine. 2018 Apr 10. pii: S0264-410X(18)30466.
    PubMed     Text format     Abstract available


  605. LOPES PD, Okino CH, Fernando FS, Pavani C, et al
    Inactivated infectious bronchitis virus vaccine encapsulated in chitosan nanoparticles induces mucosal immune responses and effective protection against challenge.
    Vaccine. 2018 Apr 10. pii: S0264-410X(18)30434.
    PubMed     Text format     Abstract available


  606. HOFFMANN A, Dumke C, Hanschmann KO, Wicker S, et al
    Local thermal reaction after influenza vaccination: Quantification by infrared imaging and biometric considerations.
    Vaccine. 2018 Apr 10. pii: S0264-410X(18)30467.
    PubMed     Text format     Abstract available


  607. LARSON WILLIAMS A, McCloskey L, Mwale M, Mwananyanda L, et al
    "When you are injected, the baby is protected:" Assessing the acceptability of a maternal Tdap vaccine based on mothers' knowledge, attitudes, and beliefs of pertussis and vaccinations in Lusaka, Zambia.
    Vaccine. 2018 Apr 10. pii: S0264-410X(18)30459.
    PubMed     Text format     Abstract available


  608. LEWIS RM, Markowitz LE
    Human papillomavirus vaccination coverage among females and males, National Health and Nutrition Examination Survey, United States, 2007-2016.
    Vaccine. 2018 Apr 9. pii: S0264-410X(18)30461.
    PubMed     Text format     Abstract available


  609. BRANDILEONE MC, Almeida SCG, Minamisava R, Andrade AL, et al
    Distribution of invasive Streptococcus pneumoniae serotypes before and 5years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil.
    Vaccine. 2018 Apr 9. pii: S0264-410X(18)30479.
    PubMed     Text format     Abstract available


  610. IBARZ-PAVON AB, French N
    No changes on viral load and CD4+ T-cell counts following immunization with 7-valent pneumococcal conjugate vaccine among HIV-infected adults in Malawi.
    Vaccine. 2018 Apr 7. pii: S0264-410X(18)30478.
    PubMed     Text format     Abstract available


  611. MATSUYAMA T, Sano N, Takano T, Sakai T, et al
    Antibody profiling using a recombinant protein-based multiplex ELISA array accelerates recombinant vaccine development: Case study on red sea bream iridovirus as a reverse vaccinology model.
    Vaccine. 2018 Apr 6. pii: S0264-410X(18)30415.
    PubMed     Text format     Abstract available


  612. DING X, Li H, Li Y, Huang D, et al
    Two B-cell epitope vaccines based on uPA effectively inhibit fertility in male mice.
    Vaccine. 2018 Apr 6. pii: S0264-410X(18)30440.
    PubMed     Text format     Abstract available


  613. REHER D, Fuhrmann V, Kluge S, Nierhaus A, et al
    A rare case of septic shock due to Neisseria meningitidis serogroup B infection despite prior vaccination in a young adult with paroxysmal nocturnal haemoglobinuria receiving eculizumab.
    Vaccine. 2018 Apr 6. pii: S0264-410X(18)30465.
    PubMed     Text format     Abstract available


  614. HYER R, McGuire DK, Xing B, Jackson S, et al
    Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults.
    Vaccine. 2018 Apr 5. pii: S0264-410X(18)30436.
    PubMed     Text format     Abstract available


  615. LAPUENTE D, Ruzsics Z, Thirion C, Tenbusch M, et al
    Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses.
    Vaccine. 2018 Apr 5. pii: S0264-410X(18)30262.
    PubMed     Text format     Abstract available


  616. MUKARATIRWA A, Berejena C, Nziramasanga P, Ticklay I, et al
    Distribution of rotavirus genotypes associated with acute diarrhoea in Zimbabwean children less than five years old before and after rotavirus vaccine introduction.
    Vaccine. 2018 Apr 5. pii: S0264-410X(18)30438.
    PubMed     Text format     Abstract available


  617. ISABEL S, Higgins RR, Peci A, Isabel MR, et al
    Rotavirus genotypes circulating in Ontario, Canada, before and after implementation of the rotavirus immunization program.
    Vaccine. 2018;36:2033-2040.
    PubMed     Text format     Abstract available


  618. HUSSAIN I, Mach O, Hamid NA, Bhatti ZS, et al
    Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017.
    Vaccine. 2018;36:1921-1924.
    PubMed     Text format     Abstract available


  619. MAERTENS K, Braeckman T, Blaizot S, Theeten H, et al
    Coverage of recommended vaccines during pregnancy in Flanders, Belgium. Fairly good but can we do better?
    Vaccine. 2018 Apr 4. pii: S0264-410X(18)30378.
    PubMed     Text format     Abstract available


  620. KORNIDES ML, Fontenot HB, McRee AL, Panozzo CA, et al
    Associations between parents' satisfaction with provider communication and HPV vaccination behaviors.
    Vaccine. 2018 Apr 4. pii: S0264-410X(18)30416.
    PubMed     Text format     Abstract available


  621. ZHAO M, Vandersluis M, Stout J, Haupts U, et al
    Affinity chromatography for vaccines manufacturing: Finally ready for prime time?
    Vaccine. 2018 Apr 4. pii: S0264-410X(18)30289.
    PubMed     Text format     Abstract available


  622. DABAGHIAN M, Latifi AM, Tebianian M, NajmiNejad H, et al
    Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model.
    Vaccine. 2018 Apr 4. pii: S0264-410X(18)30259.
    PubMed     Text format     Abstract available


  623. GIDDING HF, McCallum L, Fathima P, Moore HC, et al
    Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia.
    Vaccine. 2018 Apr 4. pii: S0264-410X(18)30414.
    PubMed     Text format     Abstract available


  624. SUTTON P, Boag JM
    Status of vaccine research and development for Helicobacter pylori.
    Vaccine. 2018 Apr 4. pii: S0264-410X(18)30017.
    PubMed     Text format     Abstract available


  625. LACOMBE-DUNCAN A, Newman PA, Baiden P
    Human papillomavirus vaccine acceptability and decision-making among adolescent boys and parents: A meta-ethnography of qualitative studies.
    Vaccine. 2018 Apr 3. pii: S0264-410X(18)30276.
    PubMed     Text format     Abstract available


  626. SPICKNALL IH, Looker KJ, Gottlieb SL, Chesson HW, et al
    Review of mathematical models of HSV-2 vaccination: Implications for vaccine development.
    Vaccine. 2018 Apr 3. pii: S0264-410X(18)30254.
    PubMed     Text format     Abstract available


  627. CONLIN AMS, Bukowinski AT, Levine JA, Khodr ZG, et al
    A follow-up comparative safety analysis of pandemic H1N1 vaccination during pregnancy and risk of infant birth defects among U.S. military mothers.
    Vaccine. 2018 Apr 3. pii: S0264-410X(18)30417.
    PubMed     Text format     Abstract available


  628. NG SS, Hutubessy R, Chaiyakunapruk N
    Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination.
    Vaccine. 2018 Apr 3. pii: S0264-410X(18)30369.
    PubMed     Text format     Abstract available


  629. PLOTKIN SA, Boppana SB
    Vaccination against the human cytomegalovirus.
    Vaccine. 2018 Apr 2. pii: S0264-410X(18)30288.
    PubMed     Text format     Abstract available


  630. NISHIKAWA AM, Sartori AMC, Mainardi GM, Freitas AC, et al
    Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60years of age or older.
    Vaccine. 2018 Apr 2. pii: S0264-410X(18)30439.
    PubMed     Text format     Abstract available


    March 2018
  631. ESPOSITO S, Franco E, Gavazzi G, de Miguel AG, et al
    The public health value of vaccination for seniors in Europe.
    Vaccine. 2018 Mar 31. pii: S0264-410X(18)30409.
    PubMed     Text format     Abstract available


  632. GARCIA D, Porras A, Rico Mendoza A, Alvis N, et al
    Hepatitis B infection control in Colombian Amazon after 15years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence.
    Vaccine. 2018 Mar 30. pii: S0264-410X(17)31546.
    PubMed     Text format     Abstract available


  633. WORLD HEALTH ORGANIZATION
    BCG vaccine: WHO position paper, February 2018 - Recommendations.
    Vaccine. 2018 Mar 30. pii: S0264-410X(18)30345.
    PubMed     Text format     Abstract available


  634. WANG Z, Wang J, Fang Y, Gross DL, et al
    Parental acceptability of HPV vaccination for boys and girls aged 9-13years in China - A population-based study.
    Vaccine. 2018 Mar 29. pii: S0264-410X(18)30413.
    PubMed     Text format     Abstract available


  635. HARRER T, Dinges W, Roman F
    Long-term follow-up of HIV-1-infected adults who received the F4/AS01B HIV-1 vaccine candidate in two randomised controlled trials.
    Vaccine. 2018 Mar 29. pii: S0264-410X(18)30388.
    PubMed     Text format     Abstract available


  636. WENDLANDT R, Cowling BJ, Chen Y, Havers F, et al
    Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China.
    Vaccine. 2018 Mar 29. pii: S0264-410X(18)30408.
    PubMed     Text format     Abstract available


  637. LANE S, MacDonald NE, Marti M, Dumolard L, et al
    Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017.
    Vaccine. 2018 Mar 28. pii: S0264-410X(18)30419.
    PubMed     Text format     Abstract available


  638. KASSIANOS G, Kuchar E, Nitsch-Osuch A, Kyncl J, et al
    Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: A comparative study in six European countries.
    Vaccine. 2018 Mar 28. pii: S0264-410X(18)30205.
    PubMed     Text format     Abstract available


  639. LU PJ, O'Halloran AC, Williams WW, Nelson NP, et al
    Hepatitis B vaccination coverage among adults aged>/=18years traveling to a country of high or intermediate endemicity, United States, 2015.
    Vaccine. 2018 Mar 28. pii: S0264-410X(18)30375.
    PubMed     Text format     Abstract available


  640. MUFLIHAH H, Florido M, Lin LCW, Xia Y, et al
    Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
    Vaccine. 2018 Mar 27. pii: S0264-410X(18)30382.
    PubMed     Text format     Abstract available


  641. LATSUZBAIA A, Arbyn M, Weyers S, Mossong J, et al
    Human papillomavirus vaccination coverage in Luxembourg - Implications of lowering and restricting target age groups.
    Vaccine. 2018 Mar 27. pii: S0264-410X(18)30410.
    PubMed     Text format     Abstract available


  642. GROMOWSKI GD, Henein S, Kannadka CB, Barvir DA, et al
    Delineating the serotype-specific neutralizing antibody response to a live attenuated tetravalent dengue vaccine.
    Vaccine. 2018 Mar 27. pii: S0264-410X(18)30411.
    PubMed     Text format     Abstract available


  643. AKMATOV MK, Rubsamen N, Deyneko IV, Karch A, et al
    Poor knowledge of vaccination recommendations and negative attitudes towards vaccinations are independently associated with poor vaccination uptake among adults - Findings of a population-based panel study in Lower Saxony, Germany.
    Vaccine. 2018 Mar 27. pii: S0264-410X(18)30406.
    PubMed     Text format     Abstract available


  644. CHEMINAY C, Korner J, Bernig C, Bruckel M, et al
    A single vaccination with non-replicating MVA at birth induces both immediate and long-term protective immune responses.
    Vaccine. 2018 Mar 27. pii: S0264-410X(18)30404.
    PubMed     Text format     Abstract available


  645. GYE HJ, Oh MJ, Nishizawa T
    Lack of nervous necrosis virus (NNV) neutralizing antibodies in convalescent sevenband grouper Hyporthodus septemfasciatus after NNV infection.
    Vaccine. 2018;36:1863-1870.
    PubMed     Text format     Abstract available


  646. PEREIRA SILVA BEZERRA I, Amaral Abib M, Rossi-Bergmann B
    Intranasal but not subcutaneous vaccination with LaAg allows rapid expansion of protective immunity against cutaneous leishmaniasis.
    Vaccine. 2018 Mar 26. pii: S0264-410X(18)30356.
    PubMed     Text format     Abstract available


  647. PORTER RM, Amin AB, Bednarczyk RA, Omer SB, et al
    Cancer-salient messaging for Human Papillomavirus vaccine uptake: A randomized controlled trial.
    Vaccine. 2018 Mar 26. pii: S0264-410X(18)30076.
    PubMed     Text format     Abstract available


  648. CITRON MP, Patel M, Purcell M, Lin SA, et al
    A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates.
    Vaccine. 2018 Mar 26. pii: S0264-410X(18)30320.
    PubMed     Text format     Abstract available


  649. KANCI A, Wijesurendra DS, Wawegama NK, Underwood GJ, et al
    Evaluation of Mycoplasma gallisepticum (MG) ts-304 vaccine as a live attenuated vaccine in turkeys.
    Vaccine. 2018 Mar 26. pii: S0264-410X(18)30329.
    PubMed     Text format     Abstract available


  650. LI X, Xu Y, Dong Y, Yang X, et al
    Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses.
    Vaccine. 2018 Mar 24. pii: S0264-410X(18)30389.
    PubMed     Text format     Abstract available


  651. CLEATON JM, Wallace RM, Crowdis K, Gibson A, et al
    Impact of community-delivered SMS alerts on dog-owner participation during a mass rabies vaccination campaign, Haiti 2017.
    Vaccine. 2018 Mar 23. pii: S0264-410X(18)30353.
    PubMed     Text format     Abstract available


  652. GALLAGHER KE, LaMontagne DS, Watson-Jones D
    Status of HPV vaccine introduction and barriers to country uptake.
    Vaccine. 2018 Mar 23. pii: S0264-410X(18)30167.
    PubMed     Text format     Abstract available


  653. MOHANTY L, Sharma S, Behera B, Panwar S, et al
    A randomized, open label trial to evaluate and compare the immunogenicity and safety of a novel liquid hexavalent DTwP-Hib/Hep B-IPV (EasySix) to licensed combination vaccines in healthy infants.
    Vaccine. 2018 Mar 23. pii: S0264-410X(17)31250.
    PubMed     Text format     Abstract available


  654. KRETZSCHMAR E, Muckenfuss H, Pfleiderer M
    Official batch control of influenza vaccines: Is it still useful?
    Vaccine. 2018 Mar 23. pii: S0264-410X(18)30275.
    PubMed     Text format     Abstract available


  655. WANG Y, Chen L, Yu J, Pang Y, et al
    The effectiveness of influenza vaccination among nursery school children in China during the 2016/17 influenza season.
    Vaccine. 2018 Mar 23. pii: S0264-410X(18)30384.
    PubMed     Text format     Abstract available


  656. POELAERT D, Pereira P, Gardner R, Standaert B, et al
    A review of recommendations for rotavirus vaccination in Europe: Arguments for change.
    Vaccine. 2018 Mar 22. pii: S0264-410X(18)30277.
    PubMed     Text format     Abstract available


  657. KLEIN NP, Habanec T, Kosina P, Shah NR, et al
    Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study.
    Vaccine. 2018 Mar 22. pii: S0264-410X(18)30284.
    PubMed     Text format     Abstract available


  658. PARK JE, Shin HJ
    Porcine epidemic diarrhea vaccine efficacy evaluation by vaccination timing and frequencies.
    Vaccine. 2018 Mar 22. pii: S0264-410X(18)30386.
    PubMed     Text format     Abstract available


  659. FERNANDES S, Jit M, Bozzani F, Griffiths UK, et al
    A bibliometric analysis of systematic reviews on vaccines and immunisation.
    Vaccine. 2018 Mar 22. pii: S0264-410X(18)30236.
    PubMed     Text format     Abstract available


  660. MARLOW R, Kuriyakose S, Mesaros N, Han HH, et al
    A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella v
    Vaccine. 2018 Mar 22. pii: S0264-410X(18)30366.
    PubMed     Text format     Abstract available


  661. WEI S, Lei Y, Yang J, Wang X, et al
    Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Vaccine. 2018 Mar 22. pii: S0264-410X(18)30381.
    PubMed     Text format     Abstract available


  662. KLINGER G, Chodick G, Levy I
    Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis.
    Vaccine. 2018 Mar 21. pii: S0264-410X(18)30373.
    PubMed     Text format     Abstract available


  663. NLINWE ON, Kusi KA, Adu B, Sedegah M, et al
    T-cell responses against Malaria: Effect of parasite antigen diversity and relevance for vaccine development.
    Vaccine. 2018 Mar 21. pii: S0264-410X(18)30368.
    PubMed     Text format     Abstract available


  664. POOL V, Tomovici A, Johnson DR, Greenberg DP, et al
    Humoral immunity 10years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA.
    Vaccine. 2018 Mar 21. pii: S0264-410X(18)30374.
    PubMed     Text format     Abstract available


  665. LEE JS, Lourenco J, Gupta S, Farlow A, et al
    A multi-country study of dengue vaccination strategies with Dengvaxia and a future vaccine candidate in three dengue-endemic countries: Vietnam, Thailand, and Colombia.
    Vaccine. 2018 Mar 21. pii: S0264-410X(18)30328.
    PubMed     Text format     Abstract available


  666. FRANCESCHI S, Clifford GM, Baussano I
    Options for design of real-world impact studies of single-dose vaccine schedules.
    Vaccine. 2018 Mar 20. pii: S0264-410X(18)30166.
    PubMed     Text format     Abstract available


  667. PANDEY RK, Ojha R, Aathmanathan VS, Krishnan M, et al
    Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection.
    Vaccine. 2018 Mar 20. pii: S0264-410X(18)30387.
    PubMed     Text format     Abstract available


  668. LIU Y, Ma C, Jia H, Xu E, et al
    Knowledge, attitudes, and practices regarding hepatitis B vaccination among hospital-based doctors and nurses in China: Results of a multi-site survey.
    Vaccine. 2018 Mar 19. pii: S0264-410X(18)30354.
    PubMed     Text format     Abstract available


  669. STELZNER JJ, Behrens M, Behrens SE, Mader K, et al
    Squalene containing solid lipid nanoparticles, a promising adjuvant system for yeast vaccines.
    Vaccine. 2018 Mar 19. pii: S0264-410X(18)30355.
    PubMed     Text format     Abstract available


  670. GLASS RI, Jiang B, Parashar U
    The future control of rotavirus disease: Can live oral vaccines alone solve the rotavirus problem?
    Vaccine. 2018 Mar 19. pii: S0264-410X(18)30344.
    PubMed     Text format     Abstract available


  671. ERMLICH SJ, Andrews CP, Folkerth S, Rupp R, et al
    Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults >/=50 years of age.
    Vaccine. 2018 Mar 17. pii: S0264-410X(18)30348.
    PubMed     Text format     Abstract available


  672. WORLD HEALTH ORGANIZATION
    Cholera vaccine: WHO position paper, August 2017 - Recommendations.
    Vaccine. 2018 Mar 17. pii: S0264-410X(17)31263.
    PubMed     Text format     Abstract available


  673. ALFELALI M, Barasheed O, Badahdah AM, Bokhary H, et al
    Influenza vaccination among Saudi Hajj pilgrims: Revealing the uptake and vaccination barriers.
    Vaccine. 2018 Mar 16. pii: S0264-410X(18)30343.
    PubMed     Text format     Abstract available


  674. LI Y, Xue M, Yu L, Luo G, et al
    Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
    Vaccine. 2018 Mar 16. pii: S0264-410X(18)30347.
    PubMed     Text format     Abstract available


  675. HOEKSEMA F, Karpilow J, Luitjens A, Lagerwerf F, et al
    Enhancing viral vaccine production using engineered knockout vero cell lines - A second look.
    Vaccine. 2018 Mar 16. pii: S0264-410X(18)30346.
    PubMed     Text format     Abstract available


  676. WALKER JL, Andrews NJ, Amirthalingam G, Forbes H, et al
    Effectiveness of herpes zoster vaccination in an older United Kingdom population.
    Vaccine. 2018 Mar 16. pii: S0264-410X(18)30195.
    PubMed     Text format     Abstract available


  677. MEUNIER M, Guyard-Nicodeme M, Vigouroux E, Poezevara T, et al
    A DNA prime/protein boost vaccine protocol developed against Campylobacter jejuni for poultry.
    Vaccine. 2018 Mar 16. pii: S0264-410X(18)30331.
    PubMed     Text format     Abstract available


  678. SANKARANARAYANAN R, Joshi S, Muwonge R, Esmy PO, et al
    Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an indian study.
    Vaccine. 2018 Mar 15. pii: S0264-410X(18)30286.
    PubMed     Text format     Abstract available


  679. SOEDJATMIKO S, Medise BE, Gunardi H, Sekartini R, et al
    Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children.
    Vaccine. 2018 Mar 15. pii: S0264-410X(18)30324.
    PubMed     Text format     Abstract available


  680. GALDO NOVO S, Malirat V, Maradei ED, Pedemonte AR, et al
    Efficacy of a high quality O1/Campos foot-and-mouth disease vaccine upon challenge with a heterologous Korean O Mya98 lineage virus in pigs.
    Vaccine. 2018;36:1570-1576.
    PubMed     Text format     Abstract available


  681. ZHU C, Lin H, Tang L, Chen J, et al
    Oral Chlamydia vaccination induces transmucosal protection in the airway.
    Vaccine. 2018 Mar 14. pii: S0264-410X(18)30351.
    PubMed     Text format     Abstract available


  682. HANSEN J, Zhang L, Eaton A, Baxter R, et al
    Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children.
    Vaccine. 2018 Mar 14. pii: S0264-410X(18)30317.
    PubMed     Text format     Abstract available


  683. LINDSAY BJ, Bonar MM, Costas-Cancelas IN, Hunt K, et al
    Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy.
    Vaccine. 2018 Mar 14. pii: S0264-410X(18)30316.
    PubMed     Text format     Abstract available


  684. SU Q, Ma C, Wen N, Fan C, et al
    Epidemiological profile and progress toward rubella elimination in China. 10 years after nationwide introduction of rubella vaccine.
    Vaccine. 2018 Mar 14. pii: S0264-410X(18)30349.
    PubMed     Text format     Abstract available


  685. ZHANG L, Yan B, Lv J, Liu J, et al
    Antibody response to hepatitis B vaccine is independently associated with hepatitis B breakthrough infection among adults: Results from a three-year follow-up study in China.
    Vaccine. 2018 Mar 13. pii: S0264-410X(18)30213.
    PubMed     Text format     Abstract available


  686. NICHOLS MK, Andrew MK, Hatchette TF, Ambrose A, et al
    Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious
    Vaccine. 2018 Mar 13. pii: S0264-410X(18)30292.
    PubMed     Text format     Abstract available


  687. TETE SM, Jul-Larsen A, Rostami S, Lunde THF, et al
    Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Vaccine. 2018 Mar 13. pii: S0264-410X(18)30196.
    PubMed     Text format     Abstract available


  688. CHEN C, Beutels P, Newall AT
    Evolution over time in the cost-effectiveness of pneumococcal conjugate vaccine (PCV13) in older Australians due to herd protection from infant vaccination.
    Vaccine. 2018 Mar 13. pii: S0264-410X(18)30342.
    PubMed     Text format     Abstract available


  689. LIU T, Zhou Z, Tian X, Liu W, et al
    A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55.
    Vaccine. 2018 Mar 13. pii: S0264-410X(18)30237.
    PubMed     Text format     Abstract available


  690. KESHTKAR-JAHROMI M, Ouyang M, Keshtkarjahromi M, Almed S, et al
    Effect of influenza vaccine on tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in older adults.
    Vaccine. 2018 Mar 13. pii: S0264-410X(17)31609.
    PubMed     Text format     Abstract available


  691. DE VLEESCHAUWER AR, Zhou X, Lefebvre DJ, Garnier A, et al
    A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
    Vaccine. 2018 Mar 12. pii: S0264-410X(18)30261.
    PubMed     Text format     Abstract available


  692. ATHERTON MJ, Stephenson KB, Nikota JK, Hu QN, et al
    Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer.
    Vaccine. 2018 Mar 12. pii: S0264-410X(18)30257.
    PubMed     Text format     Abstract available


  693. SANNEH B, Papa Sey A, Shah M, Tate J, et al
    Impact of pentavalent rotavirus vaccine against severe rotavirus diarrhoea in The Gambia.
    Vaccine. 2018 Mar 12. pii: S0264-410X(18)30290.
    PubMed     Text format     Abstract available


  694. KOLE S, Kumari R, Anand D, Kumar S, et al
    Nanoconjugation of bicistronic DNA vaccine against Edwardsiella tarda using chitosan nanoparticles: Evaluation of its protective efficacy and immune modulatory effects in Labeo rohita vaccinated by different delivery routes.
    Vaccine. 2018 Mar 12. pii: S0264-410X(18)30298.
    PubMed     Text format     Abstract available


  695. ZHENG M, Jiang J, Zhang X, Wang N, et al
    Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro.
    Vaccine. 2018 Mar 12. pii: S0264-410X(18)30341.
    PubMed     Text format     Abstract available


  696. SALAMA II, Sami SM, Said ZN, Salama SI, et al
    Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy.
    Vaccine. 2018 Mar 9. pii: S0264-410X(18)30313.
    PubMed     Text format     Abstract available


  697. CASHMAN P, Moberley S, Durrheim D
    MMRV vaccine safety.
    Vaccine. 2018 Mar 8. pii: S0264-410X(18)30318.
    PubMed     Text format    


  698. RINTA-KOKKO H, Palmu AA, Auranen K, Nuorti JP, et al
    Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.
    Vaccine. 2018 Mar 8. pii: S0264-410X(18)30327.
    PubMed     Text format     Abstract available


  699. ORBEGOZO-MEDINA RA, Martinez-Sernandez V, Gonzalez-Warleta M, Castro-Hermida JA, et al
    Vaccination of sheep with Quil-A(R) adjuvant expands the antibody repertoire to the Fasciola MF6p/FhHDM-1 antigen and administered together impair the growth and antigen release of flukes.
    Vaccine. 2018 Mar 8. pii: S0264-410X(18)30325.
    PubMed     Text format     Abstract available


  700. ROWE SL, Tay EL, Franklin LJ, Stephens N, et al
    Effectiveness of parental cocooning as a vaccination strategy to prevent pertussis infection in infants: A case-control study.
    Vaccine. 2018 Mar 7. pii: S0264-410X(18)30293.
    PubMed     Text format     Abstract available


  701. VANNICE KS, Wilder-Smith A, Barrett ADT, Carrijo K, et al
    Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.
    Vaccine. 2018 Mar 7. pii: S0264-410X(18)30249.
    PubMed     Text format     Abstract available


  702. RAMIREZ M, Santos S, Martinez O, Rodriguez R, et al
    Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA.
    Vaccine. 2018 Mar 7. pii: S0264-410X(18)30207.
    PubMed     Text format     Abstract available


  703. FERNANDEZ COTRINA J, Iniesta V, Monroy I, Baz V, et al
    A large-scale field randomized trial demonstrates safety and efficacy of the vaccine LetiFend(R) against canine leishmaniosis.
    Vaccine. 2018 Mar 7. pii: S0264-410X(18)30321.
    PubMed     Text format     Abstract available


  704. RIKIN S, Jia H, Vargas CY, Castellanos de Belliard Y, et al
    Assessment of temporally-related acute respiratory illness following influenza vaccination.
    Vaccine. 2018 Mar 7. pii: S0264-410X(18)30315.
    PubMed     Text format     Abstract available


  705. VAN RIJN PA, Maris-Veldhuis MA, Potgieter CA, van Gennip RGP, et al
    African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
    Vaccine. 2018 Mar 7. pii: S0264-410X(18)30330.
    PubMed     Text format     Abstract available


  706. PERRETT S, Lesellier S, Rogers F, Williams GA, et al
    Assessment of the safety of Bacillus Calmette-Guerin vaccine administered orally to badgers (Meles meles).
    Vaccine. 2018 Mar 7. pii: S0264-410X(18)30311.
    PubMed     Text format     Abstract available


  707. ZHU B, Shi F, Zhang A, Sun X, et al
    Prevalence and genetic characteristics of 4CMenB and rLP2086 vaccine candidates among Neisseria meningitidis serogroup B strains, China.
    Vaccine. 2018 Mar 7. pii: S0264-410X(18)30322.
    PubMed     Text format     Abstract available


  708. SCHOEPS A, Nebie E, Fisker AB, Sie A, et al
    No effect of an additional early dose of measles vaccine on hospitalization or mortality in children: A randomized controlled trial.
    Vaccine. 2018 Mar 6. pii: S0264-410X(18)30314.
    PubMed     Text format     Abstract available


  709. HERWEIJER E, Ploner A, Sparen P
    Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden.
    Vaccine. 2018 Mar 6. pii: S0264-410X(18)30296.
    PubMed     Text format     Abstract available


  710. LI S, Wen G, Cao X, Guo D, et al
    Molecular characteristics of Streptococcus agalactiae in a mother-baby prospective cohort study: Implication for vaccine development and insights into vertical transmission.
    Vaccine. 2018 Mar 5. pii: S0264-410X(18)30319.
    PubMed     Text format     Abstract available


  711. SUNDARAM N, Duckett K, Yung CF, Thoon KC, et al
    "I wouldn't really believe statistics" - Challenges with influenza vaccine acceptance among healthcare workers in Singapore.
    Vaccine. 2018 Mar 5. pii: S0264-410X(18)30312.
    PubMed     Text format     Abstract available


  712. MOUTON L, Dekker A, Bleijenberg M, Blanchet M, et al
    A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species.
    Vaccine. 2018 Mar 3. pii: S0264-410X(18)30295.
    PubMed     Text format     Abstract available


  713. MEYNET E, Laurin D, Lenormand JL, Camara B, et al
    Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections.
    Vaccine. 2018 Mar 2. pii: S0264-410X(18)30214.
    PubMed     Text format     Abstract available


  714. WARD JK, Colgrove J, Verger P
    Why France is making eight new vaccines mandatory.
    Vaccine. 2018 Mar 2. pii: S0264-410X(18)30294.
    PubMed     Text format     Abstract available


  715. WATERS R, Ludi AB, Fowler VL, Wilsden G, et al
    Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage.
    Vaccine. 2018 Mar 2. pii: S0264-410X(18)30190.
    PubMed     Text format     Abstract available


  716. SURTEES TC, Teh BW, Slavin MA, Worth LJ, et al
    Factors contributing to declination of annual influenza vaccination by healthcare workers caring for cancer patients: An Australian experience.
    Vaccine. 2018 Mar 1. pii: S0264-410X(18)30297.
    PubMed     Text format     Abstract available


  717. CZAKO R, Vogel L, Sutton T, Matsuoka Y, et al
    H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets.
    Vaccine. 2018 Mar 1. pii: S0264-410X(18)30248.
    PubMed     Text format     Abstract available


  718. CUTLAND CL, Nolan T, Halperin SA, Kurugol Z, et al
    Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study.
    Vaccine. 2018 Mar 1. pii: S0264-410X(18)30187.
    PubMed     Text format     Abstract available


  719. PALMU AA, Jokinen J, Nieminen H, Rinta-Kokko H, et al
    Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial.
    Vaccine. 2018 Mar 1. pii: S0264-410X(18)30287.
    PubMed     Text format     Abstract available


    February 2018
  720. SAUL N, Wang K, Bag S, Baldwin H, et al
    Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study.
    Vaccine. 2018 Feb 28. pii: S0264-410X(18)30234.
    PubMed     Text format     Abstract available


  721. GUERRA FM, Crowcroft NS, Friedman L, Deeks SL, et al
    Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review.
    Vaccine. 2018;36:1248-1255.
    PubMed     Text format     Abstract available


  722. NORHEIM G, Mueller JE, Njanpop-Lafourcade BM, Delrieu I, et al
    Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007.
    Vaccine. 2018;36:1297-1303.
    PubMed     Text format     Abstract available


  723. OSOWICKI J, Vekemans J, Kaslow DC, Friede MH, et al
    WHO/IVI global stakeholder consultation on group A Streptococcus vaccine development: Report from a meeting held on 12-13 December 2016.
    Vaccine. 2018 Feb 26. pii: S0264-410X(18)30255.
    PubMed     Text format     Abstract available


  724. NYON MP, Du L, Tseng CK, Seid CA, et al
    Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen.
    Vaccine. 2018 Feb 26. pii: S0264-410X(18)30252.
    PubMed     Text format     Abstract available


  725. YAN S, Zhao J, Xie D, Huang X, et al
    Attenuation, safety, and efficacy of a QX-like infectious bronchitis virus serotype vaccine.
    Vaccine. 2018 Feb 26. pii: S0264-410X(18)30240.
    PubMed     Text format     Abstract available


  726. LAI H, Paul AM, Sun H, He J, et al
    A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Vaccine. 2018 Feb 26. pii: S0264-410X(18)30260.
    PubMed     Text format     Abstract available


  727. LALSIAMTHARA J, Senevirathne A, So MY, Lee JH, et al
    Safety implication of Salmonella based Brucella vaccine candidate in mice and in vitro human cell culture.
    Vaccine. 2018 Feb 24. pii: S0264-410X(18)30256.
    PubMed     Text format     Abstract available


  728. HEALY J, Rodriguez-Lainz A, Elam-Evans LD, Hill HA, et al
    Vaccination coverage among foreign-born and U.S.-born adolescents in the United States: Successes and gaps - National Immunization Survey-Teen, 2012-2014.
    Vaccine. 2018 Feb 23. pii: S0264-410X(18)30239.
    PubMed     Text format     Abstract available


  729. ARMITAGE EP, Camara J, Bah S, Forster AS, et al
    Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia.
    Vaccine. 2018 Feb 23. pii: S0264-410X(18)30211.
    PubMed     Text format     Abstract available


  730. ATTWELL K, Wiley KE, Waddington C, Leask J, et al
    Midwives' attitudes, beliefs and concerns about childhood vaccination: A review of the global literature.
    Vaccine. 2018 Feb 23. pii: S0264-410X(18)30202.
    PubMed     Text format     Abstract available


  731. SHAGHAGHI M, Soleyman-Jahi S, Abolhassani H, Yazdani R, et al
    New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.
    Vaccine. 2018 Feb 22. pii: S0264-410X(18)30246.
    PubMed     Text format     Abstract available


  732. HARE KM, Smith-Vaughan HC, Leach AJ, Pizzutto SJ, et al
    Reduced nontypeable Haemophilus influenzae lower airway infection in children with chronic endobronchial suppuration vaccinated with the 10-valent pneumococcal H. influenzae protein D conjugate vaccine.
    Vaccine. 2018 Feb 22. pii: S0264-410X(18)30241.
    PubMed     Text format     Abstract available


  733. DORJI K, Phuntsho S, Pempa, Kumluang S, et al
    Towards the introduction of pneumococcal conjugate vaccines in Bhutan: A cost-utility analysis to determine the optimal policy option.
    Vaccine. 2018 Feb 22. pii: S0264-410X(18)30235.
    PubMed     Text format     Abstract available


  734. CHIA MY, Chung WY, Wang CH, Chang WH, et al
    Development of a high-growth enterovirus 71 vaccine candidate inducing cross-reactive neutralizing antibody responses.
    Vaccine. 2018;36:1167-1173.
    PubMed     Text format     Abstract available


  735. BRYDEN GM, Browne M, Rockloff M, Unsworth C, et al
    Anti-vaccination and pro-CAM attitudes both reflect magical beliefs about health.
    Vaccine. 2018;36:1227-1234.
    PubMed     Text format     Abstract available


  736. BAVDEKAR A, Oswal J, Ramanan PV, Aundhkar C, et al
    Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in India: A randomized, parallel group, non-inferiority trial.
    Vaccine. 2018;36:1220-1226.
    PubMed     Text format     Abstract available


  737. KING JP, McLean HQ, Meece JK, Levine MZ, et al
    Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
    Vaccine. 2018;36:1214-1219.
    PubMed     Text format     Abstract available


  738. WU W, Wang H, Li K, Pekka Nuorti J, et al
    Recipient vaccine-associated paralytic poliomyelitis in China, 2010-2015.
    Vaccine. 2018;36:1209-1213.
    PubMed     Text format     Abstract available


  739. YUE X, Black CL, O'Halloran A, Lu PJ, et al
    Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease.
    Vaccine. 2018;36:1183-1189.
    PubMed     Text format     Abstract available


  740. PINHEIRO AF, Roloff BC, da Silveira Moreira A, Berne MEA, et al
    Identification of suitable adjuvant for vaccine formulation with the Neospora caninum antigen NcSRS2.
    Vaccine. 2018;36:1154-1159.
    PubMed     Text format     Abstract available


  741. WHITE KM, Ayllon J, Mena I, Potenski A, et al
    Influenza B virus reverse genetic backbones with improved growth properties in the EB66(R) cell line as basis for vaccine seed virus generation.
    Vaccine. 2018;36:1146-1153.
    PubMed     Text format     Abstract available


  742. MEDAGLINI D, De Azero MR, Leroy O, Bietrix F, et al
    Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow.
    Vaccine. 2018;36:1136-1145.
    PubMed     Text format     Abstract available


  743. ARANA JE, Harrington T, Cano M, Lewis P, et al
    Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
    Vaccine. 2018 Feb 21. pii: S0264-410X(18)30208.
    PubMed     Text format     Abstract available


  744. SALEEM AF, Yousafzai MT, Mach O, Khan A, et al
    Evaluation of vaccine derived poliovirus type 2 outbreak response options: A randomized controlled trial, Karachi, Pakistan.
    Vaccine. 2018 Feb 21. pii: S0264-410X(18)30238.
    PubMed     Text format     Abstract available


  745. KHOURI JM, Motter RN, Arnon SS
    Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity.
    Vaccine. 2018 Feb 20. pii: S0264-410X(18)30216.
    PubMed     Text format     Abstract available


  746. NAVIN MC, Kozak AT, Clark EC
    The evolution of immunization waiver education in Michigan: A qualitative study of vaccine educators.
    Vaccine. 2018 Feb 20. pii: S0264-410X(18)30233.
    PubMed     Text format     Abstract available


  747. BERNAU M, Liesner BG, Schwanitz S, Kraus AS, et al
    Vaccine safety testing using magnetic resonance imaging in suckling pigs.
    Vaccine. 2018 Feb 19. pii: S0264-410X(18)30199.
    PubMed     Text format     Abstract available


  748. KOVAC M, Lal H, Cunningham AL, Levin MJ, et al
    Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials.
    Vaccine. 2018 Feb 17. pii: S0264-410X(18)30203.
    PubMed     Text format     Abstract available


  749. AKEDA Y, Koizumi Y, Takanami Y, Sumino S, et al
    Comparison of serum bactericidal and antibody titers induced by two Haemophilus influenzae type b conjugate vaccines: A phase III randomized double-blind study.
    Vaccine. 2018 Feb 16. pii: S0264-410X(18)30185.
    PubMed     Text format     Abstract available


  750. SHOUKAT A, Van Exan R, Moghadas SM
    Cost-effectiveness of a potential vaccine candidate for Haemophilus influenzae serotype 'a'.
    Vaccine. 2018 Feb 16. pii: S0264-410X(18)30096.
    PubMed     Text format     Abstract available


  751. KUNTZ J, Crane B, Weinmann S, Naleway AL, et al
    Myocarditis and pericarditis are rare following live viral vaccinations in adults.
    Vaccine. 2018 Feb 15. pii: S0264-410X(18)30204.
    PubMed     Text format     Abstract available


  752. DJAGBARE MD, Yu L, Parupudi A, Sun J, et al
    Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine.
    Vaccine. 2018 Feb 15. pii: S0264-410X(18)30115.
    PubMed     Text format     Abstract available


  753. IBANEZ LI, Caldevilla CA, Paredes Rojas Y, Mattion N, et al
    Genetic and subunit vaccines based on the stem domain of the equine influenza hemagglutinin provide homosubtypic protection against heterologous strains.
    Vaccine. 2018 Feb 15. pii: S0264-410X(18)30193.
    PubMed     Text format     Abstract available


  754. SYCHEVA AL, Pogorelyy MV, Komech EA, Minervina AA, et al
    Quantitative profiling reveals minor changes of T cell receptor repertoire in response to subunit inactivated influenza vaccine.
    Vaccine. 2018 Feb 15. pii: S0264-410X(18)30201.
    PubMed     Text format     Abstract available


  755. JOHN S, Yuzhakov O, Woods A, Deterling J, et al
    Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.
    Vaccine. 2018 Feb 14. pii: S0264-410X(18)30063.
    PubMed     Text format     Abstract available


  756. MOUCHET J, Salvo F, Raschi E, Poluzzi E, et al
    Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis.
    Vaccine. 2018 Feb 14. pii: S0264-410X(18)30210.
    PubMed     Text format     Abstract available


  757. AMERATUNGA R, Gillis D, Langguth D, Hawkes D, et al
    Ad hominem attacks on vaccine safety researchers.
    Vaccine. 2018 Feb 14. pii: S0264-410X(18)30102.
    PubMed     Text format    


  758. UTAZI CE, Thorley J, Alegana VA, Ferrari MJ, et al
    High resolution age-structured mapping of childhood vaccination coverage in low and middle income countries.
    Vaccine. 2018 Feb 14. pii: S0264-410X(18)30194.
    PubMed     Text format     Abstract available


  759. LEI J, Balakrishnan MR, Gidudu JF, Zuber PLF, et al
    Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015.
    Vaccine. 2018 Feb 14. pii: S0264-410X(18)30186.
    PubMed     Text format     Abstract available


  760. KOURKOUNTI S, Retsas T, Paparizos V, Tsimpidakis A, et al
    Evaluation of a convenient vaccination schedule against hepatitis B in HIV-patients with undetectable HIV viral load.
    Vaccine. 2018 Feb 12. pii: S0264-410X(18)30192.
    PubMed     Text format     Abstract available


  761. NELSON NP, Yankey D, Singleton JA, Elam-Evans LD, et al
    Hepatitis A vaccination coverage among adolescents (13-17years) in the United States, 2008-2016.
    Vaccine. 2018 Feb 12. pii: S0264-410X(18)30163.
    PubMed     Text format     Abstract available


  762. SEDITA J, Perrella S, Morio M, Berbari M, et al
    Cost of goods sold and total cost of delivery for oral and parenteral vaccine packaging formats.
    Vaccine. 2018 Feb 12. pii: S0264-410X(18)30035.
    PubMed     Text format     Abstract available


  763. ATTWELL K, Smith DT, Ward PR
    'The Unhealthy Other': How vaccine rejecting parents construct the vaccinating mainstream.
    Vaccine. 2018 Feb 12. pii: S0264-410X(18)30149.
    PubMed     Text format     Abstract available


  764. LATASA P, Garcia-Comas L, Gil de Miguel A, Barranco MD, et al
    Effectiveness of acellular pertussis vaccine and evolution of pertussis incidence in the community of Madrid from 1998 to 2015.
    Vaccine. 2018 Feb 10. pii: S0264-410X(18)30143.
    PubMed     Text format     Abstract available


  765. NIELSEN CM, Vekemans J, Lievens M, Kester KE, et al
    RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype.
    Vaccine. 2018 Feb 10. pii: S0264-410X(18)30142.
    PubMed     Text format     Abstract available


  766. BAYER L, Fertey J, Ulbert S, Grunwald T, et al
    Immunization with an adjuvanted low-energy electron irradiation inactivated respiratory syncytial virus vaccine shows immunoprotective activity in mice.
    Vaccine. 2018 Feb 10. pii: S0264-410X(18)30188.
    PubMed     Text format     Abstract available


  767. PFAFF F, Muller T, Freuling CM, Fehlner-Gardiner C, et al
    In-depth genome analyses of viruses from vaccine-derived rabies cases and corresponding live-attenuated oral rabies vaccines.
    Vaccine. 2018 Feb 10. pii: S0264-410X(18)30156.
    PubMed     Text format     Abstract available


  768. ANIL K, Desai S, Bhamare C, Dharmadhikari A, et al
    Safety and tolerability of a liquid bovine rotavirus pentavalent vaccine (LBRV-PV) in adults.
    Vaccine. 2018 Feb 10. pii: S0264-410X(18)30198.
    PubMed     Text format     Abstract available


  769. SAGY I, Novack V, Gdalevich M, Greenberg D, et al
    Mass media effect on vaccines uptake during silent polio outbreak.
    Vaccine. 2018 Feb 10. pii: S0264-410X(18)30209.
    PubMed     Text format     Abstract available


  770. DANIEL P, Rodrigo C, Bewick T, Sheppard C, et al
    13-Valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groups.
    Vaccine. 2018 Feb 10. pii: S0264-410X(18)30169.
    PubMed     Text format     Abstract available


  771. DAWSON R, Lemmon K, Trivedi NJ, Hansen S, et al
    Improving human papilloma virus vaccination rates throughout military treatment facilities.
    Vaccine. 2018 Feb 9. pii: S0264-410X(18)30171.
    PubMed     Text format     Abstract available


  772. DEBRIE AS, Coutte L, Raze D, Mooi F, et al
    Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Vaccine. 2018 Feb 9. pii: S0264-410X(18)30191.
    PubMed     Text format     Abstract available


  773. NICKEL AJ, Puumala SE, Kharbanda AB
    Vaccine-preventable, hospitalizations among American Indian/Alaska Native children using the 2012 Kid's Inpatient Database.
    Vaccine. 2018;36:945-948.
    PubMed     Text format     Abstract available


  774. SCHAUT RG, Brewer MT, Mendoza K, Jackman J, et al
    A polyanhydride-based implantable single dose vaccine platform for long-term immunity.
    Vaccine. 2018;36:1024-1025.
    PubMed     Text format    


  775. SCHAUT RG, Brewer MT, Hostetter JM, Mendoza K, et al
    A single dose polyanhydride-based vaccine platform promotes and maintains anti-GnRH antibody titers.
    Vaccine. 2018;36:1016-1023.
    PubMed     Text format     Abstract available


  776. YUN KW, Lee HJ, Park JY, Cho HK, et al
    Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivat
    Vaccine. 2018 Feb 8. pii: S0264-410X(18)30148.
    PubMed     Text format     Abstract available


  777. MASTERS NB, Wagner AL, Carlson BF, Boulton ML, et al
    Vaccination timeliness and co-administration among Kenyan children.
    Vaccine. 2018 Feb 8. pii: S0264-410X(18)30165.
    PubMed     Text format     Abstract available


  778. PANDO R, Sharabi S, Mandelboim M
    Exceptional influenza morbidity in summer season of 2017 in Israel may predict the vaccine efficiency in the coming winter.
    Vaccine. 2018 Feb 8. pii: S0264-410X(18)30158.
    PubMed     Text format     Abstract available


  779. WILSON E, Zhu C, Galea S, Marko A, et al
    Turning up the heat: Effect of new vaccine for children's (VFC) program recommendations for use of temperature monitors upon incorrect product storage adverse event reporting.
    Vaccine. 2018 Feb 8. pii: S0264-410X(17)31467.
    PubMed     Text format     Abstract available


  780. SUAYA JA, Jiang Q, Scott DA, Gruber WC, et al
    Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults.
    Vaccine. 2018 Feb 8. pii: S0264-410X(18)30098.
    PubMed     Text format     Abstract available


  781. LIU X, Jiao C, Ma Y, Wang Q, et al
    A live attenuated Vibrio anguillarum vaccine induces efficient immunoprotection in Tiger puffer (Takifugu rubripes).
    Vaccine. 2018 Feb 8. pii: S0264-410X(18)30128.
    PubMed     Text format     Abstract available


  782. HUANG T, Liu Y, Li Y, Liao Y, et al
    Evaluation on the persistence of anti-HPV immune responses to the quadrivalent HPV vaccine in Chinese females and males: Up to 3.5years of follow-up.
    Vaccine. 2018 Feb 7. pii: S0264-410X(18)30170.
    PubMed     Text format     Abstract available


  783. WIDDICE LE, Hoagland R, Callahan ST, Kahn JA, et al
    Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.
    Vaccine. 2018 Feb 7. pii: S0264-410X(17)31821.
    PubMed     Text format     Abstract available


  784. PEZZOTTI P, Bellino S, Prestinaci F, Iacchini S, et al
    The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015.
    Vaccine. 2018 Feb 7. pii: S0264-410X(18)30126.
    PubMed     Text format     Abstract available


  785. WANLAPAKORN N, Maertens K, Chaithongwongwatthana S, Srimuan D, et al
    Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women.
    Vaccine. 2018 Feb 6. pii: S0264-410X(18)30119.
    PubMed     Text format     Abstract available


  786. DE BEKKER-GROB EW, Veldwijk J, Jonker M, Donkers B, et al
    The impact of vaccination and patient characteristics on influenza vaccination uptake of elderly people: A discrete choice experiment.
    Vaccine. 2018 Feb 6. pii: S0264-410X(18)30103.
    PubMed     Text format     Abstract available


  787. LI Q, Peng O, Wu T, Xu Z, et al
    PED subunit vaccine based on COE domain replacement of flagellin domain D3 improved specific humoral and mucosal immunity in mice.
    Vaccine. 2018 Feb 6. pii: S0264-410X(18)30159.
    PubMed     Text format     Abstract available


  788. AJIBOLA O, Omoleke SA, Omisakin OA
    Current status of cerebrospinal meningitis and impact of the 2015 meningococcal C vaccination in Kebbi, Northwest Nigeria.
    Vaccine. 2018 Feb 6. pii: S0264-410X(18)30157.
    PubMed     Text format     Abstract available


  789. MARTIRE B, Azzari C, Badolato R, Canessa C, et al
    Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET).
    Vaccine. 2018 Feb 6. pii: S0264-410X(18)30121.
    PubMed     Text format     Abstract available


  790. KOECK JL, Auguste J, Floret D
    MesVaccins.net: A global, multi-functional and integrated platform for information and communication on vaccination.
    Vaccine. 2018 Feb 6. pii: S0264-410X(18)30147.
    PubMed     Text format    


  791. YANG YT, Reiss DR
    French mandatory vaccine policy.
    Vaccine. 2018 Feb 6. pii: S0264-410X(18)30146.
    PubMed     Text format    


  792. XIE Y, Wu J, Xu A, Ahmeqd S, et al
    Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 mice.
    Vaccine. 2018 Feb 5. pii: S0264-410X(18)30151.
    PubMed     Text format     Abstract available


  793. THOMPSON KM, Gellin BG, Hinman AR, Orenstein WA, et al
    The National Vaccine Advisory Committee at 30: Impact and opportunity.
    Vaccine. 2018 Feb 5. pii: S0264-410X(18)30129.
    PubMed     Text format     Abstract available


  794. VAN AALST S, Jansen MAA, Ludwig IS, van der Zee R, et al
    Routing dependent immune responses after experimental R848-adjuvated vaccination.
    Vaccine. 2018 Feb 3. pii: S0264-410X(18)30150.
    PubMed     Text format     Abstract available


  795. RUSSELL K, Chung JR, Monto AS, Martin ET, et al
    Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.
    Vaccine. 2018 Feb 2. pii: S0264-410X(18)30094.
    PubMed     Text format     Abstract available


  796. SUN X, Wang F, Zheng H, Miao N, et al
    The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004-2016.
    Vaccine. 2018 Feb 1. pii: S0264-410X(18)30092.
    PubMed     Text format     Abstract available


  797. ROBINSON C, Frykberg L, Flock M, Guss B, et al
    Strangvac: A recombinant fusion protein vaccine that protects against strangles, caused by Streptococcus equi.
    Vaccine. 2018 Feb 1. pii: S0264-410X(18)30064.
    PubMed     Text format     Abstract available


  798. BERAN J, Lattanzi M, Xie F, Moraschini L, et al
    Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10years antibody persistence.
    Vaccine. 2018 Feb 1. pii: S0264-410X(18)30022.
    PubMed     Text format     Abstract available


    January 2018
  799. N'DIAYE DS, Launay O, Picone O, Tsatsaris V, et al
    Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France.
    Vaccine. 2018 Jan 31. pii: S0264-410X(18)30091.
    PubMed     Text format     Abstract available


  800. TSOLENYANU E, Djadou KE, Fiawoo M, Akolly DAE, et al
    Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo.
    Vaccine. 2018 Jan 31. pii: S0264-410X(18)30118.
    PubMed     Text format     Abstract available


  801. XING J, Zhou X, Tang X, Sheng X, et al
    FlaC supplemented with VAA, OmpK or OmpR as bivalent subunit vaccine candidates induce immune responses against Vibrio anguillarum in flounder (Paralichthys olivaceus).
    Vaccine. 2018 Jan 31. pii: S0264-410X(17)31717.
    PubMed     Text format     Abstract available


  802. CHEN C, Wood JG, Beutels P, Menzies R, et al
    The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia.
    Vaccine. 2018 Jan 30. pii: S0264-410X(18)30101.
    PubMed     Text format     Abstract available


  803. KRISHNASWAMY S, Wallace EM, Buttery J, Giles ML, et al
    Strategies to implement maternal vaccination: A comparison between standing orders for midwife delivery, a hospital based maternal immunisation service and primary care.
    Vaccine. 2018 Jan 30. pii: S0264-410X(18)30021.
    PubMed     Text format     Abstract available


  804. TROGDON JG, Shafer P, Lindsay B, Coyne-Beasley T, et al
    Impact of introduction of the 9-valent human papillomavirus vaccine on vaccination coverage of youth in North Carolina.
    Vaccine. 2018 Jan 29. pii: S0264-410X(18)30037.
    PubMed     Text format     Abstract available


  805. PEZZI C, McCulloch A, Joo H, Cochran J, et al
    Vaccine delivery to newly arrived refugees and estimated costs in selected U.S. clinics, 2015.
    Vaccine. 2018 Jan 26. pii: S0264-410X(17)31776.
    PubMed     Text format     Abstract available


  806. QAZI U, Malik S, Raza UA, Saad M, et al
    Compliance to timely vaccination in an Expanded Program on Immunization center of Pakistan.
    Vaccine. 2018 Jan 26. pii: S0264-410X(18)30093.
    PubMed     Text format     Abstract available


  807. VEKEMANS J, Moorthy V, Giersing B, Friede M, et al
    Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics.
    Vaccine. 2018 Jan 25. pii: S0264-410X(17)31364.
    PubMed     Text format     Abstract available


  808. COOPER LV, Stuart JM, Okot C, Asiedu-Bekoe F, et al
    Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana.
    Vaccine. 2018 Jan 20. pii: S0264-410X(17)31832.
    PubMed     Text format     Abstract available


  809. LARTEY BL, Damanka S, Dennis FE, Enweronu-Laryea CC, et al
    Rotavirus strain distribution in Ghana pre- and post- rotavirus vaccine introduction.
    Vaccine. 2018 Jan 20. pii: S0264-410X(18)30034.
    PubMed     Text format     Abstract available


  810. VAN BEURDEN SJ, Berends AJ, Kramer-Kuhl A, Spekreijse D, et al
    Recombinant live attenuated avian coronavirus vaccines with deletions in the accessory genes 3ab and/or 5ab protect against infectious bronchitis in chickens.
    Vaccine. 2018 Jan 20. pii: S0264-410X(18)30051.
    PubMed     Text format     Abstract available


  811. HIRTH JM, Batuuka DN, Gross TT, Cofie L, et al
    Human papillomavirus vaccine motivators and barriers among community college students: Considerations for development of a successful vaccination program.
    Vaccine. 2018 Jan 20. pii: S0264-410X(18)30072.
    PubMed     Text format     Abstract available


  812. KAPLAN BS, Souza CK, Gauger PC, Stauft CB, et al
    Vaccination of pigs with a codon-pair bias de-optimized live attenuated influenza vaccine protects from homologous challenge.
    Vaccine. 2018 Jan 20. pii: S0264-410X(18)30061.
    PubMed     Text format     Abstract available


  813. LINDLEY MC, Hurley LP, Beaty BL, Allison MA, et al
    Vaccine financing and billing in practices serving adult patients: A follow-up survey.
    Vaccine. 2018 Jan 20. pii: S0264-410X(18)30039.
    PubMed     Text format     Abstract available


  814. TROGDON JG, Shafer P, Lindsay B, Coyne-Beasley T, et al
    Determinants of the receipt of the 9-valent human papillomavirus vaccine in the first year after introduction in North Carolina.
    Vaccine. 2018 Jan 20. pii: S0264-410X(18)30038.
    PubMed     Text format     Abstract available


  815. MARCHETTI S, Guzzetta G, Flem E, Mirinaviciute G, et al
    Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Vaccine. 2018 Jan 20. pii: S0264-410X(18)30073.
    PubMed     Text format     Abstract available


  816. KREIMER AR, Herrero R, Sampson JN, Porras C, et al
    Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.
    Vaccine. 2018 Jan 20. pii: S0264-410X(18)30018.
    PubMed     Text format     Abstract available


  817. HAN Y, Liu Q, Willias S, Liang K, et al
    A bivalent vaccine derived from attenuated Salmonella expressing O-antigen polysaccharide provides protection against avian pathogenic Escherichia coli O1 and O2 infection.
    Vaccine. 2018 Jan 18. pii: S0264-410X(18)30071.
    PubMed     Text format     Abstract available


  818. BARRERA J, Schutta C, Pisano M, Grubman MJ, et al
    Use of ENABL(R) adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Vaccine. 2018 Jan 18. pii: S0264-410X(18)30060.
    PubMed     Text format     Abstract available


  819. TAFURI S, Fortunato F, Gallone MS, Stefanizzi P, et al
    Systematic causality assessment of adverse events following HPV vaccines: Analysis of current data from Apulia region (Italy).
    Vaccine. 2018 Jan 18. pii: S0264-410X(18)30052.
    PubMed     Text format     Abstract available


  820. GARZA-CUARTERO L, Geurden T, Mahan SM, Hardham JM, et al
    Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and/or vaccinated cattle and identification of protective linear B-cell epitopes.
    Vaccine. 2018 Jan 17. pii: S0264-410X(18)30054.
    PubMed     Text format     Abstract available


  821. DE BOER PT, Kelso JK, Halder N, Nguyen TP, et al
    The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia.
    Vaccine. 2018 Jan 17. pii: S0264-410X(17)31836.
    PubMed     Text format     Abstract available


  822. MORIMOTO N, Takeishi K
    Change in the efficacy of influenza vaccination after repeated inoculation under antigenic mismatch: A systematic review and meta-analysis.
    Vaccine. 2018 Jan 17. pii: S0264-410X(18)30057.
    PubMed     Text format     Abstract available


  823. PINTO LA, Dillner J, Beddows S, Unger ER, et al
    Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development.
    Vaccine. 2018 Jan 17. pii: S0264-410X(18)30020.
    PubMed     Text format     Abstract available


  824. SUGAYA N, Shinjoh M, Nakata Y, Tsunematsu K, et al
    Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013-2016.
    Vaccine. 2018 Jan 17. pii: S0264-410X(18)30058.
    PubMed     Text format     Abstract available


  825. KOSTER S, Klevorn T, Papavinasasundaram K, Sassetti CM, et al
    Consequence of enhanced LC3-trafficking for a live, attenuated M. tuberculosis vaccine.
    Vaccine. 2018 Jan 15. pii: S0264-410X(18)30036.
    PubMed     Text format     Abstract available


  826. POULOS C, Curran D, Anastassopoulou A, De Moerlooze L, et al
    German travelers' preferences for travel vaccines assessed by a discrete choice experiment.
    Vaccine. 2018 Jan 12. pii: S0264-410X(18)30028.
    PubMed     Text format     Abstract available


  827. FORD AQ, Touchette N, Fenton Hall B, Hwang A, et al
    Meeting report: Global vaccine and immunization research forum.
    Vaccine. 2018 Jan 12. pii: S0264-410X(17)31753.
    PubMed     Text format     Abstract available


  828. ROERINK F, Morgan CL, Knetter SM, Passat MH, et al
    A novel inactivated vaccine against Lawsonia intracellularis induces rapid induction of humoral immunity, reduction of bacterial shedding and provides robust gut barrier function.
    Vaccine. 2018 Jan 11. pii: S0264-410X(17)31810.
    PubMed     Text format     Abstract available


  829. OMENACA F, Vazquez L, Garcia-Corbeira P, Mesaros N, et al
    Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity.
    Vaccine. 2018 Jan 11. pii: S0264-410X(18)30029.
    PubMed     Text format     Abstract available


  830. ORELLANO P, Vezzani D, Quaranta N, Reynoso J, et al
    Estimation of expected dengue seroprevalence from passive epidemiological surveillance systems in selected areas of Argentina: A proxy to evaluate the applicability of dengue vaccination.
    Vaccine. 2018 Jan 11. pii: S0264-410X(18)30031.
    PubMed     Text format     Abstract available


  831. ORENSTEIN WA, Cairns L, Hinman A, Nkowane B, et al
    Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
    Vaccine. 2018;36 Suppl 1:A35-A42.
    PubMed     Text format     Abstract available


  832. ORENSTEIN WA, Hinman A, Nkowane B, Olive JM, et al
    Measles and Rubella Global Strategic Plan 2012-2020 midterm review.
    Vaccine. 2018;36 Suppl 1:A1-A34.
    PubMed     Text format     Abstract available


  833. MCREE AL, Shoben A, Bauermeister JA, Katz ML, et al
    Outsmart HPV: Acceptability and short-term effects of a web-based HPV vaccination intervention for young adult gay and bisexual men.
    Vaccine. 2018 Jan 10. pii: S0264-410X(18)30033.
    PubMed     Text format     Abstract available


  834. LU PJ, Srivastav A, Amaya A, Dever JA, et al
    Association of provider recommendation and offer and influenza vaccination among adults aged >/=18years - United States.
    Vaccine. 2018 Jan 9. pii: S0264-410X(17)31759.
    PubMed     Text format     Abstract available


  835. SHIM E, Smith KJ, Nowalk MP, Raviotta JM, et al
    Impact of seasonal influenza vaccination in the presence of vaccine interference.
    Vaccine. 2018 Jan 9. pii: S0264-410X(17)31830.
    PubMed     Text format     Abstract available


  836. GIAMBI C, Fabiani M, D'Ancona F, Ferrara L, et al
    Parental vaccine hesitancy in Italy - Results from a national survey.
    Vaccine. 2018 Jan 8. pii: S0264-410X(17)31837.
    PubMed     Text format     Abstract available


  837. JUNG MH, Nikapitiya C, Jung SJ
    DNA vaccine encoding myristoylated membrane protein (MMP) of rock bream iridovirus (RBIV) induces protective immunity in rock bream (Oplegnathus fasciatus).
    Vaccine. 2018 Jan 8. pii: S0264-410X(17)31840.
    PubMed     Text format     Abstract available


  838. VOS A, Freuling C, Ortmann S, Kretzschmar A, et al
    An assessment of shedding with the oral rabies virus vaccine strain SPBN GASGAS in target and non-target species.
    Vaccine. 2018 Jan 8. pii: S0264-410X(17)31839.
    PubMed     Text format     Abstract available


  839. SCHILLER J, Lowy D
    Explanations for the high potency of HPV prophylactic vaccines.
    Vaccine. 2018 Jan 8. pii: S0264-410X(18)30019.
    PubMed     Text format     Abstract available


  840. TAHA-ABDELAZIZ K, Hodgins DC, Alkie TN, Quinteiro-Filho W, et al
    Oral administration of PLGA-encapsulated CpG ODN and Campylobacter jejuni lysate reduces cecal colonization by Campylobacter jejuni in chickens.
    Vaccine. 2018;36:388-394.
    PubMed     Text format     Abstract available


  841. MCCARTY JM, Lock MD, Hunt KM, Simon JK, et al
    Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18-45.
    Vaccine. 2018 Jan 6. pii: S0264-410X(17)31823.
    PubMed     Text format     Abstract available


  842. SEAGLE EE, Bednarczyk RA, Hill T, Fiebelkorn AP, et al
    Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
    Vaccine. 2018 Jan 6. pii: S0264-410X(17)31838.
    PubMed     Text format     Abstract available


  843. BIEZEN R, Grando D, Mazza D, Brijnath B, et al
    Why do we not want to recommend influenza vaccination to young children? A qualitative study of Australian parents and primary care providers.
    Vaccine. 2018 Jan 5. pii: S0264-410X(17)31828.
    PubMed     Text format     Abstract available


  844. YANG F, Zhu Z, Cao W, Liu H, et al
    Immunogenicity and protective efficacy of an inactivated cell culture-derived Seneca Valley virus vaccine in pigs.
    Vaccine. 2018 Jan 5. pii: S0264-410X(17)31816.
    PubMed     Text format     Abstract available


  845. CISZEWSKI A
    Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases.
    Vaccine. 2018;36:202-206.
    PubMed     Text format     Abstract available


  846. PRZEDPELSKI A, Tepp WH, Zuverink M, Johnson EA, et al
    Enhancing toxin-based vaccines against botulism.
    Vaccine. 2018 Jan 4. pii: S0264-410X(17)31826.
    PubMed     Text format     Abstract available


  847. ADRIANI R, Mousavi Gargari SL, Nazarian S, Sarvary S, et al
    Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions.
    Vaccine. 2018;36:322-330.
    PubMed     Text format     Abstract available


  848. FRAWLEY JE, Foley H, McIntyre E
    The associations between medical, allied and complementary medicine practitioner visits and childhood vaccine uptake.
    Vaccine. 2018 Jan 3. pii: S0264-410X(17)31789.
    PubMed     Text format     Abstract available


  849. RAMIREZ A, Morris S, Maucourant S, D'Ascanio I, et al
    A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
    Vaccine. 2018 Jan 3. pii: S0264-410X(17)31814.
    PubMed     Text format     Abstract available


  850. HE Q, Gao H, Gao M, Qi S, et al
    Immunogenicity and safety of a novel tetanus toxoid-conjugated anti-gastrin vaccine in BALB/c mice.
    Vaccine. 2018 Jan 3. pii: S0264-410X(17)31815.
    PubMed     Text format     Abstract available


  851. WIDDICE LE, Unger ER, Panicker G, Hoagland R, et al
    Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals.
    Vaccine. 2018 Jan 3. pii: S0264-410X(17)31795.
    PubMed     Text format     Abstract available


  852. BRYAN MA, Gunningham H, Moreno MA
    Content and accuracy of vaccine information on pediatrician blogs.
    Vaccine. 2018 Jan 2. pii: S0264-410X(17)31829.
    PubMed     Text format     Abstract available


  853. BREAKWELL L, Whaley M, Khan UI, Bandy U, et al
    Meningococcal carriage among a university student population - United States, 2015.
    Vaccine. 2018;36:29-35.
    PubMed     Text format     Abstract available


  854. PORTNOY A, Jit M, Helleringer S, Verguet S, et al
    Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Vaccine. 2018;36:170-178.
    PubMed     Text format     Abstract available


  855. SILVA MTO, Bezerra FSB, de Pinho RB, Begnini KR, et al
    Association of Corynebacterium pseudotuberculosis recombinant proteins rCP09720 or rCP01850 with rPLD as immunogens in caseous lymphadenitis immunoprophylaxis.
    Vaccine. 2018;36:74-83.
    PubMed     Text format     Abstract available


    December 2017
  856. DAI W, Zhang C, Zhang X, Xiong P, et al
    A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice.
    Vaccine. 2017 Dec 30. pii: S0264-410X(17)31818.
    PubMed     Text format     Abstract available


  857. TSUZUKI S, Schwehm M, Eichner M
    Simulation studies to assess the long-term effects of Japan's change from trivalent to quadrivalent influenza vaccination.
    Vaccine. 2017 Dec 29. pii: S0264-410X(17)31819.
    PubMed     Text format     Abstract available


  858. GUPTA A, Popowich S, Ojkic D, Kurukulasuriya S, et al
    Inactivated and live bivalent fowl adenovirus (FAdV8b+FAdV11) breeder vaccines provide broad-spectrum protection in chicks against inclusion body hepatitis (IBH).
    Vaccine. 2017 Dec 29. pii: S0264-410X(17)31808.
    PubMed     Text format     Abstract available


  859. BONKOUNGOU IJO, Aliabadi N, Leshem E, Kam M, et al
    Impact and effectiveness of pentavalent rotavirus vaccine in children <5years of age in Burkina Faso.
    Vaccine. 2017 Dec 28. pii: S0264-410X(17)31817.
    PubMed     Text format     Abstract available


  860. INGRAO F, Rauw F, Steensels M, van den Berg T, et al
    Early immune responses and profiling of cell-mediated immunity-associated gene expression in response to rHVT-IBD vaccination.
    Vaccine. 2017 Dec 28. pii: S0264-410X(17)31820.
    PubMed     Text format     Abstract available


  861. LI L, Fu J, Li S, Guo D, et al
    Phenotypic and molecular characterization of Streptococcus pneumoniae in pre-conjugate vaccine era: A Chinese hospital-based retrospective study.
    Vaccine. 2017 Dec 27. pii: S0264-410X(17)31824.
    PubMed     Text format     Abstract available


  862. SHAPIRO GK, Tatar O, Dube E, Amsel R, et al
    The vaccine hesitancy scale: Psychometric properties and validation.
    Vaccine. 2017 Dec 27. pii: S0264-410X(17)31796.
    PubMed     Text format     Abstract available


  863. JACKSON S, Lentino J, Kopp J, Murray L, et al
    Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults.
    Vaccine. 2017 Dec 27. pii: S0264-410X(17)31791.
    PubMed     Text format     Abstract available


  864. IZADI S, Zahraei SM, Salehi M, Mohammadi M, et al
    Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8-12 months: A randomized clinical trial.
    Vaccine. 2017 Dec 27. pii: S0264-410X(17)31809.
    PubMed     Text format     Abstract available


  865. YANG YT, Shaw J
    Sudden infant death syndrome, attention-deficit/hyperactivity disorder and vaccines: Longitudinal population analyses.
    Vaccine. 2017 Dec 27. pii: S0264-410X(17)31827.
    PubMed     Text format     Abstract available


  866. JORGENSEN P, Mereckiene J, Cotter S, Johansen K, et al
    How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
    Vaccine. 2017 Dec 26. pii: S0264-410X(17)31762.
    PubMed     Text format     Abstract available


  867. DAVIDSON I, Natour-Altory A, Raibstein I, Kin E, et al
    Monitoring the uptake of live avian vaccines by their detection in feathers.
    Vaccine. 2017 Dec 26. pii: S0264-410X(17)31813.
    PubMed     Text format     Abstract available


  868. ZHANG H, Xu Y, Zhang Z, You J, et al
    Protective immunity of a Multivalent Vaccine Candidate against piglet diarrhea caused by enterotoxigenic Escherichia coli (ETEC) in a pig model.
    Vaccine. 2017 Dec 26. pii: S0264-410X(17)31779.
    PubMed     Text format     Abstract available


  869. GOUNDER PP, Bruden D, Rudolph K, Zulz T, et al
    Re-emergence of pneumococcal colonization by vaccine serotype 19F in persons aged >/=5 years after 13-valent pneumococcal conjugate vaccine introduction-Alaska, 2008-2013.
    Vaccine. 2017 Dec 23. pii: S0264-410X(17)31788.
    PubMed     Text format     Abstract available


  870. BASINSKI AJ, Varrelman TJ, Smithson MW, May RH, et al
    Evaluating the promise of recombinant transmissible vaccines.
    Vaccine. 2017 Dec 23. pii: S0264-410X(17)31790.
    PubMed     Text format     Abstract available


  871. LAZALDE GE, Gilkey MB, Kornides ML, McRee AL, et al
    Parent perceptions of dentists' role in HPV vaccination.
    Vaccine. 2017 Dec 23. pii: S0264-410X(17)31763.
    PubMed     Text format     Abstract available


  872. JACKSON LA, El Sahly HM, George S, Winokur P, et al
    Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
    Vaccine. 2017 Dec 23. pii: S0264-410X(17)31822.
    PubMed     Text format     Abstract available


  873. ZAMAN K, Zaman SF, Zaman F, Aziz A, et al
    Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase
    Vaccine. 2017 Dec 22. pii: S0264-410X(17)31787.
    PubMed     Text format     Abstract available


  874. ROECA C, Polotsky AJ
    Influenza vaccination in early pregnancy.
    Vaccine. 2017 Dec 21. pii: S0264-410X(17)31785.
    PubMed     Text format    


  875. GALLAGHER N, Jessop L, Sartaj M, Johnston J, et al
    Impact of live attenuated influenza vaccination programme for healthy children in Northern Ireland: A comparison of seven influenza seasons, 2010/11-2016/17.
    Vaccine. 2017 Dec 21. pii: S0264-410X(17)31730.
    PubMed     Text format     Abstract available


  876. REGAN AK, Moore HC, Sullivan SG
    Does influenza vaccination during early pregnancy really increase the risk of miscarriage?
    Vaccine. 2017 Dec 20. pii: S0264-410X(17)31786.
    PubMed     Text format    


  877. MELIDOU A, Broberg E
    Erratum to "Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition cons
    Vaccine. 2017 Dec 20. pii: S0264-410X(17)31792.
    PubMed     Text format    


  878. FEIRING B, Laake I, Trogstad L
    No conflicting results in the article "HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway".
    Vaccine. 2017;35:7082-7083.
    PubMed     Text format    


  879. ANDERSSON L
    Conflicting results in article describing "HPV-vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis".
    Vaccine. 2017;35:7081.
    PubMed     Text format    


  880. HOSHI SL, Kondo M, Okubo I
    Response to Curran and Mrkvan, Letter to the Editor: Response to publication by Hoshi SL et al.: Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.
    Vaccine. 2017;35:7080.
    PubMed     Text format    


  881. CURRAN D, Mrkvan T
    Response to publication by Hoshi SL et al.: Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.
    Vaccine. 2017;35:7079.
    PubMed     Text format    


  882. VAN RENTERGHEM DM
    CAPiTA: The urine antigen detection (SSUAD) was not validated for PCV13 vaccinated patients.
    Vaccine. 2017;35:7077.
    PubMed     Text format    


  883. VISSER O, Hulscher MEJL, Antonise-Kamp L, Akkermans R, et al
    Assessing determinants of the intention to accept a pertussis cocooning vaccination: A survey among healthcare workers in maternity and paediatric care.
    Vaccine. 2017 Dec 18. pii: S0264-410X(17)31774.
    PubMed     Text format     Abstract available


  884. KABA SA, Karch CP, Seth L, Ferlez KMB, et al
    Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccine.
    Vaccine. 2017 Dec 18. pii: S0264-410X(17)31728.
    PubMed     Text format     Abstract available


  885. TANG N, Zhang Y, Pedrera M, Chang P, et al
    A simple and rapid approach to develop recombinant avian herpesvirus vectored vaccines using CRISPR/Cas9 system.
    Vaccine. 2017 Dec 18. pii: S0264-410X(17)31778.
    PubMed     Text format     Abstract available


  886. SHIVE CL, Judge CJ, Clagett B, Kalayjian RC, et al
    Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection.
    Vaccine. 2017 Dec 15. pii: S0264-410X(17)31761.
    PubMed     Text format     Abstract available


  887. CERNUSCHI T, Malvolti S, Nickels E, Friede M, et al
    Bacillus Calmette-Guerin (BCG) vaccine: A global assessment of demand and supply balance.
    Vaccine. 2017 Dec 15. pii: S0264-410X(17)31748.
    PubMed     Text format     Abstract available


  888. JACKSON ML, Phillips CH, Benoit J, Kiniry E, et al
    The impact of selection bias on vaccine effectiveness estimates from test-negative studies.
    Vaccine. 2017 Dec 15. pii: S0264-410X(17)31775.
    PubMed     Text format     Abstract available


  889. JACKSON ML, Phillips CH, Benoit J, Jackson LA, et al
    Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons.
    Vaccine. 2017 Dec 14. pii: S0264-410X(17)31755.
    PubMed     Text format     Abstract available


  890. ANDRADE AL, da Silva Vieira MA, Minamisava R, Toscano CM, et al
    Single-dose varicella vaccine effectiveness in Brazil: A case-control study.
    Vaccine. 2017 Dec 14. pii: S0264-410X(17)31751.
    PubMed     Text format     Abstract available


  891. FLOREK NW, Campos LM, Braun KM, McLean HQ, et al
    An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children.
    Vaccine. 2017 Dec 14. pii: S0264-410X(17)31777.
    PubMed     Text format     Abstract available


  892. ROWELL J, Lo CY, Price GE, Misplon JA, et al
    Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice.
    Vaccine. 2017 Dec 14. pii: S0264-410X(17)31676.
    PubMed     Text format     Abstract available


  893. LIPSITCH M, Li LM, Patterson S, Trammel J, et al
    Serotype-specific immune responses to pneumococcal conjugate vaccine among children are significantly correlated by individual: Analysis of randomized controlled trial data.
    Vaccine. 2017 Dec 13. pii: S0264-410X(17)31758.
    PubMed     Text format     Abstract available


  894. ASHBAUGH HR, Hoff NA, Doshi RH, Alfonso VH, et al
    Predictors of measles vaccination coverage among children 6-59months of age in the Democratic Republic of the Congo.
    Vaccine. 2017 Dec 13. pii: S0264-410X(17)31613.
    PubMed     Text format     Abstract available


  895. HIBBS BF, Miller E, Shi J, Smith K, et al
    Safety of vaccines that have been kept outside of recommended temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008-2012.
    Vaccine. 2017 Dec 13. pii: S0264-410X(17)31726.
    PubMed     Text format     Abstract available


  896. YOSHIKAWA T, Matsuki T, Sato K, Mizuno M, et al
    Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan.
    Vaccine. 2017 Dec 13. pii: S0264-410X(17)31733.
    PubMed     Text format     Abstract available


  897. WU S, Su J, Yang P, Zhang H, et al
    Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China.
    Vaccine. 2017 Dec 12. pii: S0264-410X(17)31746.
    PubMed     Text format     Abstract available


  898. HARCOURT S, Morbey RA, Bates C, Carter H, et al
    Estimating primary care attendance rates for fever in infants after meningococcal B vaccination in England using national syndromic surveillance data.
    Vaccine. 2017 Dec 12. pii: S0264-410X(17)31719.
    PubMed     Text format     Abstract available


  899. HABER P, Moro PL, Ng C, Lewis PW, et al
    Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31722.
    PubMed     Text format     Abstract available


  900. HERBECK JT, Peebles K, Edlefsen PT, Rolland M, et al
    HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31731.
    PubMed     Text format     Abstract available


  901. RABENSTEINER A, Buja A, Regele D, Fischer M, et al
    Healthcare worker's attitude to seasonal influenza vaccination in the South Tyrolean province of Italy: barriers and facilitators.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31734.
    PubMed     Text format     Abstract available


  902. KOBAYASHI M, Adachi N, Miyazaki M, Tatsumi M, et al
    Decline of rotavirus-coded hospitalizations in children under 5 years: A report from Japan where rotavirus vaccines are self-financed.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31441.
    PubMed     Text format     Abstract available


  903. DUBE E, Gagnon D, Ouakki M, Bettinger JA, et al
    Measuring vaccine acceptance among Canadian parents: A survey of the Canadian Immunization Research Network.
    Vaccine. 2017 Dec 9. pii: S0264-410X(17)31732.
    PubMed     Text format     Abstract available


  904. ZENG W, Halasa-Rappel YA, Baurin N, Coudeville L, et al
    Cost-effectiveness of dengue vaccination in ten endemic countries.
    Vaccine. 2017 Dec 8. pii: S0264-410X(17)31663.
    PubMed     Text format     Abstract available


  905. HENRY O, Brzostek J, Czajka H, Leviniene G, et al
    One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
    Vaccine. 2017 Dec 7. pii: S0264-410X(17)31724.
    PubMed     Text format     Abstract available


  906. GOTTLIEB SL, Giersing BK, Hickling J, Jones R, et al
    Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017.
    Vaccine. 2017 Dec 7. pii: S0264-410X(17)31492.
    PubMed     Text format     Abstract available


  907. DE WALS P, Lefebvre B, Deceuninck G, Longtin J, et al
    Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
    Vaccine. 2017 Dec 7. pii: S0264-410X(17)31618.
    PubMed     Text format     Abstract available


  908. NUNN A, Campbell AC, Naus M, Kwong JC, et al
    Implementing a province-wide mandatory vaccinate-or-mask policy at healthcare facilities in British Columbia, Canada.
    Vaccine. 2017 Dec 6. pii: S0264-410X(17)31713.
    PubMed     Text format     Abstract available


  909. NONVIGNON J, Atherly D, Pecenka C, Aikins M, et al
    Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031.
    Vaccine. 2017 Dec 6. pii: S0264-410X(17)31723.
    PubMed     Text format     Abstract available


  910. KIM SK, Park HY, Kim SH
    A third dose of measles vaccine is needed in young Korean health care workers.
    Vaccine. 2017 Dec 6. pii: S0264-410X(17)31720.
    PubMed     Text format    


  911. BOEF AGC, van der Klis FRM, Berbers GAM, Buisman AM, et al
    Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies.
    Vaccine. 2017 Dec 6. pii: S0264-410X(17)31697.
    PubMed     Text format     Abstract available


  912. ORTIZ JR, Hickling J, Jones R, Donabedian A, et al
    Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016.
    Vaccine. 2017 Dec 5. pii: S0264-410X(17)31645.
    PubMed     Text format     Abstract available


  913. MARTINSON B, Zoghby W, Barrett K, Bryson L, et al
    Efficacy of an inactivated Mycoplasma hyorhinis vaccine in pigs.
    Vaccine. 2017 Dec 5. pii: S0264-410X(17)31660.
    PubMed     Text format     Abstract available


  914. CLIFT C, Salisbury DM
    Enhancing the role of vaccines in combatting antimicrobial resistance.
    Vaccine. 2017;35.
    PubMed     Text format     Abstract available


  915. JIANG C, Whitmore-Sisco L, Gaur AH, Adderson EE, et al
    A quality improvement initiative to increase Tdap (tetanus, diphtheria, acellular pertussis) vaccination coverage among direct health care providers at a children's hospital.
    Vaccine. 2017 Dec 4. pii: S0264-410X(17)31712.
    PubMed     Text format     Abstract available


  916. PARKER EPK, Praharaj I, Zekavati A, Lazarus RP, et al
    Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India.
    Vaccine. 2017 Dec 4. pii: S0264-410X(17)31595.
    PubMed     Text format     Abstract available


  917. MOKIOU S, Standaert B, Li X, De Cock E, et al
    Measuring the cost of a pediatric vaccine administration in the UK.
    Vaccine. 2017 Dec 2. pii: S0264-410X(17)31606.
    PubMed     Text format     Abstract available


  918. VON DELFT A, Donnison TA, Lourenco J, Hutchings C, et al
    The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes.
    Vaccine. 2017 Dec 1. pii: S0264-410X(17)31487.
    PubMed     Text format     Abstract available


  919. SEHERI LM, Magagula NB, Peenze I, Rakau K, et al
    Rotavirus strain diversity in Eastern and Southern African countries before and after vaccine introduction.
    Vaccine. 2017 Dec 1. pii: S0264-410X(17)31679.
    PubMed     Text format     Abstract available


    November 2017
  920. SRINIVASAN R, Girish Kumar CP, Naaraayan SA, Jehangir S, et al
    Intussusception hospitalizations before rotavirus vaccine introduction: Retrospective data from two referral hospitals in Tamil Nadu, India.
    Vaccine. 2017 Nov 30. pii: S0264-410X(17)31607.
    PubMed     Text format     Abstract available


  921. RUSSELL KE, Bresee JS, Katz JM, Olsen SJ, et al
    Evaluating interest in an influenza A(H5N1) vaccine among laboratory workers who work with highly-pathogenic avian influenza viruses in the United States.
    Vaccine. 2017 Nov 30. pii: S0264-410X(17)31536.
    PubMed     Text format     Abstract available


  922. VAN DER LEE S, Sanders EAM, Berbers GAM, Buisman AM, et al
    Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.
    Vaccine. 2017 Nov 30. pii: S0264-410X(17)31677.
    PubMed     Text format     Abstract available


  923. WOLFE DN, Zarrabian AG, Disbrow GL, Espeland EM, et al
    Progress towards a vaccine against Ebola to meet emergency medical countermeasure needs.
    Vaccine. 2017 Nov 30. pii: S0264-410X(17)31661.
    PubMed     Text format     Abstract available


  924. SCOTTA MC, Paternina-de la Ossa R, Lumertz MS, Jones MH, et al
    Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil.
    Vaccine. 2017 Nov 29. pii: S0264-410X(17)31621.
    PubMed     Text format     Abstract available


  925. BONNER K, Banura C, Basta NE
    HPV vaccination strategies targeting hard-to-reach populations: Out-of-school girls in LMICs.
    Vaccine. 2017 Nov 29. pii: S0264-410X(17)31602.
    PubMed     Text format    


  926. WEI KP, Zhu FC, Liu JX, Yan L, et al
    The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother-to-child transmission of hepatitis B virus: A prospective cohort study.
    Vaccine. 2017 Nov 28. pii: S0264-410X(17)31601.
    PubMed     Text format     Abstract available


  927. KITTEL PA
    The impact of the recommendation of routine rotavirus vaccination in Germany: An interrupted time-series analysis.
    Vaccine. 2017 Nov 28. pii: S0264-410X(17)31605.
    PubMed     Text format     Abstract available


  928. GALVEZ-ROMERO G, Salas-Rojas M, Pompa-Mera EN, Chavez-Rueda K, et al
    Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection.
    Vaccine. 2017 Nov 27. pii: S0264-410X(17)31611.
    PubMed     Text format     Abstract available


  929. KRISTENSEN CS, Kvisgaard LK, Pawlowski M, Holmgaard Carlsen S, et al
    Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
    Vaccine. 2017 Nov 27. pii: S0264-410X(17)31643.
    PubMed     Text format     Abstract available


  930. SIRIKUN J, Suputtamongkol Y, Rattanachinakorn P, Primsirikunawut A, et al
    Immunogenic response in obese patients undergoing rabies post-exposure prophylaxis with combined equine rabies immunoglobulin and rabies vaccination.
    Vaccine. 2017 Nov 27. pii: S0264-410X(17)31622.
    PubMed     Text format     Abstract available


  931. CHEN Y, Zhou CL, Zhang XJ, Hao ZY, et al
    Immune memory at 17-years of follow-up of a single dose of live attenuated hepatitis A vaccine.
    Vaccine. 2017 Nov 25. pii: S0264-410X(17)31600.
    PubMed     Text format     Abstract available


  932. HOQUE SA, Kobayashi M, Takanashi S, Anwar KS, et al
    Role of rotavirus vaccination on an emerging G8P[8] rotavirus strain causing an outbreak in central Japan.
    Vaccine. 2017 Nov 25. pii: S0264-410X(17)31620.
    PubMed     Text format     Abstract available


  933. LOCHT C
    Will we have new pertussis vaccines?
    Vaccine. 2017 Nov 24. pii: S0264-410X(17)31619.
    PubMed     Text format     Abstract available


  934. BALZLI CL, Bertran K, Lee DH, Killmaster L, et al
    The efficacy of recombinant turkey herpesvirus vaccines targeting the H5 of highly pathogenic avian influenza virus from the 2014-2015 North American outbreak.
    Vaccine. 2017 Nov 24. pii: S0264-410X(17)31590.
    PubMed     Text format     Abstract available


  935. MACDONALD N, Dube E, Butler R
    Vaccine hesitancy terminology: A response to Bedford et al.
    Vaccine. 2017 Nov 24. pii: S0264-410X(17)31644.
    PubMed     Text format    


  936. SAHAY B, Colliou N, Zadeh M, Ge Y, et al
    Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.
    Vaccine. 2017 Nov 24. pii: S0264-410X(17)31550.
    PubMed     Text format     Abstract available


  937. WOUTERS I, Van Heirstraeten L, Desmet S, Blaizot S, et al
    Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9years of pneumococcal conjugate vaccine programme.
    Vaccine. 2017 Nov 24. pii: S0264-410X(17)31616.
    PubMed     Text format     Abstract available


  938. LEUNG TF, Liu AP, Lim FS, Thollot F, et al
    Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14years: Results to month 36 from a randomized trial.
    Vaccine. 2017 Nov 23. pii: S0264-410X(17)31598.
    PubMed     Text format     Abstract available


  939. LAWTON B, Howe AS, Turner N, Filoche S, et al
    Association of prior HPV vaccination with reduced preterm birth: A population based study.
    Vaccine. 2017 Nov 23. pii: S0264-410X(17)31579.
    PubMed     Text format     Abstract available


  940. MORO PL, Zheteyeva Y, Barash F, Lewis P, et al
    Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.
    Vaccine. 2017 Nov 23. pii: S0264-410X(17)31603.
    PubMed     Text format     Abstract available


  941. DEMOLIS R, Botao C, Heyerdahl LW, Gessner BD, et al
    A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique.
    Vaccine. 2017 Nov 23. pii: S0264-410X(17)31495.
    PubMed     Text format     Abstract available


  942. LAL H, Poder A, Campora L, Geeraerts B, et al
    Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study.
    Vaccine. 2017 Nov 22. pii: S0264-410X(17)31578.
    PubMed     Text format     Abstract available


  943. WILLIS ED, Woodward M, Brown E, Popmihajlov Z, et al
    Herpes zoster vaccine live: A 10year review of post-marketing safety experience.
    Vaccine. 2017 Nov 22. pii: S0264-410X(17)31572.
    PubMed     Text format     Abstract available


  944. SALES NS, Silva JR, Aps LRMM, Silva MO, et al
    In vivo electroporation enhances vaccine-mediated therapeutic control of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8(+) T cells.
    Vaccine. 2017 Nov 22. pii: S0264-410X(17)31570.
    PubMed     Text format     Abstract available


  945. CIBULSKI S, Rivera-Patron M, Suarez N, Pirez M, et al
    Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
    Vaccine. 2017 Nov 22. pii: S0264-410X(17)31594.
    PubMed     Text format     Abstract available


  946. LAPINSCKI B, Pereira LA, Nogueira MB, Vidal LR, et al
    Molecular epidemiology of influenza B virus and implications in immunization strategy, Southern Brazil.
    Vaccine. 2017 Nov 22. pii: S0264-410X(17)31597.
    PubMed     Text format     Abstract available


  947. SHIN HY, Chung JH, Hwang HJ, Kim TH, et al
    Factors influencing on influenza vaccination and its trends of coverage in patients with diabetes in Korea: A population-based cross-sectional study.
    Vaccine. 2017 Nov 21. pii: S0264-410X(17)31599.
    PubMed     Text format     Abstract available


  948. CHILDS L, Roesel S, Tohme RA
    Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.
    Vaccine. 2017 Nov 21. pii: S0264-410X(17)31591.
    PubMed     Text format     Abstract available


  949. KALIMUDDIN S, Wijaya L, Chan YFZ, Wong AWL, et al
    A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen.
    Vaccine. 2017 Nov 21. pii: S0264-410X(17)31526.
    PubMed     Text format     Abstract available


  950. WENIGER BG, Anglin IE, Tong T, Pensiero M, et al
    Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015.
    Vaccine. 2017 Nov 21. pii: S0264-410X(17)31479.
    PubMed     Text format     Abstract available


  951. SUN H, Workman A, Osorio FA, Steffen D, et al
    Development of a broadly protective modified-live virus vaccine candidate against porcine reproductive and respiratory syndrome virus.
    Vaccine. 2017 Nov 21. pii: S0264-410X(17)31592.
    PubMed     Text format     Abstract available


  952. GOLDWOOD G, Diesburg S
    The effect of cool water pack preparation on vaccine vial temperatures in refrigerators.
    Vaccine. 2017 Nov 21. pii: S0264-410X(17)31585.
    PubMed     Text format     Abstract available


  953. RAYAMAJHI A, Thapa A, Kumar M, Yen C, et al
    Preparing for rotavirus vaccine introduction - A retrospective assessment of the epidemiology of intussusception in children below 2years of age in Nepal.
    Vaccine. 2017 Nov 20. pii: S0264-410X(17)31581.
    PubMed     Text format     Abstract available


  954. BURNETT E, Lopman BA, Parashar UD
    Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.
    Vaccine. 2017 Nov 20. pii: S0264-410X(17)31423.
    PubMed     Text format     Abstract available


  955. CATES JR, Crandell JL, Diehl SJ, Coyne-Beasley T, et al
    Immunization effects of a communication intervention to promote preteen HPV vaccination in primary care practices.
    Vaccine. 2017 Nov 20. pii: S0264-410X(17)31586.
    PubMed     Text format     Abstract available


  956. LI Y, Cao H, Li Y, Li Z, et al
    Construction of a novel vaccine by conjugating a B-cell epitope of DPP4 to peptide IA2(5)-P2-1 to significantly control type 1 diabetes in NOD mice.
    Vaccine. 2017 Nov 20. pii: S0264-410X(17)31443.
    PubMed     Text format     Abstract available


  957. DING L, Widdice LE, Kahn JA
    Differences between vaccinated and unvaccinated women explain increase in non-vaccine-type human papillomavirus in unvaccinated women after vaccine introduction.
    Vaccine. 2017 Nov 20. pii: S0264-410X(17)31547.
    PubMed     Text format     Abstract available


  958. DIOP A, Thiongane A, Mwenda JM, Aliabadi N, et al
    Impact of rotavirus vaccine on acute gastroenteritis in children under 5 years in Senegal: Experience of sentinel site of the Albert Royer Children's Hospital in Dakar.
    Vaccine. 2017 Nov 18. pii: S0264-410X(17)31469.
    PubMed     Text format     Abstract available


  959. BOONNAK K, Dhitavat J, Thantamnu N, Kosoltanapiwat N, et al
    Immune responses to intradermal and intramuscular inactivated influenza vaccine among older age group.
    Vaccine. 2017 Nov 17. pii: S0264-410X(17)31538.
    PubMed     Text format     Abstract available


  960. FRAIZ LD, de Roche A, Mauro C, Catallozzi M, et al
    U.S. pregnant women's knowledge and attitudes about behavioral strategies and vaccines to prevent Zika acquisition.
    Vaccine. 2017 Nov 17. pii: S0264-410X(17)31580.
    PubMed     Text format     Abstract available


  961. MAHAPATRA M, Upadhyaya S, Aviso S, Babu A, et al
    Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007-2012) circulating in Southeast Asia, East Asia and Far East.
    Vaccine. 2017 Nov 17. pii: S0264-410X(17)31528.
    PubMed     Text format     Abstract available


  962. MALOSH RE, Martin ET, Ortiz JR, Monto AS, et al
    The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review.
    Vaccine. 2017 Nov 17. pii: S0264-410X(17)31577.
    PubMed     Text format     Abstract available


  963. CANO PG, Gamage LNA, Marciniuk K, Hayes C, et al
    Lambda display phage as a mucosal vaccine delivery vehicle for peptide antigens.
    Vaccine. 2017 Nov 16. pii: S0264-410X(17)31569.
    PubMed     Text format     Abstract available


  964. GARG R, Brownlie R, Latimer L, Gerdts V, et al
    Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity.
    Vaccine. 2017 Nov 16. pii: S0264-410X(17)31524.
    PubMed     Text format     Abstract available


  965. YAGI A, Ueda Y, Kimura T
    A behavioral economics approach to the failed HPV vaccination program in Japan.
    Vaccine. 2017 Nov 15. pii: S0264-410X(17)31472.
    PubMed     Text format    


  966. PFEIFFER G, Fisker AB, Nebie E, Hengelbrock J, et al
    Non-specific effects of childhood vaccinations - A case control study nested into a Health and Demographic Surveillance System in rural Burkina Faso.
    Vaccine. 2017 Nov 15. pii: S0264-410X(17)31497.
    PubMed     Text format     Abstract available


  967. BAGHI HB, Bazmani A, Aghazadeh M
    Canine vaccination: Bridging the rabies knowledge gap.
    Vaccine. 2017 Nov 15. pii: S0264-410X(17)31575.
    PubMed     Text format    


  968. STURKENBOOM M
    Advancing collaborative vaccine benefits and safety research in Europe via the ADVANCE code of conduct.
    Vaccine. 2017 Nov 15. pii: S0264-410X(17)31131.
    PubMed     Text format    


  969. NI Y, Springer MJ, Guo J, Finger-Baker I, et al
    Development of a synthetic Vi polysaccharide vaccine for typhoid fever.
    Vaccine. 2017 Nov 14. pii: S0264-410X(17)31489.
    PubMed     Text format     Abstract available


  970. AINSLIE KEC, Shi M, Haber M, Orenstein WA, et al
    On the bias of estimates of influenza vaccine effectiveness from test-negative studies.
    Vaccine. 2017 Nov 13. pii: S0264-410X(17)31539.
    PubMed     Text format     Abstract available


  971. VAN DEURSEN AMM, Schurink-Van't Klooster TM, Man WH, van de Kassteele J, et al
    Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands.
    Vaccine. 2017 Nov 13. pii: S0264-410X(17)31498.
    PubMed     Text format     Abstract available


  972. NYMARK LS, Sharma T, Miller A, Enemark U, et al
    Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used.
    Vaccine. 2017 Nov 13. pii: S0264-410X(17)31420.
    PubMed     Text format     Abstract available


  973. BATISTA MT, Ferreira EL, Pereira GS, Stafford P, et al
    LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1.
    Vaccine. 2017 Nov 13. pii: S0264-410X(17)31549.
    PubMed     Text format     Abstract available


  974. ESPARZA J, Schrick L, Damaso CR, Nitsche A, et al
    Equination (inoculation of horsepox): An early alternative to vaccination (inoculation of cowpox) and the potential role of horsepox virus in the origin of the smallpox vaccine.
    Vaccine. 2017 Nov 11. pii: S0264-410X(17)31545.
    PubMed     Text format     Abstract available


  975. BOND KA, Franklin LJ, Sutton B, Firestone SM, et al
    Q-Vax Q fever vaccine failures, Victoria, Australia 1994-2013.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31496.
    PubMed     Text format     Abstract available


  976. DATTA D, Bansal GP, Grasperge B, Martin DS, et al
    Comparative functional potency of DNA vaccines encoding Plasmodium falciparum transmission blocking target antigens Pfs48/45 and Pfs25 administered alone or in combination by in vivo electroporation in rhesus macaques.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31450.
    PubMed     Text format     Abstract available


  977. PETIT D, Tevi-Benissan C, Woodring J, Hennessey K, et al
    Countries' interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31421.
    PubMed     Text format     Abstract available


  978. WALTON S, Cortina-Borja M, Dezateux C, Griffiths LJ, et al
    Measuring the timeliness of childhood vaccinations: Using cohort data and routine health records to evaluate quality of immunisation services.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31493.
    PubMed     Text format     Abstract available


  979. ALBRIGHT K, Hurley LP, Lockhart S, Gurfinkel D, et al
    Attitudes about adult vaccines and reminder/recall in a safety net population.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31543.
    PubMed     Text format     Abstract available


  980. SHEN AK, Kelman JA, Warnock R, Zhang W, et al
    Beneficiary characteristics and vaccinations in the end-stage renal disease Medicare beneficiary population, an analysis of claims data 2006-2015.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31537.
    PubMed     Text format     Abstract available


  981. COLE KS, Martin JM, Horne WT, Lin CJ, et al
    Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31235.
    PubMed     Text format     Abstract available


  982. ENTWISLE C, Hill S, Pang Y, Joachim M, et al
    Safety and immunogenicity of a novel multiple antigen pneumococcal vaccine in adults: A Phase 1 randomised clinical trial.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31484.
    PubMed     Text format     Abstract available



  983. Announcing the publication of the WHO immunological basis for immunization series module on pertussis vaccines.
    Vaccine. 2017 Nov 9. pii: S0264-410X(17)31542.
    PubMed     Text format     Abstract available


  984. DU L, Chen J, Hou L, Yu X, et al
    Long-term humoral immunity induced by CVC1302-adjuvanted serotype O foot-and-mouth disease inactivated vaccine correlates with promoted T follicular helper cells and thus germinal center responses in mice.
    Vaccine. 2017 Nov 9. pii: S0264-410X(17)31523.
    PubMed     Text format     Abstract available


  985. HUO C, Yang J, Lei L, Qiao L, et al
    Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Vaccine. 2017 Nov 9. pii: S0264-410X(17)31530.
    PubMed     Text format     Abstract available


  986. MCDONALD BM, Dover DC, Simmonds KA, Bell CA, et al
    The effectiveness of shingles vaccine among Albertans aged 50years or older: A retrospective cohort study.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31475.
    PubMed     Text format     Abstract available


  987. TOSUN S, Olut AI, Tansug N
    Adverse effects of single-component measles vaccine in school children.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31531.
    PubMed     Text format     Abstract available


  988. PAN Y, Wang Q, Yang P, Zhang L, et al
    Influenza vaccination in preventing outbreaks in schools: A long-term ecological overview.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31525.
    PubMed     Text format     Abstract available


  989. DE DEUS N, Chilaule JJ, Cassocera M, Bambo M, et al
    Early impact of rotavirus vaccination in children less than five years of age in Mozambique.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31468.
    PubMed     Text format     Abstract available


  990. PUIG-BARBERA J, Guglieri-Lopez B, Tortajada-Girbes M, Lopez-Labrador FX, et al
    Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31529.
    PubMed     Text format     Abstract available


  991. PILLSBURY A, Quinn H, Cashman P, Leeb A, et al
    Active SMS-based influenza vaccine safety surveillance in Australian children.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31499.
    PubMed     Text format     Abstract available


  992. HEYERDAHL LW, Ngwira B, Demolis R, Nyirenda G, et al
    Innovative vaccine delivery strategies in response to a cholera outbreak in the challenging context of Lake Chilwa. A rapid qualitative assessment.
    Vaccine. 2017 Nov 7. pii: S0264-410X(17)31540.
    PubMed     Text format     Abstract available


  993. RIESEN M, Garcia V, Low N, Althaus CL, et al
    Modeling the consequences of regional heterogeneity in human papillomavirus (HPV) vaccination uptake on transmission in Switzerland.
    Vaccine. 2017 Nov 7. pii: S0264-410X(17)31532.
    PubMed     Text format     Abstract available


  994. CROUSE QUINN S, Jamison AM, Freimuth VS, An J, et al
    Determinants of influenza vaccination among high-risk Black and White adults.
    Vaccine. 2017 Nov 7. pii: S0264-410X(17)31491.
    PubMed     Text format     Abstract available


  995. WAGNER LD, Corvette LJ, Ngundi MM, Burns DL, et al
    Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice.
    Vaccine. 2017 Nov 6. pii: S0264-410X(17)31490.
    PubMed     Text format     Abstract available


  996. DIOS-GUERRA C, Carmona-Torres JM, Lopez-Soto PJ, Morales-Cane I, et al
    Prevalence and factors associated with influenza vaccination of persons over 65 years old in Spain (2009-2014).
    Vaccine. 2017 Nov 6. pii: S0264-410X(17)31494.
    PubMed     Text format     Abstract available


  997. NANNI A, Meredith S, Gati S, Holm K, et al
    Strengthening global vaccine access for adolescents and adults.
    Vaccine. 2017 Nov 6. pii: S0264-410X(17)31419.
    PubMed     Text format     Abstract available


  998. LYONS NA, Ludi AB, Wilsden G, Hamblin P, et al
    Evaluation of a polyvalent foot-and-mouth disease virus vaccine containing A Saudi-95 against field challenge on large-scale dairy farms in Saudi Arabia with the emerging A/ASIA/G-VII viral lineage.
    Vaccine. 2017 Nov 3. pii: S0264-410X(17)31425.
    PubMed     Text format     Abstract available


  999. MCELHANEY JE, Andrew MK, McNeil SA
    Estimating influenza vaccine effectiveness: Evolution of methods to better understand effects of confounding in older adults.
    Vaccine. 2017;35:6269-6274.
    PubMed     Text format     Abstract available


  1000. PENKERT RR, Iverson A, Rosch JW, Hurwitz JL, et al
    Prevnar-13 vaccine failure in a mouse model for vitamin A deficiency.
    Vaccine. 2017;35:6264-6268.
    PubMed     Text format     Abstract available


  1001. MISHRA N, Smyth JA
    Oral vaccination of broiler chickens against necrotic enteritis using a non-virulent NetB positive strain of Clostridium perfringens type A.
    Vaccine. 2017 Nov 1. pii: S0264-410X(17)31426.
    PubMed     Text format     Abstract available


  1002. LLOYD-JONES K, Mahapatra M, Upadhyaya S, Paton DJ, et al
    Genetic and antigenic characterization of serotype O FMD viruses from East Africa for the selection of suitable vaccine strain.
    Vaccine. 2017 Nov 1. pii: S0264-410X(17)31448.
    PubMed     Text format     Abstract available


    October 2017
  1003. ROLFES MA, Goswami D, Sharmeen AT, Yeasmin S, et al
    Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31482.
    PubMed     Text format     Abstract available


  1004. YAN J, Morrow MP, Chu JS, Racine T, et al
    Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31358.
    PubMed     Text format     Abstract available


  1005. TESEMA B, Zhao JY, Jiang XP, Liu GQ, et al
    Kisspeptin recombinant oral vaccine: A master gene vaccine inhibiting the reproductive physiology and behavior of ram lambs.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31201.
    PubMed     Text format     Abstract available


  1006. FROTA ACC, Ferreira B, Harrison LH, Pereira GS, et al
    Safety and immune response after two-dose meningococcal C conjugate immunization in HIV-infected children and adolescents in Rio de Janeiro, Brazil.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31451.
    PubMed     Text format     Abstract available


  1007. KATZ J, Englund JA, Steinhoff MC, Khatry SK, et al
    Nutritional status of infants at six months of age following maternal influenza immunization: A randomized placebo-controlled trial in rural Nepal.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31372.
    PubMed     Text format     Abstract available


  1008. ZHONG G, Brunham RC, de la Maza LM, Darville T, et al
    National institute of allergy and infectious diseases workshop report: "Chlamydia vaccines: the way forward".
    Vaccine. 2017 Oct 30. pii: S0264-410X(17)31483.
    PubMed     Text format     Abstract available


  1009. SHIRATSUCHI T, Rai U, Kaneko I, Zhang M, et al
    A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII.
    Vaccine. 2017 Oct 28. pii: S0264-410X(17)31474.
    PubMed     Text format     Abstract available


  1010. GUSTIN MP, Ohannessian R, Giard M, Caillat-Vallet E, et al
    Use of surveillance data to calculate the sample size and the statistical power of randomized clinical trials testing Staphylococcus aureus vaccine efficacy in orthopedic surgery.
    Vaccine. 2017 Oct 28. pii: S0264-410X(17)31476.
    PubMed     Text format     Abstract available


  1011. STOCKWELL MS, Marchant CD, Wodi AP, Barnett ED, et al
    A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging.
    Vaccine. 2017 Oct 28. pii: S0264-410X(17)31481.
    PubMed     Text format     Abstract available


  1012. LANDI A, Law J, Hockman D, Logan M, et al
    Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes.
    Vaccine. 2017 Oct 28. pii: S0264-410X(17)31480.
    PubMed     Text format     Abstract available


  1013. PAGE NA, Seheri LM, Groome MJ, Moyes J, et al
    Temporal association of rotavirus vaccination and genotype circulation in South Africa: Observations from 2002 to 2014.
    Vaccine. 2017 Oct 27. pii: S0264-410X(17)31470.
    PubMed     Text format     Abstract available


  1014. LEE JS, Lim JK, Dang DA, Nguyen THA, et al
    Dengue vaccine supplies under endemic and epidemic conditions in three dengue-endemic countries: Colombia, Thailand, and Vietnam.
    Vaccine. 2017 Oct 27. pii: S0264-410X(17)31478.
    PubMed     Text format     Abstract available


  1015. METHNER U, Berndt A, Locke M
    Salmonella Enteritidis with double deletion in phoP fliC and a competitive exclusion culture elicit substantial additive protective effects against Salmonella exposure in newly hatched chicks.
    Vaccine. 2017;35:6076-6082.
    PubMed     Text format     Abstract available


  1016. NG S, Saborio S, Kuan G, Gresh L, et al
    Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.
    Vaccine. 2017;35:6202-6207.
    PubMed     Text format     Abstract available


  1017. GUISO N, Levy C, Romain O, Guillot S, et al
    Whooping cough surveillance in France in pediatric private practice in 2006-2015.
    Vaccine. 2017;35:6083-6088.
    PubMed     Text format     Abstract available


  1018. ANDERSEN A, Bjerregaard-Andersen M, Rodrigues A, Umbasse P, et al
    Sex-differential effects of diphtheria-tetanus-pertussis vaccine for the outcome of paediatric admissions? A hospital based observational study from Guinea-Bissau.
    Vaccine. 2017 Oct 26. pii: S0264-410X(17)31455.
    PubMed     Text format     Abstract available


  1019. ANWARI P, Debellut F, Pecenka C, Parwiz SM, et al
    Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.
    Vaccine. 2017 Oct 26. pii: S0264-410X(17)31466.
    PubMed     Text format     Abstract available


  1020. NI Y, Guo J, Turner D, Tizard I, et al
    Development of a novel dual-domain nanoparticle antigen construct for universal influenza vaccine.
    Vaccine. 2017 Oct 25. pii: S0264-410X(17)31459.
    PubMed     Text format     Abstract available


  1021. BAR-ON L, Cohen H, Elia U, Rotem S, et al
    Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
    Vaccine. 2017 Oct 25. pii: S0264-410X(17)31461.
    PubMed     Text format     Abstract available


  1022. LI B, Du L, Yu Z, Sun B, et al
    Poly (d,l-lactide-co-glycolide) nanoparticle-entrapped vaccine induces a protective immune response against porcine epidemic diarrhea virus infection in piglets.
    Vaccine. 2017 Oct 25. pii: S0264-410X(17)31462.
    PubMed     Text format     Abstract available


  1023. WELDEGEBRIEL G, Mwenda JM, Chakauya J, Daniel F, et al
    Impact of rotavirus vaccine on rotavirus diarrhoea in countries of East and Southern Africa.
    Vaccine. 2017 Oct 25. pii: S0264-410X(17)31458.
    PubMed     Text format     Abstract available


  1024. PLATTEEL ACM, Henri S, Zaiss DM, Sijts AJAM, et al
    Dissecting antigen processing and presentation routes in dermal vaccination strategies.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31452.
    PubMed     Text format     Abstract available


  1025. PRYSLIAK T, Maina T, Yu L, Suleman M, et al
    Induction of a balanced IgG1/IgG2 immune response to an experimental challenge with Mycoplasma bovis antigens following a vaccine composed of Emulsigen, IDR peptide1002, and poly I:C.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31445.
    PubMed     Text format     Abstract available


  1026. MORIYAMA M, Takeyama H, Hasegawa H, Ichinohe T, et al
    Induction of lung CD8+ T cell responses by consecutive inoculations of a poly(I:C) influenza vaccine.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31446.
    PubMed     Text format     Abstract available


  1027. STREZOVA A, Godeaux O, Aggarwal N, Leroux-Roels G, et al
    A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ/su.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31396.
    PubMed     Text format     Abstract available


  1028. WERA E, Mourits MCM, Hogeveen H
    Cost-effectiveness of mass dog rabies vaccination strategies to reduce human health burden in Flores Island, Indonesia.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31374.
    PubMed     Text format     Abstract available


  1029. WOHLGEMUTH N, Ye Y, Fenstermacher KJ, Liu H, et al
    The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31414.
    PubMed     Text format     Abstract available


  1030. LU Y, Zhu FC, Liu JX, Zhai XJ, et al
    The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31428.
    PubMed     Text format     Abstract available


  1031. HARRINGTON L, Van Damme P, Vandermeulen C, Mali S, et al
    Recruitment barriers for prophylactic vaccine trials: A study in Belgium.
    Vaccine. 2017 Oct 23. pii: S0264-410X(17)31449.
    PubMed     Text format     Abstract available


  1032. WALLACE AS, Willis F, Nwaze E, Dieng B, et al
    Vaccine wastage in Nigeria: An assessment of wastage rates and related vaccinator knowledge, attitudes and practices.
    Vaccine. 2017 Oct 21. pii: S0264-410X(17)31335.
    PubMed     Text format     Abstract available


  1033. YANG YT
    European Court of Justice ruling on vaccine liability and its implications for the United States.
    Vaccine. 2017 Oct 20. pii: S0264-410X(17)31427.
    PubMed     Text format    



  1034. Ethics, pregnancy, and ZIKV vaccine research & development.
    Vaccine. 2017 Oct 19. pii: S0264-410X(17)31318.
    PubMed     Text format    


  1035. LEITE A, Thomas SL, Andrews NJ
    Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD).
    Vaccine. 2017 Oct 19. pii: S0264-410X(17)31239.
    PubMed     Text format     Abstract available


  1036. SABADIN GA, Parizi LF, Kiio I, Xavier MA, et al
    Effect of recombinant glutathione S-transferase as vaccine antigen against Rhipicephalus appendiculatus and Rhipicephalus sanguineus infestation.
    Vaccine. 2017 Oct 19. pii: S0264-410X(17)31422.
    PubMed     Text format     Abstract available


  1037. WALTER EB, Hornik CP, Grohskopf L, McGee CE, et al
    The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children.
    Vaccine. 2017 Oct 19. pii: S0264-410X(17)31416.
    PubMed     Text format     Abstract available


  1038. BERNSTEIN HH, Seyferth ER
    Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid.
    Vaccine. 2017 Oct 17. pii: S0264-410X(17)31395.
    PubMed     Text format     Abstract available


  1039. WANG X, Zhou D, Wang G, Huang L, et al
    A novel multi-variant epitope ensemble vaccine against avian leukosis virus subgroup J.
    Vaccine. 2017 Oct 17. pii: S0264-410X(17)31415.
    PubMed     Text format     Abstract available


  1040. SMITH TG, Millien M, Vos A, Fracciterne FA, et al
    Evaluation of immune responses in dogs to oral rabies vaccine under field conditions.
    Vaccine. 2017 Oct 17. pii: S0264-410X(17)31388.
    PubMed     Text format     Abstract available


  1041. YUE X, Zhao X, Dai Y, Shu Q, et al
    Episode of Kasabach-Merritt phenomenon following Japanese encephalitis vaccination: Case report.
    Vaccine. 2017 Oct 16. pii: S0264-410X(17)31078.
    PubMed     Text format     Abstract available


  1042. MEHTA PA, Sauter S, Zhang X, Davies SM, et al
    Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia.
    Vaccine. 2017 Oct 14. pii: S0264-410X(17)31394.
    PubMed     Text format     Abstract available


  1043. FREULING CM, Eggerbauer E, Finke S, Kaiser C, et al
    Efficacy of the oral rabies virus vaccine strain SPBN GASGAS in foxes and raccoon dogs.
    Vaccine. 2017 Oct 14. pii: S0264-410X(17)31366.
    PubMed     Text format     Abstract available


  1044. ORTIZ JR, Hombach J
    Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines.
    Vaccine. 2017 Oct 14. pii: S0264-410X(17)31226.
    PubMed     Text format     Abstract available


  1045. PARK J, Goldstein J, Haran M, Ferrari M, et al
    An ensemble approach to predicting the impact of vaccination on rotavirus disease in Niger.
    Vaccine. 2017;35:5835-5841.
    PubMed     Text format     Abstract available


  1046. PUIG-BARBERA J, Mira-Iglesias A, Tortajada-Girbes M, Lopez-Labrador FX, et al
    Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015.
    Vaccine. 2017;35:5799-5807.
    PubMed     Text format     Abstract available


  1047. KARAN D
    Formulation of the bivalent prostate cancer vaccine with surgifoam elicits antigen-specific effector T cells in PSA-transgenic mice.
    Vaccine. 2017;35:5794-5798.
    PubMed     Text format     Abstract available


  1048. WANG J, Qiu J, Zhu Y, Zhou H, et al
    Molecular evolution of hepatitis B vaccine escape variants in China, during 2000-2016.
    Vaccine. 2017;35:5808-5813.
    PubMed     Text format     Abstract available


  1049. MO Z, Mo Y, Li M, Tao J, et al
    Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial.
    Vaccine. 2017;35:5897-5904.
    PubMed     Text format     Abstract available


  1050. GEE J, Sukumaran L, Weintraub E
    Risk of Guillain-Barre Syndrome following quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink.
    Vaccine. 2017;35:5756-5758.
    PubMed     Text format     Abstract available


  1051. OLATUNBOSUN OD, Esterhuizen TM, Wiysonge CS
    A cross sectional survey to evaluate knowledge, attitudes and practices regarding seasonal influenza and influenza vaccination among diabetics in Pretoria, South Africa.
    Vaccine. 2017 Oct 13. pii: S0264-410X(17)31370.
    PubMed     Text format     Abstract available


  1052. FREY SE, Lottenbach K, Graham I, Anderson E, et al
    A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066).
    Vaccine. 2017 Oct 13. pii: S0264-410X(17)31323.
    PubMed     Text format     Abstract available


  1053. REYBURN R, Nand D, Nguyen C, Naidu S, et al
    Validation of administrative data to estimate vaccine impact: Audit of the Fiji hospital admissions electronic database, 2007-2011 & 2014-2015.
    Vaccine. 2017 Oct 13. pii: S0264-410X(17)31363.
    PubMed     Text format     Abstract available


  1054. OZAWA S, Wonodi C, Babalola O, Ismail T, et al
    Using best-worst scaling to rank factors affecting vaccination demand in northern Nigeria.
    Vaccine. 2017 Oct 13. pii: S0264-410X(17)31332.
    PubMed     Text format     Abstract available


  1055. KLUBERG SA, McGinnis DP, Hswen Y, Majumder MS, et al
    County-level assessment of United States kindergarten vaccination rates for measles mumps rubella (MMR) for the 2014-2015 school year.
    Vaccine. 2017 Oct 13. pii: S0264-410X(17)31333.
    PubMed     Text format     Abstract available


  1056. VOYSEY M, Pollard AJ, Sadarangani M, Fanshawe TR, et al
    Prevalence and decay of maternal pneumococcal and meningococcal antibodies: A meta-analysis of type-specific decay rates.
    Vaccine. 2017;35:5850-5857.
    PubMed     Text format     Abstract available


  1057. NIC LOCHLAINN LM, Woudenberg T, van Lier A, Zonnenberg I, et al
    A novel measles outbreak control strategy in the Netherlands in 2013-2014 using a national electronic immunization register: A study of early MMR uptake and its determinants.
    Vaccine. 2017;35:5828-5834.
    PubMed     Text format     Abstract available


  1058. IZURIETA HS, Moro PL, Chen RT
    Hospital-based collaboration for epidemiological investigation of vaccine safety: A potential solution for low and middle-income countries?
    Vaccine. 2017 Oct 12. pii: S0264-410X(17)31365.
    PubMed     Text format    


  1059. BERAUD G
    Mathematical models and vaccination strategies.
    Vaccine. 2017 Oct 12. pii: S0264-410X(17)31393.
    PubMed     Text format     Abstract available


  1060. ENKEL SL, Attwell K, Snelling TL, Christian HE, et al
    'Hesitant compliers': Qualitative analysis of concerned fully-vaccinating parents.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31360.
    PubMed     Text format     Abstract available


  1061. HO HJ, Chan YY, Ibrahim MAB, Wagle AA, et al
    A formative research-guided educational intervention to improve the knowledge and attitudes of seniors towards influenza and pneumococcal vaccinations.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31369.
    PubMed     Text format     Abstract available


  1062. HOWLADER DR, Koley H, Maiti S, Bhaumik U, et al
    A brief review on the immunological scenario and recent developmental status of vaccines against enteric fever.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31319.
    PubMed     Text format     Abstract available


  1063. TAYLOR S, Khan M, Muhammad A, Akpala O, et al
    Understanding vaccine hesitancy in polio eradication in northern Nigeria.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31328.
    PubMed     Text format     Abstract available


  1064. HOSANGADI D, Smith PG, Giersing BK
    Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31343.
    PubMed     Text format     Abstract available


  1065. WU J, Zhao C, Liu Q, Huang W, et al
    Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31371.
    PubMed     Text format     Abstract available


  1066. FUKUSHIMA S, Kiyohara T, Ishii K, Nakano T, et al
    Immunogenicity of aluminum-adsorbed hepatitis A vaccine (Havrix(R)) administered as a third dose after primary doses of Japanese aluminum-free hepatitis A vaccine (Aimmugen(R)) for Japanese travelers to endemic countries.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31357.
    PubMed     Text format     Abstract available


  1067. TIPPINS A, Leidner AJ, Meghani M, Griffin A, et al
    Timeliness of childhood vaccination in the Federated States of Micronesia.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31356.
    PubMed     Text format     Abstract available


  1068. ANA-SOSA-BATIZ F, Johnston APR, Hogarth PM, Wines BD, et al
    Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31315.
    PubMed     Text format     Abstract available


  1069. LI J, Chen S, Ge J, Lu F, et al
    A novel therapeutic vaccine composed of a rearranged human papillomavirus type 16 E6/E7 fusion protein and Fms-like tyrosine kinase-3 ligand induces CD8+ T cell responses and antitumor effect.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31203.
    PubMed     Text format     Abstract available


  1070. HALSTEAD SB
    Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31361.
    PubMed     Text format     Abstract available


  1071. VOORMAN A, Hoff NA, Doshi RH, Alfonso V, et al
    Polio immunity and the impact of mass immunization campaigns in the Democratic Republic of the Congo.
    Vaccine. 2017;35:5693-5699.
    PubMed     Text format     Abstract available


  1072. SCHMIDT SAJ, Vestergaard M, Baggesen LM, Pedersen L, et al
    Prevaccination epidemiology of herpes zoster in Denmark: Quantification of occurrence and risk factors.
    Vaccine. 2017;35:5589-5596.
    PubMed     Text format     Abstract available


  1073. PILEGGI C, Papadopoli R, Bianco A, Pavia M, et al
    Hepatitis B vaccine and the need for a booster dose after primary vaccination.
    Vaccine. 2017 Oct 5. pii: S0264-410X(17)31329.
    PubMed     Text format     Abstract available


  1074. KRACALIK I, Malania L, Broladze M, Navdarashvili A, et al
    Changing livestock vaccination policy alters the epidemiology of human anthrax, Georgia, 2000-2013.
    Vaccine. 2017 Oct 5. pii: S0264-410X(17)31334.
    PubMed     Text format     Abstract available


  1075. MARTINELLI D, Azzari C, Bonanni P, Esposito S, et al
    Impact of Haemophilus influenzae type b conjugate vaccination on hospitalization for invasive disease in children fifteen years after its introduction in Italy.
    Vaccine. 2017 Oct 5. pii: S0264-410X(17)31330.
    PubMed     Text format     Abstract available


  1076. OFORI-ANYINAM O, Leroux-Roels G, Drame M, Aerssens A, et al
    Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults >/=50years of age: Results from a phase III, randomized, non-i
    Vaccine. 2017 Oct 5. pii: S0264-410X(17)31228.
    PubMed     Text format     Abstract available


  1077. WALKER RI, Wierzba TF, Mani S, Bourgeois AL, et al
    Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE Conference.
    Vaccine. 2017 Oct 4. pii: S0264-410X(17)31274.
    PubMed     Text format     Abstract available


  1078. PARRISH-SPROWL J
    Vaccine hesitancy communication: What counts as evidence.
    Vaccine. 2017 Oct 4. pii: S0264-410X(17)31317.
    PubMed     Text format     Abstract available


  1079. SUN J, Li M, Wang Y, Hao P, et al
    Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence.
    Vaccine. 2017 Oct 4. pii: S0264-410X(17)31316.
    PubMed     Text format     Abstract available


  1080. SUN P, Crum-Cianflone NF, Defang G, Williams M, et al
    Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individuals.
    Vaccine. 2017 Oct 4. pii: S0264-410X(17)31307.
    PubMed     Text format     Abstract available


  1081. FLASCHE S
    The scope for pneumococcal vaccines that do not prevent transmission.
    Vaccine. 2017 Oct 3. pii: S0264-410X(17)31326.
    PubMed     Text format     Abstract available


  1082. GESSNER BD, Kaslow D, Louis J, Neuzil K, et al
    Estimating the full public health value of vaccination.
    Vaccine. 2017 Oct 3. pii: S0264-410X(17)31296.
    PubMed     Text format     Abstract available


    September 2017
  1083. SMITH LE, Amlot R, Weinman J, Yiend J, et al
    A systematic review of factors affecting vaccine uptake in young children.
    Vaccine. 2017 Sep 30. pii: S0264-410X(17)31275.
    PubMed     Text format     Abstract available


  1084. FORERO A, Fenstermacher K, Wohlgemuth N, Nishida A, et al
    Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells.
    Vaccine. 2017 Sep 28. pii: S0264-410X(17)31306.
    PubMed     Text format     Abstract available


  1085. DOSHI RH, Eckhoff P, Cheng A, Hoff NA, et al
    Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Vaccine. 2017 Sep 28. pii: S0264-410X(17)31267.
    PubMed     Text format     Abstract available


  1086. LEE CHJ, Duck IM, Sibley CG
    Personality and demographic correlates of New Zealanders' confidence in the safety of childhood vaccinations.
    Vaccine. 2017 Sep 28. pii: S0264-410X(17)31309.
    PubMed     Text format     Abstract available


  1087. DIPASQUALE V, Romano C
    Vaccination strategies in pediatric inflammatory bowel disease.
    Vaccine. 2017 Sep 26. pii: S0264-410X(17)31252.
    PubMed     Text format     Abstract available


  1088. HOGAN AB, Campbell PT, Blyth CC, Lim FJ, et al
    Potential impact of a maternal vaccine for RSV: A mathematical modelling study.
    Vaccine. 2017 Sep 26. pii: S0264-410X(17)31272.
    PubMed     Text format     Abstract available


  1089. HOLBROOK BC, D'Agostino RB Jr, Tyler Aycock S, Jorgensen MJ, et al
    Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6months in a nonhuman primate neonate model.
    Vaccine. 2017 Sep 26. pii: S0264-410X(17)31302.
    PubMed     Text format     Abstract available


  1090. NONZEE NJ, Baldwin SB, Cui Y, Singhal R, et al
    Disparities in parental human papillomavirus (HPV) vaccine awareness and uptake among adolescents.
    Vaccine. 2017 Sep 26. pii: S0264-410X(17)31134.
    PubMed     Text format     Abstract available


  1091. CHAMBERS CD, Xu R, Mitchell AA
    Commentary on: "Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12".
    Vaccine. 2017;35:5323-5324.
    PubMed     Text format    


  1092. DONAHUE JG, Kieke BA, King JP, DeStefano F, et al
    Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12.
    Vaccine. 2017;35:5314-5322.
    PubMed     Text format     Abstract available


  1093. VALLEE-TOURANGEAU G, Promberger M, Moon K, Wheelock A, et al
    Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: Development and validation of two short scales.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31092.
    PubMed     Text format     Abstract available


  1094. KANDEIL A, Mostafa A, El-Shesheny R, El-Taweel AN, et al
    Avian influenza H5N1 vaccination efficacy in Egyptian backyard poultry.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31269.
    PubMed     Text format     Abstract available


  1095. GOUJON C, Gougeon ML, Tondeur L, Poirier B, et al
    CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31295.
    PubMed     Text format     Abstract available


  1096. HALSEY NA, Proveaux T
    Value of an in-depth analysis of unpublished data on the safety of influenza vaccines in pregnant women.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31297.
    PubMed     Text format     Abstract available


  1097. LOW MSF, Tan H, Hartman M, Tam CC, et al
    Parental perceptions of childhood seasonal influenza vaccination in Singapore: A cross-sectional survey.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31308.
    PubMed     Text format     Abstract available


  1098. FINNEY RUTTEN LJ, St Sauver JL, Beebe TJ, Wilson PM, et al
    Association of both consistency and strength of self-reported clinician recommendation for HPV vaccination and HPV vaccine uptake among 11- to 12-year-old children.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31304.
    PubMed     Text format     Abstract available


  1099. RAHAJAMANANA VL, Raboba JL, Rakotozanany A, Razafindraibe NJ, et al
    Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31205.
    PubMed     Text format     Abstract available


  1100. SCHIFFER JT, Gottlieb SL
    Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31273.
    PubMed     Text format     Abstract available


  1101. COX AD, Williams D, Cairns C, St Michael F, et al
    Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: A solution for an unmet public health need.
    Vaccine. 2017 Sep 23. pii: S0264-410X(17)31303.
    PubMed     Text format     Abstract available


  1102. JACOBS DM, Yung F, Hart E, Nguyen MNH, et al
    Trends in pneumococcal meningitis hospitalizations following the introduction of the 13-valent pneumococcal conjugate vaccine in the United States.
    Vaccine. 2017 Sep 23. pii: S0264-410X(17)31298.
    PubMed     Text format     Abstract available


  1103. KIM SY, Nguyen C, Russell LB, Tomczyk S, et al
    Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.
    Vaccine. 2017 Sep 23. pii: S0264-410X(17)31185.
    PubMed     Text format     Abstract available


  1104. MAYERS J, Mansfield KL, Brown IH
    The role of vaccination in risk mitigation and control of Newcastle disease in poultry.
    Vaccine. 2017 Sep 23. pii: S0264-410X(17)31223.
    PubMed     Text format     Abstract available


  1105. KULKARNI PS, Desai S, Tewari T, Kawade A, et al
    A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
    Vaccine. 2017 Sep 23. pii: S0264-410X(17)31230.
    PubMed     Text format     Abstract available


  1106. ZIMMERMAN RK, Raviotta JM, Nowalk MP, Moehling KK, et al
    Using the 4 Pillars Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination.
    Vaccine. 2017 Sep 22. pii: S0264-410X(17)31268.
    PubMed     Text format     Abstract available


  1107. SIRIMA SB, Durier C, Kara L, Houard S, et al
    Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel(R) in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.
    Vaccine. 2017 Sep 22. pii: S0264-410X(17)31247.
    PubMed     Text format     Abstract available


  1108. HANSEN J, Zhang L, Klein NP, Robertson CA, et al
    Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine.
    Vaccine. 2017 Sep 20. pii: S0264-410X(17)31259.
    PubMed     Text format     Abstract available


  1109. TSENG CW, Chiu CJ, Kanci A, Noormohammadi AH, et al
    Safety and efficacy of a Mycoplasma gallisepticum oppD knockout mutant as a vaccine candidate.
    Vaccine. 2017 Sep 20. pii: S0264-410X(17)31171.
    PubMed     Text format     Abstract available


  1110. VENKATRAMAN N, Anagnostou N, Bliss C, Bowyer G, et al
    Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M.
    Vaccine. 2017 Sep 20. pii: S0264-410X(17)31248.
    PubMed     Text format     Abstract available


  1111. MENENDEZ R, Espana PP, Perez-Trallero E, Uranga A, et al
    The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study.
    Vaccine. 2017;35:5264-5270.
    PubMed     Text format     Abstract available


  1112. HOWITZ MF, Harboe ZB, Ingels H, Valentiner-Branth P, et al
    A nationwide study on the impact of pneumococcal conjugate vaccination on antibiotic use and ventilation tube insertion in Denmark 2000-2014.
    Vaccine. 2017 Sep 16. pii: S0264-410X(17)31213.
    PubMed     Text format     Abstract available


  1113. PRINCIPI N, Esposito S
    Influenza vaccine use to protect healthy children: A debated topic.
    Vaccine. 2017 Sep 16. pii: S0264-410X(17)31232.
    PubMed     Text format     Abstract available


  1114. MANDAL S, Campbell H, Ribeiro S, Gray S, et al
    Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine.
    Vaccine. 2017 Sep 16. pii: S0264-410X(17)31241.
    PubMed     Text format     Abstract available


  1115. ZIMMERMANN P, Curtis N
    The influence of probiotics on vaccine responses - A systematic review.
    Vaccine. 2017 Sep 15. pii: S0264-410X(17)31167.
    PubMed     Text format     Abstract available


  1116. MO L, Chen Q, Zhang X, Shi X, et al
    Depletion of regulatory T cells by anti-ICOS antibody enhances anti-tumor immunity of tumor cell vaccine in prostate cancer.
    Vaccine. 2017 Sep 15. pii: S0264-410X(17)31224.
    PubMed     Text format     Abstract available


  1117. SKORSTENGAARD M, Thamsborg LH, Lynge E
    Burden of HPV-caused cancers in Denmark and the potential effect of HPV-vaccination.
    Vaccine. 2017 Sep 15. pii: S0264-410X(17)31160.
    PubMed     Text format     Abstract available


  1118. BOHM K, Filomena A, Schneiderhan-Marra N, Krause G, et al
    Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology.
    Vaccine. 2017 Sep 14. pii: S0264-410X(17)31189.
    PubMed     Text format     Abstract available


  1119. JOO H, Maskery B, Mitchell T, Leidner A, et al
    A comparative cost analysis of the Vaccination Program for US-bound Refugees.
    Vaccine. 2017 Sep 14. pii: S0264-410X(17)31240.
    PubMed     Text format     Abstract available


  1120. TAN S, Zhang S, Wu B, Zhao Y, et al
    Hemagglutinin-specific CD4+ T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans.
    Vaccine. 2017 Sep 13. pii: S0264-410X(17)31159.
    PubMed     Text format     Abstract available


  1121. LISTORTI V, Laconi A, Catelli E, Cecchinato M, et al
    Identification of IBV QX vaccine markers : Should vaccine acceptance by authorities require similar identifications for all live IBV vaccines?
    Vaccine. 2017 Sep 13. pii: S0264-410X(17)30798.
    PubMed     Text format     Abstract available


  1122. EATON A, Lewis N, Fireman B, Hansen J, et al
    Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.
    Vaccine. 2017 Sep 13. pii: S0264-410X(17)31180.
    PubMed     Text format     Abstract available


  1123. BRYSON PD, Han X, Truong N, Wang P, et al
    Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth.
    Vaccine. 2017 Sep 12. pii: S0264-410X(17)31233.
    PubMed     Text format     Abstract available


  1124. FRANKE MF, Jerome JG, Matias WR, Ternier R, et al
    Comparison of two control groups for estimation of oral cholera vaccine effectiveness using a case-control study design.
    Vaccine. 2017 Sep 12. pii: S0264-410X(17)31242.
    PubMed     Text format     Abstract available


  1125. AL-HUMADI N
    Pre-clinical toxicology considerations for vaccine development.
    Vaccine. 2017 Sep 12. pii: S0264-410X(17)31237.
    PubMed     Text format     Abstract available


  1126. KHODR ZG, Bukowinski AT, Gumbs GR, Conlin AMS, et al
    Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections.
    Vaccine. 2017 Sep 12. pii: S0264-410X(17)31129.
    PubMed     Text format     Abstract available


  1127. SUI X, Yan L, Jiang YY
    The vaccines and antibodies associated with Als3p for treatment of Candida albicans infections.
    Vaccine. 2017 Sep 11. pii: S0264-410X(17)31182.
    PubMed     Text format     Abstract available


  1128. ALICINO C, Paganino C, Orsi A, Astengo M, et al
    The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis.
    Vaccine. 2017 Sep 11. pii: S0264-410X(17)31207.
    PubMed     Text format     Abstract available


  1129. ELDEMERY F, Joiner KS, Toro H, van Santen VL, et al
    Protection against infectious bronchitis virus by spike ectodomain subunit vaccine.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31229.
    PubMed     Text format     Abstract available


  1130. MENDEL-VAN ALSTYNE JA, Nowak GJ, Aikin AL
    What is 'confidence' and what could affect it?: A qualitative study of mothers who are hesitant about vaccines.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31222.
    PubMed     Text format     Abstract available


  1131. GIEL-MOLONEY M, Rumyantsev AA, David F, Figueiredo M, et al
    A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31153.
    PubMed     Text format     Abstract available


  1132. ISLAM S, Mohn KG, Krammer F, Sanne M, et al
    Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31132.
    PubMed     Text format     Abstract available


  1133. VORNO T, Lutsar K, Uuskula A, Padrik L, et al
    Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31183.
    PubMed     Text format     Abstract available


  1134. KAILASHIYA C, Sharma HB, Kailashiya J
    Telomerase based anticancer immunotherapy and vaccines approaches.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31227.
    PubMed     Text format     Abstract available


  1135. SOW SO, Steele AD, Mwenda JM, Armah GE, et al
    Reaching every child with rotavirus vaccine: Report from the 10th African rotavirus symposium held in Bamako, Mali.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31184.
    PubMed     Text format     Abstract available


  1136. WILLAME C, Henry O, Lin L, Vetter V, et al
    Pain caused by measles, mumps, and rubella vaccines: A systematic literature review.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31166.
    PubMed     Text format     Abstract available


  1137. WICHMANN O, Vannice K, Asturias EJ, de Albuquerque Luna EJ, et al
    Live-attenuated tetravalent dengue vaccines: The needs and challenges of post-licensure evaluation of vaccine safety and effectiveness.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31164.
    PubMed     Text format     Abstract available


  1138. LEINO T, Baum U, Scott P, Ollgren J, et al
    Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31140.
    PubMed     Text format     Abstract available


  1139. NEUZIL KM, Bresee JS, de la Hoz F, Johansen K, et al
    Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31188.
    PubMed     Text format     Abstract available


  1140. SHAPIRO GK, Guichon J, Kelaher M
    Canadian school-based HPV vaccine programs and policy considerations.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31005.
    PubMed     Text format     Abstract available


  1141. RAVIOTTA JM, Smith KJ, DePasse J, Brown ST, et al
    Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)30977.
    PubMed     Text format     Abstract available


  1142. KROISS SJ, Famulare M, Lyons H, McCarthy KA, et al
    Evaluating cessation of the type 2 oral polio vaccine by modeling pre- and post-cessation detection rates.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)31136.
    PubMed     Text format     Abstract available


  1143. LUZ PM, Johnson RE, Brown HE
    Workplace availability, risk group and perceived barriers predictive of 2016-17 influenza vaccine uptake in the United States: A cross-sectional study.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)31178.
    PubMed     Text format     Abstract available


  1144. WALLDORF JA, Cloessner EA, Hyde TB, MacNeil A, et al
    Considerations for use of Ebola vaccine during an emergency response.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)31156.
    PubMed     Text format     Abstract available


  1145. LIN X, Rodgers L, Zhu L, Stokley S, et al
    Human papillomavirus vaccination coverage using two-dose or three-dose schedule criteria.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)31200.
    PubMed     Text format     Abstract available


  1146. VICKERS ER, McClure DL, Naleway AL, Jacobsen SJ, et al
    Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31186.
    PubMed     Text format     Abstract available


  1147. SUNDARAMURTHI JC, Ashokkumar M, Swaminathan S, Hanna LE, et al
    HLA based selection of epitopes offers a potential window of opportunity for vaccine design against HIV.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31168.
    PubMed     Text format     Abstract available


  1148. ADAMSON PJ, Al Kindi MA, Wang JJ, Colella AD, et al
    Proteomic analysis of influenza haemagglutinin-specific antibodies following vaccination reveals convergent immunoglobulin variable region signatures.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31151.
    PubMed     Text format     Abstract available


  1149. NOWAK GJ, Shen AK, Schwartz JL
    Using campaigns to improve perceptions of the value of adult vaccination in the United States: Health communication considerations and insights.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31162.
    PubMed     Text format     Abstract available


  1150. WOO EJ, Moro PL, Cano M, Jankosky C, et al
    Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31135.
    PubMed     Text format     Abstract available


  1151. WONG LP, Alias H, Hassan J, AbuBakar S, et al
    Attitudes towards Zika screening and vaccination acceptability among pregnant women in Malaysia.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31172.
    PubMed     Text format     Abstract available


  1152. SANTOS JJS, Obadan AO, Garcia SC, Carnaccini S, et al
    Short- and long-term protective efficacy against clade 2.3.4.4 H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31157.
    PubMed     Text format     Abstract available


    August 2017
  1153. FELL DB, Azziz-Baumgartner E, Baker MG, Batra M, et al
    Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group.
    Vaccine. 2017 Aug 31. pii: S0264-410X(17)31125.
    PubMed     Text format     Abstract available


  1154. OHFUJI S, Deguchi M, Tachibana D, Koyama M, et al
    Estimating influenza disease burden among pregnant women: Application of self-control method.
    Vaccine. 2017;35:4811-4816.
    PubMed     Text format     Abstract available


  1155. PATERSON P, Chantler T, Larson HJ
    Reasons for non-vaccination: Parental vaccine hesitancy and the childhood influenza vaccination school pilot programme in England.
    Vaccine. 2017 Aug 14. pii: S0264-410X(17)31083.
    PubMed     Text format     Abstract available


    July 2017
  1156. HE H, Zhou Y, Xie S
    Assessment of the duplicate notifiable reporting of hepatitis B infection in Zhejiang province, China, 2005-2015.
    Vaccine. 2017 Jul 24. pii: S0264-410X(17)30947.
    PubMed     Text format     Abstract available


  1157. MAKARKOV AI, Chierzi S, Pillet S, Murai KK, et al
    Plant-made virus-like particles bearing influenza hemagglutinin (HA) recapitulate early interactions of native influenza virions with human monocytes/macrophages.
    Vaccine. 2017 Jul 13. pii: S0264-410X(17)30908.
    PubMed     Text format     Abstract available


  1158. LI X, Heffelfinger J, Wiesen E, Diorditsa S, et al
    Improving hepatitis B birth dose coverage through village health volunteer training and pregnant women education.
    Vaccine. 2017 Jul 5. pii: S0264-410X(17)30853.
    PubMed     Text format     Abstract available


  1159. ZHOU Y, He H, Deng X, Yan R, et al
    Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
    Vaccine. 2017 Jul 4. pii: S0264-410X(17)30875.
    PubMed     Text format     Abstract available


    June 2017
  1160. YANG M, Dent M, Lai H, Sun H, et al
    Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus.
    Vaccine. 2017 Jun 29. pii: S0264-410X(17)30544.
    PubMed     Text format     Abstract available


  1161. BUHLER S, Lang P, Bally B, Hatz C, et al
    Stop measles in Switzerland - The importance of travel medicine.
    Vaccine. 2017;35:3760-3763.
    PubMed     Text format     Abstract available


  1162. JIMENEZ TRUJILLO I, Lopez de Andres A, Hernandez-Barrera V, Martinez-Huedo MA, et al
    Decrease in the incidence and in hospital mortality of community-acquired pneumonia among children in Spain (2001-2014).
    Vaccine. 2017;35:3733-3740.
    PubMed     Text format     Abstract available


  1163. VENEREO-SANCHEZ A, Simoneau M, Lanthier S, Chahal P, et al
    Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line.
    Vaccine. 2017 Jun 22. pii: S0264-410X(17)30801.
    PubMed     Text format     Abstract available


  1164. SINHA R, Howlader DR, Ta A, Mitra S, et al
    Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity.
    Vaccine. 2017;35:3534-3547.
    PubMed     Text format     Abstract available


  1165. SADAT SMA, Snider M, Garg R, Brownlie R, et al
    Local innate responses and protective immunity after intradermal immunization with bovine viral diarrhea virus E2 protein formulated with a combination adjuvant in cattle.
    Vaccine. 2017;35:3466-3473.
    PubMed     Text format     Abstract available


  1166. KINOSHITA R, Nishiura H
    Assessing age-dependent susceptibility to measles in Japan.
    Vaccine. 2017;35:3309-3317.
    PubMed     Text format     Abstract available


    May 2017
  1167. ZHOU Q, Wang Q, Shen H, Zhang Y, et al
    Rubella virus immunization status in preconception period among Chinese women of reproductive age: A nation-wide, cross-sectional study.
    Vaccine. 2017;35:3076-3081.
    PubMed     Text format     Abstract available


  1168. PRINS W, Butcher E, Hall LL, Puckrein G, et al
    Improving adult immunization equity: Where do the published research literature and existing resources lead?
    Vaccine. 2017;35:3020-3025.
    PubMed     Text format     Abstract available


  1169. TANG L, Zhou Y, Pan Y, Zhu H, et al
    Measles epidemics and seroepidemiology of population in Wujin, Changzhou city, Jiangsu province, China 2015.
    Vaccine. 2017;35:2925-2929.
    PubMed     Text format     Abstract available


  1170. SYED SF, Sun Y, Du T, Chen Y, et al
    Evaluation of recombinant Chinese avian hepatitis E virus (CaHEV) ORF2 and ORF3 proteins for protection of chickens against CaHEV infection.
    Vaccine. 2017 May 18. pii: S0264-410X(17)30638.
    PubMed     Text format     Abstract available


  1171. LI P, Liu Q, Huang C, Zhao X, et al
    Reversible synthesis of colanic acid and O-antigen polysaccharides in Salmonella Typhimurium enhances induction of cross-immune responses and provides protection against heterologous Salmonella challenge.
    Vaccine. 2017;35:2862-2869.
    PubMed     Text format     Abstract available


  1172. TRUCK J, Thompson A, Morales-Aza B, Clutterbuck EA, et al
    Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13.
    Vaccine. 2017;35:2701-2708.
    PubMed     Text format     Abstract available


  1173. DIAZ A, Romero M, Vazquez T, Lechner S, et al
    Metformin improves in vivo and in vitro B cell function in individuals with obesity and Type-2 Diabetes.
    Vaccine. 2017;35:2694-2700.
    PubMed     Text format     Abstract available


  1174. PAL S, Favaroni A, Tifrea DF, Hanisch PT, et al
    Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.
    Vaccine. 2017;35:2543-2549.
    PubMed     Text format     Abstract available


    April 2017
  1175. BAZAN M, Villacorta E, Barbagelatta G, Jimenez MM, et al
    Health workers' attitudes, perceptions and knowledge of influenza immunization in Lima, Peru: A mixed methods study.
    Vaccine. 2017 Apr 21. pii: S0264-410X(17)30485.
    PubMed     Text format     Abstract available


  1176. LAU A, Singh V, Soualhine H, Hmama Z, et al
    Expression of Cathepsin S in BCG converts it into a pro-apoptotic and highly immunogenic strain.
    Vaccine. 2017;35:2060-2068.
    PubMed     Text format     Abstract available


  1177. WHITTAKER R, Dias JG, Ramliden M, Kodmon C, et al
    The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014.
    Vaccine. 2017;35:2034-2041.
    PubMed     Text format     Abstract available


    March 2017
  1178. VAN REGENMORTEL MH
    Immune systems rather than antigenic epitopes elicit and produce protective antibodies against HIV.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30323.
    PubMed     Text format    


  1179. HUANG X, Zhu Q, Huang X, Yang L, et al
    In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.
    Vaccine. 2017 Mar 16. pii: S0264-410X(17)30312.
    PubMed     Text format     Abstract available


    October 2016
  1180. XEUATVONGSA A, Datta SS, Moturi E, Wannemuehler K, et al
    Improving hepatitis B birth dose in rural Lao People's Democratic Republic through the use of mobile phones to facilitate communication.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30883.
    PubMed     Text format     Abstract available


  1181. MAERTENS K, Braeckman T, Top G, Van Damme P, et al
    Maternal pertussis and influenza immunization coverage and attitude of health care workers towards these recommendations in Flanders, Belgium.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30882.
    PubMed     Text format     Abstract available


    July 2016
  1182. RITZ N, Casalaz D, Donath S, Tebruegge M, et al
    Comparable CD4 and CD8 T cell responses and cytokine release after at-birth and delayed BCG immunisation in infants born in Australia.
    Vaccine. 2016 Jul 5. pii: S0264-410X(16)30557.
    PubMed     Text format     Abstract available


    May 2016
  1183. THOMAS RE
    Do we have enough evidence how seasonal influenza is transmitted and can be prevented in hospitals to implement a comprehensive policy?
    Vaccine. 2016 May 9. pii: S0264-410X(16)30271.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: